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Abstract 
Biocatalysis, the use of enzymes to catalyse the generation of specific chemicals, has a number 
of advantages including high specificity, lower energy requirements and greater sustainability 
over an equivalent chemical process. Several methods exist for optimisation of enzymes for 
use in industrial processes, including introduction of mutations to generate libraries of variants 
which are then screened for the desired properties, such as stability or substrate specificity. 
Galactose oxidase catalyses the oxidation of primary alcohols to the corresponding aldehyde, 
with concomitant reduction of dioxygen to hydrogen peroxide. It has already been developed 
for use in a range of biotechnological processes and is an ideal candidate for further 
development due to features including high stability, a surface exposed active site displaying 
broad substrate specificity, and an autocatalytically-generated cofactor. 
Research presented in this thesis investigates the effect on activity towards a range of 
alternative substrates of mutations at selected active site residues with the aim of expanding 
the biotechnological potential of galactose oxidase. Libraries of variants were designed and 
generated using high quality oligonucleotides constructed using trimer phosphoramidites. 
Screening assays used by other groups were optimised by varying different components. These 
assays were then used to identify a number of variants displaying enhanced activity towards D-
arabinose, D-glucose, D-xylose or glycerol. A selection of these variants were then further 
characterised in order to understand the biochemical basis of the altered activities and 
determine some of the conditions required for potential industrial application of the variants. 
The most exciting results include identification of a variant displaying higher levels of activity 
towards glycerol than towards the native substrate D-galactose; determination of the position 
of oxidation of D-arabinose at the C-4 hydroxyl; and the observation that mutation of Phe194 
significantly affects binding of D-glucose in the active site. 
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2 
 
1.1 Exploiting biology for industrial processes 
The use of biology in industrial processes is not a new concept; yeast fermentation in beer and 
bread production and the use of various microorganisms in cheese manufacture has been 
documented for thousands of years. However, within the last century, significant advances 
have been made in the development of biotechnology. The discovery of a fungus which 
produces the antibiotic penicillin in 1928 and its development into a viable therapeutic 
resulted in the award of a Nobel Prize to Fleming, Chain and Florey in 1945. Meanwhile the use 
of mice, and later rabbits, in diagnosis of pregnancy by the Aschheim-Zondek test (Zondek and 
Aschheim, 1927) was used until the development of tests based on antibodies towards human 
chorionic gonadotropin in the 1960s. 
The use of a variety of organisms in removal of environmental pollutants is known as 
bioremediation. While still an emerging area, bioremediation has great potential as a simple, 
cheap and environmentally safe option for removing contaminants such as petroleum 
hydrocarbons, halogenated solvents from industry, heavy metals, explosives and agricultural 
chemicals from the environment (Harms et al., 2011). Bioremediation processes can use 
bacteria, fungi (Harms et al., 2011) or even plants (Meagher, 2000) to either sequester the 
pollutant away from the surrounding environment or convert it to a less toxic species. Brim et 
al. (2000), engineered a bacterium for metal remediation in environments contaminated with 
radioactive material, for example as a result of nuclear weapons production. The mer operon, 
which encodes six proteins conferring mercury resistance, was cloned into the radiation 
resistant bacterium Deinococcus radiodurans and the bacterium was shown to reduce ionic Hg 
(II) to the less toxic Hg (O) while resisting high radiation levels as well as high mercury 
concentrations (Brim et al., 2000). 
Metal and metal oxide nanoparticles have various functions including as antimicrobial agents 
(silver), in sunscreen (zinc oxide), or in electronic data storage (magnetic materials). 
Conventional methods for nanoparticle generation often use harsh methods such as thermal 
decomposition of organometallic compounds in high-boiling organic solvents. These consume 
large quantities of energy and result in significant waste product generation (Lu et al., 2007). 
Magnetic nanoparticles are naturally generated by magnetic bacteria to allow the organisms to 
align with external magnetic fields. Work is underway to optimise generation of these 
nanoparticles which often display better size consistency and biocompatibility than the 
Chapter 1: Introduction 
3 
 
inorganically synthesised equivalents and can be generated under mild conditions with low 
environmental and economic cost (Galloway and Staniland, 2012). 
1.2 Biocatalysis 
Biocatalysis exploits the chemical reactions carried out by enzymes and microbes in order to 
synthesise chemicals for various industries including pharmaceuticals, food and agriculture as 
well as in the manufacture of specialist and commodity chemicals. Use of biological systems 
has a number of advantages over traditional chemical synthesis methods: 
i. High levels of specificity which means that starting products present in a mixture 
can be used to generate the final product. This feature is also exploited in the use 
of enzymes for diagnostic purposes, where the amount of a specific component 
within a mixture such as blood can be determined. The high selectivity, including 
chemoselectivity, stereoselectivity and regioselectivity (where a specific part of the 
substrate is modified), also generally results in low generation of unwanted by-
products, such as different isomeric forms of the desired product, thus reducing 
waste and improving yields - an important consideration in large scale processes.  
ii. Biocatalysts (enzymes and microbes) are biodegradable and the reactions 
catalysed are generally carried out under much milder conditions than the 
equivalent chemical process: neutral pH, aqueous solution, atmospheric pressures 
and ambient temperatures. These conditions result in lower energy and economic 
demands, increased safety and also reduce the impact on the local environment in 
terms of disposal of reaction solutions such as solvents or waste products. Where 
the process requires different conditions, such as the use of solvent for product 
solubility, enzymes can be genetically modified as detailed below. 
iii. The use of enzymes and biological systems can be considered a sustainable 
resource; as a result the process is often cheaper than the use of chemical 
catalysts, such as rare earth metals which are generally expensive due to their 
rarity and complexity of mining. For example vanadium (V) oxide, used to catalyse 
sulfuric acid production at 400-620 °C, has to be purified from the extremely rare 
mineral shcherbinaite (Hughes and Finger, 1983, Thompson, 1931). 
The use of microbes in biocatalysis exploits pathways within organisms which have evolved to 
efficiently generate complex metabolites. Metabolic engineering is generally carried out to 
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optimise production of the chemical via a pathway of enzymes within the host organism, such 
as Escherichia coli or Saccharomyces cerevisiae, or to combine different aspects of pathways 
from different organisms in order to generate a compound not created in nature. The product 
may then be secreted from the host in order to avoid toxicity effects and ease purification. 
Successful examples of metabolic engineering include the generation of potential biofuel 
components from microbial sources such as isopropanol (Hanai et al., 2007, Jojima et al., 2008) 
and 1-butanol (Atsumi et al., 2008, Inui et al., 2008) from E. coli. 1,3-propanediol, an important 
component in the polymer and cosmetic industries, is now exclusively produced by 
microorganisms either from glycerol, a by-product of bio-diesel production (Saxena et al., 
2009), or from D-glucose contained in corn syrup in a process patented by DuPont, Tate & Lyle 
and Genencor International (Nakamura and Whited, 2003). A relatively famous example is that 
of artemisinic acid production by S. cerevisiae. Artemisinin is highly effective in treatment of 
malaria but it is difficult to purify large quantities from the host plant Artemisia annua 
resulting in a high cost of the drug. Metabolic engineering to enable efficient generation of the 
precursor artemisinic acid in S. cerevisiae involved optimisation of the farnesyl pyrophosphate 
biosynthetic pathway and introduction of genes for amorphadiene synthase and a novel 
cytochrome P450 from A. annua (Ro et al., 2006). This has opened the door to reducing the 
cost of the drug with potentially significant effects on global health. 
The use of isolated enzymes in generation of chemicals is generally simpler than the enzyme 
pathways which need to be considered in metabolic engineering projects and there are a 
greater number of success stories. Early examples include the use of cellulases and proteases 
in laundry detergent (Estell et al., 1985) and the production of acrylamide by nitrile hydratase 
(Nagasawa and Yamada, 1989). Some enzymes exist which require little optimisation for use in 
a particular process, for example Sethi et al. (2013) identified an enantioselective 
ketoreductase which can be used to generate an intermediate for the pharmaceutical 
ingredient rivastigmine with >99% enantiomeric excess (Sethi et al., 2013). Extremophilic 
organisms provide a good source of robust enzymes which are often more resilient to the 
conditions required in industrial processes, such as high temperatures, extremes of pH and the 
presence of organic solvents. For example, an aldo-keto reductase from the thermophilic 
organism Thermotoga maritima is stable up to 80 °C and retains 70% activity in solutions 
containing 20% (v/ v) isopropanol or DMSO (Willies et al., 2010). However, where suitable 
enzymes are not available in nature, major developments in bioscience over the last 30 years 
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have led to significant advances in the optimisation of enzymes as discussed in the next 
section. 
1.3 Optimisation of enzymes for biocatalysis 
Numerous factors must be considered in development of enzymes for use in different 
applications as detailed below. 
1.3.1 Immobilisation 
In order to improve the stability of the enzymes, as well as facilitate their reuse in the 
industrial process, technology to immobilise enzymes was developed. Immobilisation of 
enzymes, generally by adsorption, entrapment or cross-linking (Singh et al., 2013) has a 
number of advantages. These include the enhancement of activity, as seen in immobilisation 
of glucose oxidase (Hashemifard et al., 2010, Pandey et al., 2007); improvement of 
thermostability, as seen with lipase from Candida rugosa (Matsumoto and Ohashi, 2003); and 
improved solvent stability, as seen with laccase activity in diethyl ether or ethyl acetate (Ruiz 
et al., 2000). Depending on the method of immobilisation, substrate selectivity may also be 
affected (Singh et al., 2013). 
1.3.2 Traditional directed evolution 
Since the 1980s, enzyme characteristics such as catalytic activity, thermostability, solvent 
resistance and substrate specificity have been targeted for improvement by the development 
of protein engineering technologies. The traditional method for improving enzyme activity is 
directed evolution whereby mutations are introduced at random throughout the DNA 
sequence using iterative cycles of error prone Polymerase Chain Reaction (epPCR) (You and 
Arnold, 1996). Variants displaying desirable changes in activity are identified at each stage by 
screening or selection methods (Section 1.4) and subjected to further rounds of mutagenesis. 
epPCR protocols contain modifications of the standard PCR protocol resulting in enhancement 
of the natural error rate of the polymerase, often Taq polymerase which already displays a 
naturally high error rate. These modifications include increased MgCl2 concentrations, addition 
of MnCl2 at different concentrations, alterations in the ratios of nucleotides in the reaction or 
inclusion of nucleotide analogues such as dITP (Cirino et al., 2003). Other methods of 
introducing mutations randomly across the gene of interest include the use of mutator strains 
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of E. coli such as XL1 Red (Agilent), chemical or physical mutagens such as UV light, or more 
complex methods such as random insertion/ deletion mutagenesis which simultaneously 
deletes part of the sequence at random and inserts a random sequence at the same place 
(Murakami et al., 2002). 
1.3.3 The need for smaller libraries 
The majority of changes in enzyme properties require mutation of more than one residue in 
combination to generate a library of variants. If two substitutions are to be made in a 200-
residue protein, there are over 7 x 106 possibilities while three substitutions results in over 9 x 
109 possibilities (Bornscheuer et al., 2012). In order to statistically screen all possible variants, 
or even a high proportion of variants, ultra high-throughput screening is required and this is 
not possible for many enzyme characteristics (Section 1.4). Introduction of mutations by epPCR 
can also lead to a significant bias towards the introduction of certain residues in a sequence for 
three distinct reasons (Neylon, 2004). The first is that the polymerase used can display a 
preference for AT to GC substitutions or vice versa and the position of the mutation can also 
be affected by surrounding sequence, meaning randomisation to every amino acid is not 
equally likely at each position. The second source of bias comes from the genetic code which 
displays a significant codon bias, for example there are six codons for arginine but only one for 
tryptophan. Mutation of a single nucleotide of the valine codon GTT can form a codon for Phe, 
Leu, Ile, Ala, Asp or Gly, however two substitutions are required for most other residues and 
three changes are necessary to form codons for Gln, Trp or Lys. The final source of bias is 
introduced via the mutagenesis protocol due to the exponential nature of PCR - mutations 
introduced early in the amplification process will be over-represented in the final library. 
1.3.4 Reducing the bias problem 
Bias introduced by the polymerase used in epPCR can be reduced by use of an engineered 
polymerase, such as Mutazyme (Stratagene), in combination with Taq polymerase (van Hercke 
et al., 2005). An alternative method of introducing mutations across the sequence without the 
bias of polymerases was developed by the Schwaneberg group (Wong et al., 2004). Sequence 
saturation mutagenesis (SeSaM) introduces a universal base such as inosine at random 
positions and then replaces this base with random nucleotides. 
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Site-directed mutagenesis, whereby mutation(s) are introduced at a specific position using 
oligonucleotides containing the mutated codon (Figure 1.1) was originally developed by 
Michael Smith, for which he shared the 1993 Nobel Prize in Chemistry. This method has proved 
invaluable in structure-function studies of proteins as well as in mutant library generation.  
 
Figure 1.1. Schematic illustrating the Quikchange approach to site-directed mutagenesis 
A plasmid containing the coding region of interest (A) is denatured and oligonucleotide 
primers, both containing the desired mutation (red), are annealed (B). A heat-stable DNA 
polymerase is used to extend and incorporate the mutagenic primers (C) to generate 
two circular strands which contain nicks (green). DpnI digestion is then carried out to 
remove the parental DNA (black) (D) and the circular strands containing the mutation in 
both strands are transformed into E. coli (E). 
 
Saturation mutagenesis, whereby particular residue(s) are mutated to each of the other 19 
amino acids, is a well used technique in library construction. Oligonucleotides are generated as 
for site-directed mutagenesis but, instead of a specific codon being introduced at the position 
of interest, a mixture of nucleotides is provided during oligonucleotide synthesis. If the full 
mixture of four nucleotides is provided for all three positions the codon is written as NNN 
(where N = any nucleotide). As before, generation of libraries by this method will lead to 
significant codon bias and also results in a 3/ 64 chance of stop codon incorporation. It is 
therefore more common to limit the mixture of nucleotides at the third position by using NNK 
or NNS codons (where K = T or G and S = G or C). These degenerate codons encode all 20 
amino acids but with only 32 codons, resulting in reduced over-representation of the most 
common residues. The probability of stop codon incorporation is also reduced to 1/ 32. 
Unfortunately, there is still some level of codon bias in the NNK/ S libraries which caused Reetz 
and co-workers to develop the NDT codon (where D = A, G or T) (Reetz et al., 2008). This 
degenerate codon encodes 12 amino acids using 12 codons with no stop codons: Phe, Leu, Ile, 
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Val, Tyr, His, Asn, Asp, Cys, Arg, Ser and Gly. The 12 residues include examples of all the 
different amino acid characteristics and exclude most cases of structural similarity. The NDT 
codon was shown to generate a much higher quality library (measured by frequency of 
positive variants and magnitude of improvement) than the equivalent NNK library in 
mutagenesis of the epoxide hydrolase from Aspergillus niger (Reetz et al., 2008). Subsequent 
development in the Reetz group has led to a further reduction in library redundancy by ‘the 
22-codon trick’ which uses a combination of the degenerate codons NDT, VHG (where V = A, C 
or G and H = A, T or C) and TGG resulting in 22 possible codons encoding all 20 amino acids, no 
stop codons, and only Val and Leu encoded by more than one codon (Kille et al., 2013). 
A method for completely removing the codon bias problem involves the use of trimer 
phosphoramidites in oligonucleotide synthesis. Instead of adding one nucleotide at a time, the 
oligonucleotide is constructed one codon at a time. This means that no stop codons are 
incorporated, the codons can be optimised for expression in the host organism (i.e. E. coli), 
and multiple randomised codons can be included in one oligonucleotide. By this method, it is 
possible to exquisitely control the mutation at the desired position(s) i.e. the proportion of WT 
to mutated sequence can be varied as well as inclusion of only a subset of codons if desired. 
Each residue is equally likely to appear at the randomised position. Despite a number of 
available protocols for production of randomised oligonucleotides by this method (Gaytan et 
al., 1998, Janczyk et al., 2012, Kayushin et al., 2000, Yagodkin et al., 2007), the complexity and 
relatively high cost of the process limits their use in mutagenesis projects. In laboratories 
without access to DNA synthesising equipment, oligonucleotides generated using trimer 
phosphoramidites can be sourced from companies such as Ella Biotech GmbH.  
Another similar method, called the MAX method, which only requires simple primers was 
developed by the Hine group (Hughes et al., 2003) (Figure 1.2). A template oligonucleotide is 
generated covering the region to be mutated and the codons targeted for randomisation are 
replaced with the NNN codon. A set of 20 primers for each position targeted are synthesised, 
each containing a codon for a different residue optimised for expression in E. coli (termed MAX 
codons). These primers are then hybridised to the template containing the NNN codons and 
ligated together. PCR is then carried out to replace the template strand, resulting in a double 
stranded fragment containing mutations at the desired positions ready for cloning. 
Unfortunately this method cannot be used to randomise adjacent codons independently and, 
depending on the number of codons to be randomised, may require generation of a very large 
number of primers. 
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Figure 1.2. Schematic illustrating the MAX method of library generation 
Copied from Neylon (2004). A description of the method is given in the text. MAX codons 
for Ala, Cys, Asp and Trp are shown as an example. 
 
1.3.5 Combining beneficial mutations 
A range of methods exist for combining selected point mutations in random combinations. 
These same methods are also used in generating libraries by recombination of similar genes 
from different sources. The most popular and straightforward recombination technique is DNA 
shuffling (Figure 1.3, left) which was pioneered by Willem P. C. Stemmer in the 1990s 
(Stemmer, 1994a, Stemmer, 1994b). The technique involves deoxyribonuclease I digestion of 
the DNA sequences to be combined to generate random fragments. The fragments are then 
size fractionated, mixed and repeated cycles of melting, annealing and extension carried out to 
reassemble the fragments. Recombination occurs at regions of high sequence identity causing 
fragments from different parents to anneal. PCR amplification of the recombined sequence is 
then carried out followed by cloning.  
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Figure 1.3. Schematic illustration of DNA shuffling (left) and StEP (right) 
Copied from Neylon (2004). A description of each method is given in the text. 
 
A related method developed in the lab of Frances Arnold (Zhao et al., 1998) is termed the 
Staggered Extension Process (StEP) (Figure 1.3, right). Here, gene fragments are extended by 
repeated cycles of melting, annealing and extension as before, but the duration and 
temperature of the extension steps results in only partial elongation of the growing strand 
before melting and annealing to a different strand with potentially different mutation(s). 
Libraries generated by both DNA shuffling and StEP are prone to bias as different mutations 
will recombine more easily than others based on their position within the sequence (Maheshri 
and Schaffer, 2003, Moore et al., 2001, Moore and Maranas, 2002). A number of variations 
have therefore been developed including Random Chimeragenesis on Transient Templates 
(RaChiTT) which is designed to enhance the number of cross-overs; and the three similar 
methods Degenerate Homoduplex Recombination (Coco et al., 2002), Synthetic Shuffling (Ness 
et al., 2002) and Assembly of Designed Oligonucleotides (Zha et al., 2003) which remove the 
potential for bias in the generated library. A number of methods also exist for generation of 
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libraries by homology-independent recombination, including Incremental Truncation for the 
Creation of Hybrid enzymes (ITCHy) (Ostermeier et al., 1999) and Sequence Homology-
Independent Protein Recombination (SHIPRec) (Sieber et al., 2001). 
1.3.6 Design of mutagenesis strategies 
As discussed by Manfred Reetz (Reetz et al., 2008), there are a number of factors to consider 
when designing a mutagenesis strategy. The size of the library is often dictated by the 
screening or selection method which will be used to identify clones showing the desired 
activity (Section 1.4). Changes in certain enzyme characteristics such as enantioselectivity and 
regioselectivity can often only be detected by relatively low-throughput techniques such as gas 
chromatography (GC) and high performance liquid chromatography (HPLC) and so library sizes 
must be kept small. The consideration of the ‘completeness’ of library screening is also 
important. Work by different groups (Bosley and Ostermeier, 2005, Patrick et al., 2003, Patrick 
and Firth, 2005) has led to the development of algorithms which can be used to estimate the 
number of variants that need to be screened in order to statistically sample a given percentage 
of the possible variants. Regardless of codon usage or mutagenesis method, it is necessary to 
screen at least a three-fold excess of transformants in order to statistically cover 95% of the 
library (Reetz et al., 2008).  
While it is possible to apply saturation mutagenesis to every residue in an enzyme individually 
(Funke et al., 2003), even for small proteins this still requires a large amount of time and effort 
and is perhaps not the most sensible use of resources. The rapidly increasing amount of 
information from sequencing, structural and biochemical studies can also aid in the design of 
so called ‘smart’ libraries where a selection of specific residues are chosen to be mutated. The 
residues they will be mutated to is also often limited based on what is considered most likely 
to have a positive effect on the characteristic to be altered (Reetz and Carballeira, 2007). 
Alignments of protein sequences of enzymes from the same family can be used to identify the 
residues present at a given position in the common ancestor which is likely to display greater 
thermostability (Miyazaki et al., 2001). An example of such an approach is 3-isopropylmalate 
dehydrogenase where six mutants showed greater thermal stability than the original enzyme 
after substitution with an ancestral amino acid (Watanabe et al., 2006). Sequence alignments 
of enzymes within a family have also been used by other groups to identify the residues 
permitted at specific positions, resulting in generation of higher quality libraries i.e. more 
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variants displaying improved thermostability (Amin et al., 2004), activity or enantioselectivity 
(Reetz and Wu, 2008). 
The use of alignments in library design has also been used with structural data. In work 
presented by Jochens and Bornscheuer (2010) the amino acids present at four positions of 
interest in Pseudomonas fluorescens esterase were determined in 1751 structurally related 
enzymes identified using the 3DM software (Kuipers et al., 2010). Libraries were designed 
whereby the residues at each of the four positions were only randomised to those which 
appeared frequently at structurally equivalent positions. The resulting library contained 
significantly more variants showing improved activity and/ or enantioselectivity than control 
libraries which either included all 20 residues, or only those occurring rarely at the selected 
positions. Other structural analyses have also been used in library design, such as the B-FIT test 
(Reetz et al., 2006a) which identifies amino acids based on their flexibility in the crystal 
structure (higher flexibility is indicated by higher B-factors). Reetz and co-workers successfully 
demonstrated that saturation mutagenesis of the surface residues showing highest flexibility in 
Bacillus subtilis lipase A resulted in variants displaying significantly improved thermostability 
(Reetz et al., 2006a). Structural data and homology models, especially of enzyme-substrate 
complexes, are particularly useful in identifying which residues are involved in substrate 
binding and catalysis. Along with biochemical and functional studies, this information can be 
used in rational design of libraries which include or exclude particular residues. For example, 
solution of the crystal structure of the serine:pyruvate aminotransferase from Sulfolobus 
sulfataricus and comparison with the closely related alanine:glyoxylate aminotransferase, 
combined with biochemical studies, identified the structural features likely to determine 
substrate specificity which could be targeted for mutagenesis in the future with the aim of 
introducing activity against different substrate(s) (Sayer et al., 2012). 
The use of computational techniques is an emerging area in the rational design of mutant 
libraries. Modelling of mutations within the enzyme active site using programs such as Coot 
(Emsley et al., 2010) and docking of different substrates, for example using Auto Dock 4.2 
(Sanner, 1999) can greatly reduce the number of mutants which need to be synthesised in the 
lab. Substrate docking was used in the redesign of isomaltulose synthase to identify residues 
which could be changed to permit synthesis of isomelezitose, a potential sucrose alternative 
(Gorl et al., 2012). In another study, the generation of the potential anti-tumour substance 
perillyl alcohol by cytochrome P450 monoxygenase 102A1 was achieved following multiple 
rounds of molecular modelling using the Amber 9 molecular dynamics simulation program 
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(ambermd.org) (Seifert et al., 2011). Numerous computational tools and algorithms have been 
developed to help in the design of mutant libraries such as HotSpot wizard (Pavelka et al., 
2009), ProSAR (Fox et al., 2007) and PoPMuSic 2.1 (Dehouck et al., 2011). There is also an 
increasing interest in design of de novo enzymes by computational methods (Kries et al., 2013) 
and some significant successes have been reported (Jiang et al., 2008, Rothlisberger et al., 
2008, Siegel et al., 2010). 
Numerous examples exist where mutation of multiple residues in combination leads to higher 
quality libraries than when only one residue is targeted at a time. This is not surprising given 
that residue changes often have synergistic effects on the environment and conformation of 
other nearby residues in the structure (Reetz et al., 2005). In a study to alter the 
enantioselectivity of P450-BM3 monoxygenase a series of single and double mutants were 
generated. The greatest shifts were observed with the double mutants in all but one case 
(Agudo et al., 2012). Unfortunately, mutation of multiple residues simultaneously can lead to 
large libraries which are difficult to screen effectively. In order to reduce this problem, Reetz et 
al. developed iterative saturation mutagenesis (ISM) (Figure 1.4) (Reetz et al., 2006b, Reetz et 
al., 2006a). This technique involves first identifying a number of regions or positions to target 
based on the characteristic to be altered – each site consists of one or more amino acids. 
Saturation mutagenesis is then carried out at each of the sites independently to generate a 
number of small libraries which are screened and the best hit identified from each library. Each 
of these hits is then used in another round of randomisation at one of the different sites (it is 
possible, but not essential to randomise all of the different sites in combination with the initial 
hit). The libraries are then screened and hits identified to take forward to the next round. The 
process can be continued as many times as desired. ISM was successfully used to increase the 
stability of lipase from B. subtilis towards the organic solvents acetonitrile, dimethylsulfoxide 
and dimethylformamide (Reetz et al., 2010). 
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Figure 1.4. Schematic illustration of ISM whereby four sites were randomised: A, B, C and D 
Copied from Reetz and Carballeira (2007). A description of the method is given in the 
text. 
 
Another significant contribution from the Reetz group is the Combinatorial Active-site 
Saturation Test (CAST) (Reetz et al., 2005) which is designed to alter the substrate acceptance 
and/ or enantioselectivity of an enzyme. As mentioned above, randomisation of multiple 
residues at the same time allows for synergistic conformational effects from side chains of 
nearby residues which are otherwise difficult to predict in rational library design (Reetz et al., 
2005). The CASTing procedure involves generation of a number of small libraries, each 
constructed by simultaneous saturation mutagenesis of two or three residues adjacent to each 
other in the 3D structure with side chains occurring next to the substrate binding site. 
Depending on the structural element (loop, β-sheet, α-helix, 310 helix), the residues may or 
may not be adjacent in the protein sequence so structural analysis is essential in design of 
CASTing libraries. Following identification of hits within the CASTing libraries, the technique 
may be combined with ISM to further alter the substrate scope. Significant success has been 
reported by various groups using this method, such as enhancement of lipase activity towards 
various substrates (Reetz et al., 2005), and development of an amine dehydrogenase 
(Abrahamson et al., 2012). 
There are numerous examples of rational design strategies where a combination of techniques 
have been employed, such as in the enhancement of the substrate scope of transketolase 
(Ranoux et al., 2012) where in silico docking experiments, sequence alignments and ISM were 
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all used to generate multiple variants with altered activities. epPCR is often used to identify 
residues of interest which are then incorporated into rational library design. A frequently 
quoted and relatively high profile example is the engineering of a transaminase to produce the 
antidiabetic compound sitagliptin (Savile et al., 2010) (Figure 1.5). The inability of the WT 
transaminase to bind pro-sitagliptin ketone was explored by docking studies and residues were 
identified for mutagenesis. Saturation mutagenesis was then carried out on a number of 
residues in the binding pocket, both individually and in a combinatorial approach, to generate 
variants showing a 75-fold enhancement in activity. Further evolution of the best variant by 
methods including random mutagenesis and DNA shuffling optimised the enzyme for use in 
industrial processes by improving its tolerance to high substrate and product concentrations, 
organic solvents and increased pH and temperature. The final biocatalyst contained 27 
mutations and resulted in improved yield and productivity and reduced waste and cost 
compared to the previously used synthetic process as well as the elimination of heavy metals 
(rhodium) and the need for specialised high pressure hydrogenation equipment (Hansen et al., 
2009). 
 
Figure 1.5. A schematic of the engineering of transaminase to catalyse production of 
sitagliptin 
Taken from Lutz (2010). Initial stages of the enzyme engineering involved rational design 
and mutagenesis to introduce activity towards pro-sitagliptin ketone: mutations 
introduced are shown in red. The activity was then optimised for industrial manufacture 
of sitagliptin by numerous rounds of directed evolution: mutations introduced are 
shown in yellow, many occurred away from the substrate binding site at the dimer 
interface. 
 
1.3.7 The argument for ‘blind’ evolution 
Where limited information is available on the chosen enzyme, and particularly where there is 
no structural information, random mutagenesis methods such as epPCR are often the only 
option for introduction of new activities. The large number of successful studies where enzyme 
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activity was altered by such methods confirms the continuing value of ‘blind’ evolution, 
compared to rational design (Arnold, 1998). Arnold wrote in 1998 of our “dismally sparse 
understanding of protein structure-function” which, despite major advances in the last two 
decades, is still a limitation in rational design projects. Many protein features, especially 
resistance to high temperatures or organic solvents, are often dictated by residues found away 
from the substrate binding site and catalytic residues of the enzyme making them difficult to 
predict. Within the enzyme structure, more residues occur far from the active site than close 
to it so random mutagenesis will statistically target more distant mutations than close ones 
(Morley and Kazlauskas, 2005). In general, residues involved in determining enantioselectivity, 
regioselectivity and substrate selectivity occur in the first coordination sphere or have their Cα 
within 10 Å of the substrate or key catalytic residues (Morley and Kazlauskas, 2005). However, 
there are examples where this is not the case. Distant residues can often affect catalysis due to 
major structural rearrangements, changes at the subunit interface or by affecting protein 
folding (Horsman et al., 2003). However, in many cases the changes are due to more subtle 
effects. For example, in β-lactamase the hydrogen bonding network which determines the 
position of the catalytic residue Arg244 was disrupted by mutation of the second sphere 
residue Asn276 (Bonomo et al., 1995). In mitochondrial creatine kinase a P207A mutation, 
which is over 15 Å from the active site, resulted in reduced activity and a shift in the pH 
optimum, presumably due to changes in long range electrostatic interactions (Forstner et al., 
1998). 
In summary, long range interactions can have significant effects on enzyme function which are 
difficult to predict with the current level of understanding of how enzyme structure relates to 
function. The easiest way to identify residues involved in these relatively unpredictable effects 
is by random mutagenesis methods such as epPCR. 
1.3.8 Enzymes in industrial processes 
Optimisation of catalysis of a specific reaction by an enzyme does not necessarily mean the 
enzyme is suitable for use in industrial processes. Numerous other factors, such as high 
turnover numbers, stability over longer time periods (hours, days or weeks) and resistance to 
harsh reaction conditions such as pH, temperature or organic solvents, also need to be 
considered. As mentioned in Section 1.3.1, immobilisation is often used to improve stability 
and other characteristics as well as reduce enzyme loss and many studies where various 
characteristics were optimised for industrial processes have been reported, such as for 
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sitagliptin (Section 1.3.6). If the enzyme is not optimised for the industrial process it may be 
necessary to increase the amount added which, even with cheaply available enzymes, will 
increase the cost of the process. As stated by Woodley (2013) typical examples of operating 
conditions that may be used in a biocatalytic process include: 
 High concentrations of substrate and product (typically 50-400 g/ L, depending on 
application) 
 High salt concentration 
 Temperature and pH determined by substrate and product solubility and stability 
 Gas-liquid interface (for reactions consuming or producing gas) 
 Liquid-liquid interface (for aqueous-organic two-liquid phase reactions where organic 
phase is used as a carrier for the substrate and/ or product) 
 Organic solvent (for assistance in solubilising substrates) 
 Heterogeneity of temperature, pH and concentration of substrate and product (for 
large scale applications limited by mixing) 
It is therefore generally important that the developed biocatalyst does not display substrate or 
product inhibition and is optimised for the required conditions of the process. While it is 
becoming increasingly possible to optimise the enzyme for the biocatalytic process, rather 
than vice versa (Bornscheuer et al., 2012), some limitations still exist such as the reaction 
vessel used. There are generally three types of reaction vessel: batch stirred tank reactor, 
continuous stirred tank reactor and continuous packed bed reactor, all of which require stable 
enzymes which are active at high substrate and/ or product concentrations (Woodley, 2013). 
1.4 Screening for altered activities 
A significant factor of any enzyme engineering project is how variants displaying the desired 
properties will be identified. The number of variants which can realistically be screened 
frequently determines the library generation method. For example, identifying changes in 
enantioselectivity can often only be carried out using HPLC and/ or GC and therefore two-stage 
screening is often carried out whereby the first screen identifies variants showing any activity 
and the second screen identifies changes compared to WT (van Leeuwen et al., 2012).  
  
Chapter 1: Introduction 
18 
 
1.4.1 Selection techniques 
Selection techniques provide a simple method for analysing large libraries efficiently, however 
the improved or acquired enzyme function must have a direct link with cell growth limiting the 
widespread use of these techniques (Leemhuis et al., 2009). Selection techniques are most 
frequently used in studies which aim to alter the substrate specificity of an enzyme (Griffiths et 
al., 2004, McLoughlin et al., 2005, Evnin et al., 1990). For example Bornscheuer and co-workers 
developed a selection method when introducing epoxide hydrolase activity into Pseudomonas 
fluorescens esterase (Jochens et al., 2009). Colonies expressing the variants could only grow on 
plates containing toxic glycidol butyrate if they displayed epoxide hydrolase activity which 
converted it to glycerol butyrate which could be used as a carbon source. Selection methods 
have also been used to identify changes in enantioselectivity, such as in the improvement of 
enantioselectivity of Bacillus subtilis lipase A. Aspartate auxotroph E. coli expressing variants 
showing activity against the (R)-enantiomer were unable to grow on plates containing the toxic 
phosphonate ester of (R)-(-)-1,2-O-isopropylidene-sn-glycerol while variants active against the 
(S)-enantiomer were selected for by inclusion of the aspartate ester of (S)-(+)-1,2-O-
isopropylidene-sn-glycerol (Boersma et al., 2008). 
1.4.2 Screening techniques 
The use of screening techniques is much more common and there are a wide variety of 
examples with different benefits and limitations. The most simplistic screening format is agar 
plate based screening. Here colonies expressing the library variants are incubated with the 
enzyme substrate, or an analogue, resulting in a visual signal such as formation of colour or 
fluorescence. The signal may be generated by formation of a coloured product, either directly 
by the enzyme being screened (Parikh and Matsumura, 2005) or by another enzyme which 
uses a product of the reaction to convert a colourless substrate to a coloured product. An 
example of this was used by Alexeeva et al. (2002) to identify enantioselective amine oxidases. 
E. coli BL21 expressing the mutant library was plated out onto nitrocellulose filters on agar 
plates before cell lysis and addition of an assay mix containing the D- or L-enantiomer of the 
substrate, horseradish peroxidase (HRP) and 3,3’-diaminobenzidine (DAB). Hydrogen peroxide 
generated by any variants showing activity was used by HRP to oxidise DAB to a coloured 
product (Alexeeva et al., 2002) (Figure 1.6). A coloured product may also be generated as a 
result of pH change brought about by the catalysed reaction. A pH indicator is then used to 
identify colonies expressing active variants (Ben-David et al., 2008).  
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Figure 1.6. The coupled assay to detect oxidase activity used in many screening methods 
Hydrogen peroxide produced as a by-product of the oxidation reaction is used to convert 
a colourless substrate such as DAB into a coloured product in a reaction catalysed by 
HRP. 
 
The major advantage of agar plate-based screening is its simplicity. However, it does have the 
disadvantage of a limited dynamic range, i.e. while active versus inactive variants can be easily 
distinguished, relative levels of activity are generally not possible to measure. As a result, 
microtitre plate-based screening has developed as the most commonly applied technique in 
library screening (Leemhuis et al., 2009). Each well of the plate is inoculated with a single 
transformant expressing a different variant. The enzyme is either secreted into the growth 
medium or cells are lysed and, following centrifugation, the supernatant is added to a separate 
assay plate. Activity is detected by similar methods to the agar plate-based screens including 
use of pH indicators and colorimetric substrates which can be detected spectrophotometrically 
such as phenol red (Yi et al., 2012) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 
diammonium salt (ABTS) (Torres-Salas et al., 2013). In directed evolution of a 
glycosyltransferase to expand the substrate promiscuity, a microtitre plate-based assay was 
used which measured the loss of fluorescence upon catalysis with various UDP-sugars as 
donors and the fluorescent coumarin 4-methylumbelliferone as acceptor (Williams et al., 
2007). Microtitre plate-based screening has the advantage that analytical methods can be used 
to measure enzyme activity and relative activities of different variants compared to WT can 
accurately be measured. However, the relatively low throughput of ~104 variants per day has 
led to the development of various ultra-high throughput screening methods. 
The most successful ultra-high throughput methods use fluorescence activated cell sorting 
(FACS) which permits screening of libraries of up to 109 or even 1010 variants (Leemhuis et al., 
2009). Kolmar and co-workers labelled the two enantiomers of 2-methyldecanoic acid so that 
hydrolysis by Pseudomonas aeruginosa esterase A gave rise to green or red fluorescence. 
Esterase variants were expressed on the cell surface and, if hydrolysis of the substrate was 
catalysed, the red or green fluorescent product was immediately attached to a tyrosine 
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residue on the cell surface via radical formation catalysed by cell surface-expressed peroxidase 
(Figure 1.7) (Becker et al., 2007). Cells expressing variants active against each enantiomer 
could then be separated by FACS (Becker et al., 2008). 
 
Figure 1.7. The reactions that lead to hydrolysis of the substrate and covalent attachment of 
the product to the cell surface 
Taken from Becker et al. (2008). The esterase (E) cleaves the fluorescently labelled 
substrate. The product is then oxidised by peroxidase (P) to form a radical species which 
covalently attaches to a cell surface-displayed tyrosine. 
 
Other methods which use FACS involve water-in-oil droplets which each contain a single 
bacterial cell expressing a different variant. The fluorescent product generated by variants 
active against the given substrate remains in the same droplet as the cell which can then be 
isolated by FACS (Aharoni et al., 2005). A similar method designed previously by the same 
group involved a cell-free water-in-oil droplet system whereby each droplet contained a 
different gene (as linear DNA) and a translation/ transcription mixture, resulting in multiple 
copies of the encoded variant which is retained within the droplet ready for FACS (Tawfik and 
Griffiths, 1998). There are numerous successful examples of this in vitro compartmentalisation 
being used in library screening (Taly et al., 2007, Leemhuis et al., 2005). 
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1.5 Enzyme cofactors 
The functional groups of the 20 standard amino acids found within enzymes are capable of 
participating in acid-base reactions, charge-charge interactions and some group transfer 
reactions. However, a variety of reactions, including oxidation-reduction and group transfer 
processes, require the presence of small molecule cofactors (Voet and Voet, 1995). The 
majority of enzymes explored for biocatalytic processes utilise cofactors such as the organic 
compounds nicotinamide adenine dinucleotide (NAD(H)) and adenosine 5’-triphosphate (ATP) 
(Liu and Wang, 2007). The high cost of these cofactors can have significant implications for the 
economic feasibility of the biocatalytic process and, as such, the area of cofactor regeneration 
is a significant area of research (Zhao and van der Donk, 2003). A number of different 
regeneration processes have been developed, for example fusion of the biocatalyst with a 
reductase (Schuckel et al., 2012), development of robust cofactor-regenerating enzymes to 
include in the reaction vessel (Vazquez-Figueroa et al., 2007), and immobilisation-based 
techniques (Ngamsom et al., 2010). 
There are a number of enzymes which contain cofactors generated by post-translational 
modification of encoded residues, rather than acquiring the cofactor from exogenous sources 
(Figure 1.8). A number of different residues can be modified to form these cofactors including 
serine in histidine decarboxylase (van Poelje and Snell, 1990), cysteine in various sulfatases 
(Schmidt et al., 1995) and lysine in ribulose-1,5-bisphosphate carboxylase (RuBisCo) (Taylor 
and Andersson, 1997). Numerous examples also exist of the formation of a cross-link between 
two residues to form protein-derived cofactors such as His-Tyr in catalase HPII from E. coli 
(Bravo et al., 1997) and cytochrome c oxidase (Ostermeier et al., 1997) and Tyr-Lys in lysyl 
oxidase (Wang et al., 1996).  
Formation of protein-derived cofactors often requires additional proteins; for example, 
biogenesis of tryptophan tryptophylquinone from two active site tryptophans in methylamine 
dehydrogenase requires four gene products (van der Palen et al., 1997, van der Palen et al., 
1995, Wilmot and Davidson, 2009). However, for some cofactors generation is self-catalysed 
and only requires components already present in the enzyme – this feature gives the enzymes 
great potential for development for the biocatalysis industry. An example of a self-processing 
enzyme is the copper amine oxidase family which contains a 2, 4, 5-trihydroxyphenylalanyl 
quinone cofactor. This is generated spontaneously in the presence of oxygen and copper from 
a highly conserved active site tyrosine (DuBois and Klinman, 2005). 
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Figure 1.8. Structures of protein-derived cofactors from ten different enzymes 
Adapted from Okeley and van der Donk (2000). 
 
1.5.1 Metalloenzymes 
Proteins incorporate metal ions for a number of different functions (Holm et al., 1996): 
i) Structural roles 
ii) Storage and/ or transport, such as metallothioneins which sequester zinc, 
cadmium and copper ions 
iii) Electron transfer, such as plastocyanin in photosynthesis 
iv) Dioxygen binding, such as haemoglobin 
v) Catalytic roles including substrate binding, activation and turnover 
Up to a third of all enzymes use metal ion cofactors for catalytic roles (Voet and Voet, 1995) 
making the study of metalloenzymes a significant research area. Alkali and alkaline earth metal 
ions such as sodium, magnesium and calcium are generally loosely bound to the enzyme. 
Transition metal ions such as iron, cobalt, vanadium and copper are often found tightly bound 
at the active site via coordination by specifically orientated amino acid side chains. The ions 
may be directly incorporated into the protein, or may form part of prosthetic groups or 
complexes. Iron-containing enzymes are perhaps the most extensively studied of 
metalloenzymes due to their essential roles in generation of ATP via the haem-containing 
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cytochromes. The structure of the haem prosthetic group is shown in Figure 1.9. Other haem-
containing enzymes include peroxidases and oxidoreductases, such as hydroxylamine 
oxidoreductase (Igarashi et al., 1997). There are also examples of iron-containing proteins 
where the metal ion is directly incorporated into the enzyme such as naphthalene 1,2-
dioxygenase (Karlsson et al., 2003) and protocatechuate 3,4-dioxygenase (Vetting et al., 2000).  
 
Figure 1.9. Structures of the haem (left) and cobalamin (right) prosthetic groups 
Taken from Roper et al. (2000). 
 
Cobalt generally exists within enzymes as coenzyme B12 (cobalamin) (Figure 1.9) which is found 
in three different enzyme subfamilies: adenosylcobalamin-dependent isomerases, 
methylcobalamin-dependent methyltransferases and the dehalogenases (Banerjee and 
Ragsdale, 2003). The incorporation of vanadium into enzymes is relatively rare although a key 
example is the vanadium haloperoxidases, originally identified in seaweed (Vilter, 1984, de 
Boer et al., 1986). These enzymes catalyse the two electron oxidation of halides and may be of 
biotechnological interest due to their high stability and resistance to high substrate (hydrogen 
peroxide) and product (hypohalous acid) concentrations (Vollenbroek et al., 1995, van 
Schijndel et al., 1994, Liu et al., 1987) as well as their ability to halogenate compounds of 
potential industrial interest (Littlechild et al., 2002). 
Copper-containing enzymes are widespread in nature due to their ability for involvement in 
redox reactions and the high solubility of copper oxides (MacPherson and Murphy, 2007). 
Fe(III)/ Fe(II) redox pairs are used for many enzyme-catalysed reactions, however, the Cu(II)/ 
Cu(I) redox potentials of copper proteins are generally higher than the potentials of 
functionally analogous iron proteins, permitting catalysis of more difficult reactions (Kaim and 
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Rall, 1996). Copper centres within proteins are generally classified into different types based 
on the coordinating ligands and the geometry of the metal centre which result in different 
spectroscopic properties and reduction potentials (Rubino and Franz, 2012, MacPherson and 
Murphy, 2007): 
 Type 1 copper sites are typically coordinated by a Cys and two His residues in a trigonal 
planar arrangement. Additional axial ligands, such as Met, result in either tetrahedral 
or trigonal bipyramidal geometries. Charge transfer between the copper and the sulfur 
atom of the Cys ligand results in an intense blue-green colour. These sites are involved 
in single electron transfer reactions in electron transfer proteins, such as plastocyanin, 
and in intramolecular electron transfer in enzymes such as nitrite reductase. 
 Type 2 copper sites take on a variety of geometries with a variety of different ligands; 
although most are three or four coordinate with His as at least one of the ligands. 
Coordination positions are often left vacant to be occupied by exogenous ligands such 
as enzyme substrates. Key examples of enzymes containing a type 2 copper centre 
include Cu, Zn superoxide dismutase and copper amine oxidase. 
 Type 3 copper sites contain two coppers; each coordinated by three His residues in a 
trigonal planar geometry. Binding of dioxygen brings the copper atoms closer together 
to take on a trigonal bipyramidal geometry. A type 3 site is found in catechol oxidase 
and in the oxygen transporter haemocyanin. 
 Additional types of copper sites include CuA and CuB sites which are both found in 
cytochrome c oxidase and contain two and one copper atoms, respectively. CuZ copper 
sites which contain four copper atoms are the most recent type to be identified and 
are found in N2O reductase. 
1.6 Galactose oxidase 
The enzyme galactose oxidase (GO) (EC 1.1.3.9) contains a type 2 copper site and a protein 
derived cofactor which permit catalysis of the oxidation of primary alcohols to the 
corresponding aldehyde with concomitant reduction of dioxygen to hydrogen peroxide (Figure 
1.10). 
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Figure 1.10. The reaction catalysed by GO 
Primary alcohol is oxidised to the corresponding aldehyde while molecular oxygen is 
reduced to hydrogen peroxide. 
 
GO was first reported in the growth medium of Polyporus circinatus (Cooper et al., 1959), 
although the organism was later identified as Dactylium dendroides (Nobles and Madhosingh, 
1963) and then Fusarium graminearum (Ogel et al., 1994). It is thought that the primary 
function of the enzyme is generation of hydrogen peroxide which is then used for either 
antibiotic defence roles, or for use by peroxidases in lignin degradation (Whittaker et al., 
1998). This theory is backed up by the fact that GO displays a broad substrate specificity 
(Section 1.6.2) which may be a compromise with the need to achieve a high rate of turnover to 
generate hydrogen peroxide from a range of available substrates (Whittaker et al., 1998). 
GO is an ideal candidate for development as an industrial biocatalyst due to a number of 
different features: 
 An autocatalytically generated protein-derived cofactor removes the need for 
expensive exogenous cofactors or regeneration processes 
 A broad substrate specificity provides a good starting point for introduction of novel 
activities or improving specificity for a particular substrate 
 A high stability, demonstrated by activity after incubation for 1 hour in 8 M urea (Kelly-
Falcoz et al., 1965) 
 It has been extensively characterised since the 1950s, including solution of the crystal 
structure (Ito et al., 1991) (Section 1.6.1) and numerous mutagenesis studies (Section 
1.6.2) 
 It has a surface exposed active site, meaning modifications are unlikely to disrupt the 
overall protein fold 
 There are established methods for recombinant expression and purification (Section 
1.6.4) 
 It is tolerant of high substrate and product concentrations. 
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1.6.1 Structure of GO 
The crystal structure of GO was solved in 1991 at the University of Leeds (Ito et al., 1991) 
(Figure 1.11). The structure was particularly significant as it revealed the presence of a novel 
thioether bond in the active site which had not been previously observed (Section 1.6.1.2). The 
enzyme is monomeric, made up of 639 amino acids (McPherson et al., 1992) and has a relative 
molecular mass of 68.5 kDa. The structure consists of three domains made up of 
predominantly β-sheet (the only α-helix occurs between residues 327-332) which is likely to 
account for the high stability of the enzyme. 
1.6.1.1 The three-domain structure 
Domain 1 (residues 1 to 155) (Figure 1.11, yellow) is at the N-terminus of the protein and 
consists of eight β-strands in a β-sandwich structure where a five-stranded antiparallel β-sheet 
faces a three-stranded antiparallel β-sheet. Within Domain 1 a pair of β-strands is also rolled to 
form a jelly roll motif (Ito et al., 1994). The function of this domain is unclear, although the 
identification of a binding site showing some affinity for D-galactose led to the proposal that it 
may be involved in binding polysaccharides in cell walls thus anchoring the enzyme in position 
(Ito et al., 1994). The domain may also play a role in correct folding of the enzyme but has 
been shown to not be required for catalytic activity (Mahmoud et al., 2000). 
Domain 2 (residues 156-532) (Figure 1.11, green) consists of one α-helix and 28 β-strands 
which are arranged in seven antiparallel β-sheets, each containing four β-strands. The β-sheets 
are aligned with pseudo seven-fold symmetry in an arrangement resembling a ‘seven-petalled 
flower’ (Ito et al., 1991, Ito et al., 1994), now known as a β-propeller (Murzin, 1992). The tight 
packing of the seven β-sheets is thought to contribute towards the high stability of the enzyme 
(Ito et al., 1994). Similar arrangements have been observed in other proteins such as 
methylamine dehydrogenase (Vellieux et al., 1989). Each of the seven ‘blades’ of the propeller 
are made up of the ~50 residue kelch sequence motif, originally identified in Drosophila 
mutants (Bork and Doolittle, 1994). Solution of the GO crystal structure provided the first 
evidence that each copy of the kelch sequence motif encodes a ‘blade’ of the β-propeller 
which has been seen to consist of four to eight blades in different proteins. The copper ion 
(Figure 1.11, cyan sphere) is found near the pseudo seven-fold axis of the β-propeller at the 
surface-exposed active site. Most of the residues important for substrate binding and catalysis 
are found within Domain 2 (Section 1.6.1.2). 
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Domain 3 (residues 533-639) (Figure 1.11, brown) is found on the opposite side of Domain 2 
from the copper ion and consists of seven β-strands surrounding a hydrophobic core (Ito et al., 
1994). Two of the β-strands are significantly longer than the others and form an antiparallel β-
ribbon which penetrates the middle of Domain 2 along the pseudo seven-fold axis. The copper 
ligand His581 is found at the end of the β-ribbon. It is thought that Domain 3 acts to stabilise 
the β-propeller of Domain 2 (Ito et al., 1994). 
 
 
Figure 1.11. Representations of the crystal structure of GO 
The top image is rotated 90 ° out of the plane of the paper to generate the bottom 
image. The figure was created with PyMOL using .pdb file 1GOF. Domain 1 is shown in 
yellow, domain 2 is shown in green and domain 3 is shown in brown. Copper is shown as 
a cyan sphere and the D-galactose molecule in yellow is modelled into the active site 
according to Wachter and Branchaud (1996). 
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1.6.1.2 The active site  
Before determination of the crystal structure, a number of theories existed as to how the 
mononuclear metal ion active site of GO was able to catalyse the oxidation of the alcohol 
group and the reduction of dioxygen; both two-electron processes. The catalysed reaction is 
essentially the same as transfer of dihydrogen between the two substrates, a process which 
generally involves redox cofactors such as NAD(H) or quinones (Whittaker, 2005). An early 
theory suggested the involvement of a Cu(III)-Cu(I) redox couple (Hamilton et al., 1978) while 
the presence of a pyrroloquinoline quinone cofactor was implied by work carried out by Duine 
and co-workers (van der Meer et al., 1989). Around the same time, Whittaker and co-workers 
proposed that oxidation of GO resulted in a protein-based radical which was involved in 
catalysis, as well as the copper (Whittaker and Whittaker, 1988). They also suggested that a 
ligated tyrosine was involved in stabilisation of the radical within the active site (Whittaker et 
al., 1989). 
Solution of the crystal structure of GO identified a novel thioether bond between an active site 
tyrosine (272) and the cysteine at position 228 (Figure 1.12) (Ito et al., 1991). This covalent 
bond between the Cε1 of the tyrosine and the sulfur of the cysteine results in increased rigidity 
of the active site, in a similar way to the effect of a disulfide bond, although the thioether bond 
cannot be reduced in the same way. As a result, when analysed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) the 68.5 kDa protein migrates with an apparent 
size of ~65.5 kDa. This is because the presence of the thioether bond causes the 44 residues 
between Cys228 and Tyr272 to form a loop leading to a slightly more compact structure which 
migrates faster than the fully extended protein without the thioether bond (McPherson et al., 
1993). 
 
Figure 1.12. The thioether bond present in the GO active site 
 
Along with other features of the protein environment within the active site, the thioether 
bond lowers the redox potential of Tyr272 from around 1000 to 400 mV making it more 
accessible for catalysis (Stubbe and van der Donk, 1998, Harriman, 1987, Hamilton et al., 
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1978). The protein radical, formed upon oxidation of Tyr272, is stabilised by delocalisation 
across the thioether bond (Babcock et al., 1992, Gerfen et al., 1996). Other residues within the 
active site are thought to also contribute to radical stabilisation, particularly Trp290 which 
stacks over the thioether bond. Its six-membered ring is located exactly above the sulfur atom 
(Figure 1.13) (Ito et al., 1991). The side chain of Trp290 is in almost exactly the same plane as 
the two residues involved in the thioether bond (Figure 1.13, right) (Ito et al., 1994). It also 
appears likely that Trp290 protects the stabilised radical from solvent. 
 
Figure 1.13. Trp290 (green) stacks over the sulfur atom of the thioether bond between 
Tyr272 and Cys228 (white) 
The arrangement is shown looking down on the active site from bulk solvent (left) and 
looking from the side (right). Copper is shown as a cyan sphere. Figure created with 
PyMOL using .pdb file 1GOF. 
 
Of particular interest for industrial development of GO, generation of the thioether bond 
cofactor does not require any additional proteins. Only copper and dioxygen are required to 
generate the catalytically active enzyme (Firbank et al., 2003, Rogers et al., 2000). In fact, the 
thioether bond can be generated under anaerobic conditions, although the enzyme is left with 
Cu(I) in the active site which must be oxidised to Cu(II) for catalysis to occur (Rogers et al., 
2008). Since discovery of the thioether bond in GO, the same cofactor has been identified in 
other redox proteins, such as the iron-containing cysteine dioxygenase (McCoy et al., 2006, 
Simmons et al., 2006), sulfite reductase (Schnell et al., 2005) and nitrite reductase (Polyakov et 
al., 2009); and a copper-containing glyoxal oxidase which is closely related to GO (Whittaker et 
al., 1996). 
Another essential component of the GO active site is the type 2 copper centre where the Cu(II) 
is coordinated by five ligands: Tyr272, Tyr496, His496, His581 and an exogenous ligand such as 
water or acetate (Ito et al., 1991). The position of the acetate molecule in the crystal structure 
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is proposed to mimic the binding site of the alcohol substrate during catalysis, discussed 
further in Section 1.6.3 (Whittaker, 2005). The site displays significant physical rigidity, due to 
the tight packing of Domains 2 and 3, which is suggested to result in the high specificity for 
copper as the metal cofactor (Ito et al., 1994). The arrangement of the copper ligands in the 
crystal structure at pH 4.5 is shown in Figure 1.14. In the crystal structure at pH 7.0 the acetate 
is replaced by a water molecule and the copper site takes on a distorted tetrahedral geometry 
(Ito et al., 1991). 
 
Figure 1.14. The type 2 copper centre of GO 
The four equatorial ligands: acetate, Tyr272, His581 and His496 and the axial ligand: 
Tyr495, are shown with the copper (cyan sphere) in the centre. Figure created with 
PyMOL using .pdb file 1GOF. 
 
1.6.1.3 GO family members 
As mentioned above, the enzyme glyoxal oxidase is closely related to GO. Glyoxal oxidase is 
secreted by the fungus Phanerochaete chrysosporium and catalyses the oxidation of aldehydes 
to the corresponding carboxylic acid with reduction of dioxygen to hydrogen peroxide 
(Whittaker et al., 1996, Kersten and Kirk, 1987). Sequence alignments and mutagenesis studies 
have shown that GO and glyoxal oxidase have the same active site architecture with the 
copper coordinated by two histidines and two tyrosines, one of which forms a thioether bond 
with a cysteine. The key difference, which is likely to account for the biochemical differences in 
the two enzymes, is in the stacking tryptophan (W290 in GO) which is replaced with a histidine 
in glyoxal oxidase (Whittaker et al., 1999). 
The increase in genomic data over the past decade has resulted in identification of numerous 
other potential GO family members. Analysis of the DNA sequence of GO from F. graminearum 
using the Basic Local Alignment Search Tool (BLAST) at www.ncbi.nlm.nih.gov identifies 
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sequences with >40% identity from over 50 different organisms. While most of these are from 
different fungal species such as Cordyceps militaris (Zheng et al., 2011) and Beauveria bassiana 
(Xiao et al., 2012), there are also examples of sequences showing as much as 47% sequence 
similarity from bacterial genera such as Actinoplanes, Burkholderia and Streptomyces. The vast 
majority of these gene products have not undergone any characterisation, but the ever 
increasing list of potential GO homologues may prove very useful in future development 
projects.  
1.6.2 Substrate specificity & binding 
GO displays broad substrate specificity with activity towards a wide range of primary alcohols 
reported (Table 1.1). This is a desirable trait in an industrial biocatalyst (Breuer et al., 2004). 
GO activity has also been reported towards polysaccharides where D-galactose occurs on the 
non-reducing end (Bretting and Jacobs, 1987, Avigad, 1985, Schlegel et al., 1968). The relative 
activities towards the different substrates, especially where activity was not detectable, have 
provided valuable information for modelling the enzyme-substrate interactions which occur 
during catalysis. Unfortunately, the crystal structure of an enzyme-substrate complex has not 
yet been solved, perhaps due to crystal packing limitations (Ito et al., 1994), or due to the 
relatively low affinity GO has for the substrate D-galactose, implied by a relatively high KM.  
Following solution of the crystal structure, Ito et al. (1994) used calculations of the water 
accessible surface (Connolly, 1983) to identify the active site at the position of the copper and 
thioether bond and demonstrated that the site is complementary to D-galactose in the chair 
conformation. They also proposed that the substrate binds at the equatorial copper ligand site 
occupied by acetate or water in the crystal structures. Detailed molecular modelling studies by 
Wachter and Branchaud (1996) predicted the most favourable conformation for D-galactose to 
bind in the active site. Seven hydrogen bonds were predicted (Figure 1.15): O-1 as a hydrogen 
bond donor to the Oη of Y329; O-3 as a hydrogen bond acceptor to Nη1 of R330 and a donor to 
Oε of Q406; O-4 as a hydrogen bond acceptor to both Nη1 and Nη2 of R330 and also a donor to 
Oη of Y495; and O-5 as a hydrogen bond acceptor to Nε of W290. The B-face of the D-galactose 
molecule (defined as the side where numbering of the carbon atoms is anti-clockwise (Spurlino 
et al., 1991)) is much more hydrophobic than the A-face (where numbering is clockwise) due to 
protruding C-H groups rather than C-OH groups. Because of this feature, the D-galactose fits 
well against the hydrophobic residues F464 and F194, which may be important for positioning 
the substrate for hydrogen bonding interactions in other areas of the active site. It is proposed 
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that D-glucose binding is disfavoured due to its equatorial hydrophilic O-4 hydroxyl which 
would be too close to these hydrophobic residues if D-glucose bound in the same 
conformation as D-galactose in the WT enzyme (Wachter and Branchaud, 1996). The O-4 
hydroxyl may also cause a steric clash with Tyr495, a theory which likely explains why 
substitutions at positions C-1, C-2 and C-3 are much better tolerated than those at positions C-
4, C-5 or C-6 (Table 1.1 and (Schlegel et al., 1968)). 
 
Figure 1.15. The proposed interactions of D-galactose in the active site of GO 
The D-galactose molecule (black) is shown docked into the active site according to 
Wachter and Branchaud (1996). F194 and F464 (green) are potentially involved in 
hydrophobic interactions with the B-face of the D-galactose molecule. Hydrogen bonds 
between O-1 (black), O-3 (green), O-4 (red) and O-5 (blue) with active site residues are 
shown as dotted lines. Copper is shown as a cyan sphere and is proposed to interact 
with the C-6 hydroxyl of D-galactose. Figure created with PyMOL using .pdb file 1GOF. 
 
The strict regioselectivity of GO, where only the C-6 hydroxyl of D-galactose is oxidised 
(Whittaker and Whittaker, 1998), is important for potential industrial applications as use of the 
enzyme removes the need for protective group chemistry (Schoevaart and Kieboom, 2004). 
This regioselectivity is likely brought about by the multiple interactions between D-galactose 
and the active site, as well as the overall rigidity of the structure. 
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Table 1.1. Some of the substrates towards which GO activity has been explored 
Activity higher than with D-galactose 
1,5-Anhydrogalactitol (a) 
Dihydroxyacetone (b) 
2-Methylene-1,3-propanediol (b) 
1,3-Dihyroxy-2-propanone (c) 
Methyl α-D-galactopyranoside (d) 
3-O-Methyl D-galactose (d) 
1,5-Anhydro-D-galactitol (d) 
Raffinose (d) 
Guaran (d) 
 
Activity lower than with D-galactose 
Dulcitol (a) β-D-Lactose (c) 
2-Deoxy-D-galactose (a) 2-Propene-1-ol (c) 
D-Talose (a) 2-Pyridine methanol (c) 
D-Galactosamine (a) 3-Pyridine methanol (c) 
N-Acetyl-D-galactosamine (a) 4-Pyridine methanol (c) 
D-Tagatose (a) O-Nitrophenyl β-D-galactopyranoside (d) 
D-Gulose (a) 1-O-(α-D-galactopyranosyl)-myo-inositol (d) 
D-Lyxose (a) 2-O-Methyl D-galactose (d) 
Methanol (b) 2,3-Di-O-Methyl D-galactose (d) 
2-Chloroethanol (b) O-α-D-Galactopyranosyl-(1-3)-D-galactose (d) 
2-Nitroethanol (b) 2’-O-(α-D-fructopyranosyl) lactose (d) 
1,3-Propanediol (b) 2-Amino-2-deoxy-D-galactose (d) 
Ethylene glycol (b) Methyl 2-acetamido-2-deoxy-3-O-methyl α-D-
galactopyranoside (d) Glycerol (b) 
Benzyl alcohol (b) O-β-D-Galactopyranosyl-(1-3)-2-acetamido-2-
deoxy-D-galactose (d) Acetol (b) 
α-Hydroxyacetophenone (b) Ovomucoid (d) 
 
No detectable activity 
D-Galactonate (a) 2-Deoxy-D-glucopyranose (c) 
D-Glucose (a, c) Methyl β-D-glucopyranoside (c) 
2-Deoxy-D-glucose (a) D-Mannose (c) 
D-Fucose (a) D-Maltose (c) 
L-Arabinose (a) Amylose (c) 
D-Galacturonic acid (a) 3-Buten-2-ol (c) 
D-Glycero-D-galactoheptose (a) 4-O-Methyl D-galactose (d) 
L-Galactose (a, c) 2,4-Di-O-Methyl D-galactose (d) 
D-Fructose (a) 1,2:3,4-Di-O-isopropylidene-α-D-galactose (d) 
L-Arabitol (a) Chondrosine (d) 
Ethanol (b) O-β-D-Glucopyranosyl-(1-3)-2-acetamido-2-
deoxy-D-galactose (d) Propanol (b) 
Butanol (b, c) Chondroitin 4-sulfate (d) 
2,2-Dichloroethanol (b) Dermatan sulfate (d) 
Different relative rates of activity were reported in (Avigad et al., 1962) (a), (Kosman, 
1984) (b), (Sun et al., 2002) (c) or (Schlegel et al., 1968) (d). 
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A number of mutagenesis studies have been carried out on GO with the aim of improving its 
activity or altering the substrate specificity. In the process, other residues involved in substrate 
binding and catalysis have been identified. Delagrave et al. (2001) carried out epPCR to evolve 
GO and identified mutations at three positions which resulted in improved activity towards 
methyl D-galactose: Cys383Ser, Tyr436His/ Asn and Val494Ala. These mutations were further 
explored by Wilkinson et al. (2004), revealing significant effects on KM(D-galactose) upon mutation 
of Cys383. Mutations of Tyr436 or Val494, however, only led to improvements in activity 
towards D-galactose when combined with other mutations, confirming the value of targeting 
multiple positions simultaneously when mutating enzymes (Section 1.3.6). Position 383 was 
later subjected to saturation mutagenesis (Deacon and McPherson, 2011) revealing significant 
effects on the kinetic parameters of the reaction with D-galactose (Table 1.2). C383E/ K/ M/ S 
showed reductions in KM with only moderate or no effect on kcat, while the C383T mutation 
greatly increased activity. It is unclear how the residue at position 383 is involved in substrate 
binding and catalysis – the crystal structure of the C383S variant revealed only minor changes 
compared to WT (Wilkinson et al., 2004). However, as the only unpaired cysteine in GO and 
with obvious effects on activity upon mutagenesis, this residue is of particular interest. 
Table 1.2. Kinetic data for C383 variants 
GO variant KM (mM) kcat (s
-1) kcat/ KM (M
-1 s-1) 
WT 54 ± 6.1 1100 ± 41 20000 ± 3200 
C383A 160 ± 21 1200 ± 50 7700 ± 1500 
C383D 84 ± 2.6 440 ± 3.8 5200 ± 210 
C383E 21 ± 1.8 550 ± 9.0 26000 ± 2700 
C383F 130 ± 29 190 ± 13 1500 ± 450 
C383G 83 ± 3.3 1100 ± 12 14000 ± 690 
C383H 30 ± 3.7 210 ± 5.7 7000 ± 1100 
C383I 510 ± 35.7 260 ± 8.5 510 ± 54 
C383K 48 ± 6.7 1100 ± 30 23000 ± 3900 
C383L 55 ± 8.3 450 ± 17 8200 ± 1600 
C383M 33 ± 4.5 510 ± 15 15000 ± 2600 
C383N 390 ± 38 410 ± 17 1100 ± 150 
C383P 140 ± 3.9 490 ± 4.3 3500 ± 130 
C383Q 64 ± 17 170 ± 12 2600 ± 960 
C383R 290 ± 23 8.8 ± 0.3 30 ± 3.4 
C383S 34 ± 3.6 1100 ± 30 32000 ± 4500 
C383T 530 ± 99 3400 ± 300 6400 ± 1800 
C383V 430 ± 21 360 ± 7.8 830 ± 59 
C383W 60 ± 7.4 0.011 ± 0.0004 0.19 ± 0.033 
C383Y Not determined Not determined Not determined 
Taken from Deacon and McPherson (2011). 
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Other studies have mutated residues known to be involved in substrate binding, such as 
R330K/ Q406T/ W290F which led to a 100-fold increase in D-glucose activity (Sun et al., 2002); 
R330M/ Q406T/ W290F which improved the activity and enantioselectivity towards secondary 
alcohols (Escalettes and Turner, 2008); and R330K which improved the catalytic efficiency of 
the reaction with D-fructose over eight-fold (Deacon et al., 2004). A directed evolution study 
also led to improved expression of GO in E. coli and enhanced the stability of the enzyme as 
discussed in Section 1.6.4 (Sun et al., 2001). 
1.6.3 Mechanism of alcohol oxidation 
1.6.3.1 The different redox states of GO 
GO can exist in three distinct redox states: an oxidised state with Cu(II) and the tyrosyl radical 
which is the active form of the enzyme; a semi-reduced state with Cu(II) but no tyrosyl radical 
which is inactive; and a reduced state with Cu(I) and no tyrosyl radical which only occurs during 
catalysis or upon addition of substrate under anaerobic conditions (Figure 1.16) (Whittaker 
and Whittaker, 1988). 
 
Figure 1.16. Schematic representation of the three redox states of GO 
Adapted from Deacon (2008). 
 
GO is isolated as a mixture of oxidised and semi-reduced states, thus addition of a mild oxidant 
such as ferricyanide is required to ensure all of the GO is present in the oxidised, active form 
(Whittaker and Whittaker, 1988). HRP, commonly used in coupled assays of GO activity, has 
also been shown to oxidise GO to the active form (Kwiatkowski and Kosman, 1973, Cleveland 
et al., 1975, Tressel and Kosman, 1980). The semi-reduced form can be generated by addition 
of a mild reductant such a ferrocyanide. The three different states show characteristic UV/ vis 
spectra (Figure 1.17). The peak at 445 nm corresponds to a ligand to metal charge transfer 
(LMCT) between Tyr495 and Cu2+ (present in both the oxidised and semi-reduced states) 
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combined with a π – π* transition of the tyrosyl radical (present in the oxidised state only). The 
broad peak at ~810 nm has been attributed to ligand through LMCT coupling Tyr495, Tyr272 
and the Cu2+, combined with weaker Cu2+ d-orbital transitions (Whittaker et al., 1989, 
Whittaker and Whittaker, 1993, Messerschmidt et al., 2001). As the radical is not present in 
the semi-reduced form, the spectral feature associated with the stacking interactions is not 
visible. 
 
Figure 1.17. Typical UV/ vis spectra of the three different redox states of GO 
Adapted from Messerschmidt et al. (2001). 
 
1.6.3.2 The catalytic cycle of GO 
It is currently accepted that oxidation of D-galactose by GO occurs by a ‘bi-bi ping-pong’ 
mechanism where the alcohol substrate binds, is oxidised, and aldehyde released and then 
dioxygen binds, is reduced, and hydrogen peroxide is released (Figure 1.18). 
 
Figure 1.18. Schematic representation of the bi-bi ping-pong mechanism proposed for GO 
Adapted from Deacon (2008). 
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In the reductive half reaction, substrate binds at the equatorial copper site normally occupied 
by solvent (Ito et al., 1994, Wachter and Branchaud, 1996), and a proton is abstracted from the 
C-6 hydroxyl by the axial copper ligand, Tyr495, which acts as the catalytic base (Figure 1.19, 
(i)). This step is supported by studies of binding of the inhibitor azide (Whittaker and 
Whittaker, 1993), as well as mutagenesis of Tyr495 to Phe which removes the ability of the 
residue to abstract protons (Reynolds et al., 1995). The radical present at Tyr272 then 
abstracts the pro-S hydrogen atom from the C-6 methylene group of the substrate 
intermediate, resulting in a substrate radical (Figure 1.19, (ii)). This transfer of a hydrogen 
atom is backed up by the observation of significant kinetic isotope effects and no detectable 
solvent isotope effects (Whittaker et al., 1998), while the stereoselective nature of hydrogen 
abstraction was shown by Whittaker and co-workers and proposed to be due to constraints 
imposed by the active site structure on the orientation of substrate binding (Wachter and 
Branchaud, 1996, Minasian et al., 2004). In the final step of the reductive half reaction, 
transfer of a single electron from Cu2+ to the substrate radical results in formation of a Cu+ 
centre and release of the aldehyde product (Figure 1.19, (iii)). 
The oxidative half reaction is significantly less well characterised, perhaps due to the extremely 
fast reaction of Cu+ with dioxygen. Dioxygen is proposed to bind at the equatorial copper site 
in an end-on coordination and an electron is transferred from the Cu+ to yield a metal-bound 
superoxide and reform the Cu2+ centre (Figure 1.20, (iv)). The superoxide then abstracts a 
hydrogen atom from the tyrosyl group of the Tyr-Cys cofactor to form hydroperoxide and 
reform the cofactor radical at the same time (Figure 1.20, (v)). A proton is then transferred 
from Tyr495 resulting in hydrogen peroxide, which is released from the active site (Figure 1.20, 
(vi)). A hydrogen bond is reformed between Tyr495 and the Cu2+ and GO is restored to its fully 
reoxidised state (Humphreys et al., 2009). 
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Figure 1.19. The reductive half reaction of GO 
Adapted from Messerschmidt et al. (2001). 
 
 
Figure 1.20. The oxidative half reaction of GO 
Adapted from Messerschmidt et al. (2001).  
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1.6.4 Expression and purification of recombinant GO 
In order to permit protein engineering studies, it is necessary to express GO in a host organism 
which does not contain endogenous GO activity. Expression has been previously optimised in 
the filamentous fungus Aspergillus nidulans (Baron et al., 1994) and in the methylotrophic 
yeast Pichia pastoris (Whittaker and Whittaker, 2000, Deacon et al., 2004). WT GO is initially 
translated as a precursor protein with an N-terminal pro region, including a secretion signal 
sequence, which is cleaved autocatalytically during maturation of the enzyme within the 
eukaryotic host (Rogers et al., 2000). In optimising the enzyme for expression in E. coli, Arnold 
and co-workers omitted the pro sequence from the initial clone and, following directed 
evolution, generated a variant which showed 18-fold increased expression compared to WT 
GO in E. coli, as well as improved stability and activity towards D-galactose (Sun et al., 2001). 
The mutant, later termed M1, contained six mutations: Ser10Pro and Met70Val in Domain 1; 
Pro136 (silent); Gly195Glu and Val494Ala in loops surrounding the active site; and Asn535Asp 
in a surface exposed loop of Domain 3.  
Combination of these mutations with three silent mutations at positions 2, 3 and 5 (the ‘N6’ 
mutations) resulted in even greater enhancement of expression; this mutant was termed 
N6M1 (Deacon and McPherson, 2011). These silent mutations are predicted to reduce 
formation of mRNA secondary structures around the initiating codon resulting in more 
efficient initiation of translation. One of the many advantages of using E. coli as an expression 
host is that numerous different strains are available for optimising expression of the desired 
protein (Terpe, 2006). Deacon and McPherson (2011) compared expression levels in seven 
different strains and found BL21 Star (DE3) (Stratagene) gave the highest expression of soluble 
GO. Expression by autoinduction in 8ZYM-4x(5052) broth containing succinate (Studier, 2005) 
was also found to give the highest expression of all expression broths trialled (Deacon and 
McPherson, 2011). 
Purification of GO from the host organism was traditionally carried out in a multi-step process 
involving ammonium sulfate precipitation (Avigad et al., 1962) and chromatographic 
separation using resins based on cellulose (Amaral et al., 1966) or agarose (Hatton and 
Regoeczi, 1976). Expression in E. coli enables use of polypeptide fusion partners, known as 
affinity tags, in protein purification. Examples include the widely used polyhistidine-tag or 
Strep II-tag which permit one-step purification procedures with minimal effect on the tertiary 
structure and biological activity of the protein (Terpe, 2003). Turner and co-workers first 
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reported purification of GO using a polyhistidine-tag added to the N-terminal end of the 
enzyme (Escalettes and Turner, 2008) enabling purification by nickel affinity chromatography. 
In order to avoid potential contamination of GO with metal ions other than copper, Deacon 
and McPherson (2011) added a Strep II-tag to the C-terminal end of GO-N6M1 permitting 
efficient purification using Strep-Tactin resin. Following optimisation of the cell lysis step, the 
expression of GO-N6M1 by autoinduction and purification by Strep-Tactin chromatography 
resulted in reported yields of up to 240 mg per litre of culture (Deacon and McPherson, 2011). 
1.6.5 Uses of GO 
1.6.5.1 Previous and existing applications 
There are numerous examples of the use of WT GO in biotechnological applications: 
 Detection and quantification of D-galactose is important in a number of different 
situations. For example, the condition galactosaemia, where one of the enzymes 
required for D-galactose metabolism is absent, requires the patient to closely monitor 
their D-galactose intake and blood and urine levels (Holton, 1990). There are also 
numerous examples where it is necessary to monitor the levels of D-galactose and 
other GO substrates in the food industry, for example in processing of sugar beet 
(Rorem and Lewis, 1962) and in the dairy industry (Adanyi et al., 1999, Mannino et al., 
1999). Significant work has been undertaken to develop GO-based biosensors to 
enable accurate detection of D-galactose and there are a large variety of reported 
methods for immobilisation of GO within a biosensor (Taylor et al., 1977, Dicks et al., 
1986, Vrbova et al., 1992, Sharma et al., 2006, Cevik et al., 2010, Charmantray et al., 
2013, Kanyong et al., 2013, Kim et al., 2012). 
 Labelling of D-galactose-terminating glycans on cell surfaces has been used by several 
groups in characterising and quantifying different cell types, such as in brain tissue 
(Singh and Kanfer, 1980). GO is also used in characterising changes in cell surface 
glycan expression, such as during human erythrocyte aging (Gattegno et al., 1981) or 
upon virus infection of fibroblasts (Critchley, 1974). The original methods involved 
oxidation of terminal galactosyl residues by GO followed by reduction of the resulting 
aldehyde by tritiated borohydride (Morell et al., 1966). However, more recently, 
methods have been developed where the aldehyde product is detected by fluorescent 
(Rannes et al., 2011) or chemiluminescent methods (Han et al., 2012). 
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 Labelling of cell surface glycans is also used in cancer diagnosis as the disaccharide D-
galactose-β-(1-3)-N-acetyl-D-galactosamine (Gal-GalNAc) is expressed on the surface of 
colon cells in the early stages of carcinogenesis. After oxidation by GO, the aldehyde 
groups are detected using Schiff’s reagent which produces a magenta coloration 
(Shamsuddin and Elsayed, 1988, Carter et al., 1997, Yang and Shamsuddin, 1996). The 
same method has also been used for detection of breast carcinoma (Chagpar et al., 
2004). 
 Lymphocyte blastogenesis and generation of growth factors is induced upon 
treatment with neuraminidase and GO (Novogrodsky and Katchalski, 1973) permitting 
research into lymphocytes and associated disorders such as leukaemia (Berzins et al., 
1983, Zafar et al., 1981). 
 Modification of polysaccharides by GO, often followed by further modifications by 
additional enzymes, provides access to a wide range of derivatives (Yalpani and Hall, 
1982). For example, oxidation of the natural plant-based polymer guar has uses in 
paper strengthening (Delagrave et al., 2001) while derivatives of galactoxyloglucan 
have potential uses in abrasion resistant clothing or diagnostic strips (Parikka et al., 
2012). 
 Generation of chemicals such as unnatural sugars (Root et al., 1985); sugar-based 
polymers used in hydrogels, adsorbents and biorecognition agents (Liu and Dordick, 
1999); and 5-C-(hydroxymethyl)hexoses, a potential group of artificial sweeteners 
(Mazur and Hiler, 1997), can all be carried out using WT GO as a catalyst which 
removes the need for protection of hydroxyl groups resulting in a more efficient 
process.  
1.6.5.2 Potential future applications 
In many ways GO represents an ideal enzyme for use in biotechnological applications as it is a 
stable enzyme, easily purified in high quantities and does not require expensive cofactors in 
order to function. Modification of the enzyme to introduce or improve activity towards 
substrates other than D-galactose has the potential to greatly expand the areas in which GO 
can be used. Introduction of activity towards D-monosaccharides other than D-galactose seems 
a realistic concept due to the similarity in structure to the native substrate. 
D-glucose and D-xylose make up a significant proportion of the carbohydrate content of acid-
treated corn stover, the parts of the maize plant remaining following harvest of the grain. The 
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sugars present in the acid-treated biomass are fermented to produce bioethanol. 
Measurement of the levels of D-glucose and D-xylose is important in monitoring the progress 
of sugar fermentation. This process is traditionally carried out using time-consuming HPLC-
based methods. Quantification by an enzyme-based process using a variant of GO active 
against D-xylose and/ or D-glucose has the potential to significantly speed up this method and 
provide near real-time feedback information to help optimise bioethanol production and 
maximise yields. GO variants could also be used in the quantification of different sugars in the 
food industry as well as in biosensors, such as those for measuring blood glucose levels. 
As well as D-galactose, cell surface glycans are frequently made up of D-glucose and D-mannose 
residues. GO variants showing activity towards these components could be used to label cell 
surfaces in a similar approach to that currently used for the labelling of D-galactose (Section 
1.6.5.1) (Rannes et al., 2011). This has potential uses in diagnostic and research applications as 
different pathogens exploit different cell surface carbohydrates for entry into host cells (Disney 
and Seeberger, 2004, Doores et al., 2006).  
D-arabinose has been identified as a building block in the generation of more complex 
molecules with potential roles in various pharmaceuticals such as noricumazole A, a potential 
drug against hepatitis C virus (Barbier et al., 2012b, Barbier et al., 2012a), and glycosidase 
inhibitors used in treatment of type 2 diabetes (Merino-Montiel et al., 2012). Regioselective 
oxidation of D-arabinose and other monosaccharides by GO variants has the potential to 
diversify the functionality of the sugar molecules facilitating their use in construction of more 
complex molecules and polymers. The oxidation of D-glucose and D-mannose at the C-6 
position is not catalysed by any currently known enzymes (Rannes et al., 2011, Sun et al., 2002) 
so introduction of activity towards D-glucose or D-mannose into GO would provide access to 
enzyme-catalysed chemistry which is not currently available. Modification of polysaccharides 
containing D-glucose or D-mannose also has the potential to lead to new properties with 
various applications, for example in hair colouring and waving (Tsujino et al., 1991).  
GO already shows some level of activity towards glycerol (Table 1.1) so enhancing this activity 
seems a realistic aim. The surge in biofuel development in the last decade has resulted in 
generation of large quantities of glycerol which forms the primary by-product in biodiesel 
production. As a result, glycerol prices have fallen significantly and the excess of available 
glycerol is now treated as a waste product. In order to reduce the economical and 
environmental impact of this waste storage and handling there is now great interest in 
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development of processes to convert glycerol into high-value products with uses in various 
industries, including generation of alternatives to petroleum-based chemicals (Johnson and 
Taconi, 2007). Oxidation of glycerol can lead to a variety of different products with a range of 
potential uses, some examples of which are shown in Table 1.3. 
Table 1.3. Some products which can be generated by oxidation of glycerol 
Product Structure Applications 
Glyceraldehyde 
 
Organic synthesis industry 
Dihydroxyacetone 
 
Organic synthesis and cosmetic industries 
(Hu et al., 2010) 
Glyceric acid 
 
Organic synthesis & pharmaceutical 
industries including generation of polymers 
Malonic acid 
 
Plastic manufacture, silver plating 
brightening agent (Paster et al., 2003) 
Hydroxypyruvic acid 
 
Production of amino acids 
Tartronic acid 
 
Used to make mesoxalic acid 
Mesoxalic acid 
 
Pharmaceuticals e.g. anti-HIV drug (Davis et 
al., 2000) 
Lactic acid 
 
Organic synthesis including petroleum 
product alternatives, food additives, textile/ 
leather treatment (Paster et al., 2003)  
Pyruvic acid 
 
Derivatives used as emulsifiers and in 
pharmaceuticals (Paster et al., 2003) 
 
Many of these chemicals are currently generated from glycerol using metal catalysts such as 
gold or platinum (Garcia et al., 1995, Demirel-Gulen et al., 2005). Development of an efficient 
enzyme variant showing high activity and specificity would remove the need for these 
expensive catalysts. The oxidation of glycerol by WT GO has not been previously characterised 
so it is unclear where on the glycerol molecule oxidation occurs. However, it may be possible 
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to generate variants which produce different products depending on the mutations 
introduced. 
Production of hydrogen peroxide through oxidation of a variety of different substrates also has 
potential industrial uses. These include the generation of bleaching agents in laundry 
detergents or toothpaste, or as a preservative in foodstuffs. Expanding the substrate 
repertoire of GO to include cheaply available substances such as glycerol and D-glucose is 
therefore also of interest in industrial hydrogen peroxide generation. 
1.7 Aims of the project 
The overall aim of this project was to identify mutations in GO which improve activity towards 
alternative substrates to D-galactose. Chapter 2 details the materials and methods which were 
used throughout the project. In Chapter 3 screening assays used by other groups to detect 
changes in GO activity were further optimised to improve a number of aspects, including 
sensitivity, to enable detection of activity towards all of the substrates used in screening 
(Figure 1.21). 
  
 
D-galactose 
 
D-glucose D-mannose 
  
 
D-xylose D-arabinose glycerol 
Figure 1.21. The six substrates for which activity will be screened  
The structures of glycerol and the pyranose ring form of the five sugars are shown. 
 
The substrate targets for this project were initially chosen due to their structural similarity to 
the native substrate D-galactose (D-glucose, D-mannose, D-arabinose and D-xylose) or because 
the WT enzyme already shows an appreciable level of activity towards the substrate (glycerol, 
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D-xylose). However, oxidation of each of the substrates also has potential biotechnological 
uses as detailed in Section 1.6.5.2. 
Chapter 4 details the selection of amino acids around the GO active site which are thought to 
be involved in determining the substrate acceptance of GO; followed by design and generation 
of mutant libraries using randomised oligonucleotides generated using trimer 
phosphoramidites (Section 1.3.4). Screening of these libraries against the range of selected 
substrates (Figure 1.21) was then carried out using the assays developed in Chapter 3 and 
altered activities were confirmed with purified proteins. 
Chapter 5 describes the further characterisation of nine of the variants identified in Chapter 4 
with the aim of further understanding the basis behind the observed new activities. Also 
discussed is assessment of some of the conditions under which the new biocatalysts may 
function if further developed for use in biotechnological processes. The features of the 
enzymes explored include the effect of single versus double mutations, the pH optima of the 
variants, activity towards different forms of the substrate(s), the effect of increasing the 
oxygen concentration and Nuclear Magnetic Resonance (NMR) analysis of the oxidised 
products. 
Finally, Chapter 6 compares the work presented here with that of other groups and discusses 
the future directions for this research.  
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Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich or Fisher Scientific; 
randomised oligonucleotide primers were generated by Ella Biotech while other 
oligonucleotide primers were generated by Sigma-Aldrich. 
2.1 Growth media 
2.1.1 2TY broth 
Tryptone (16 g/ L), yeast extract (10 g/ L) and NaCl (5 g/ L) were dissolved in deionised water 
and the solution was autoclaved at 121 °C, 15 psi for 20 minutes. 
2.1.2 2TY agar plates 
Tryptone (16 g/ L), yeast extract (10 g/ L) and NaCl (5 g/ L) were dissolved in deionised water, 
agar (12 g/ L) was added and the solution was autoclaved at 121 °C, 15 psi for 20 minutes. 
After autoclaving, the solution was cooled in a 50 °C water bath for 30 minutes before addition 
of antibiotic to the appropriate concentration (Section 2.1.7) followed by dispensing of 
approximately 25 ml into petri dishes, or 180 ml into 245 x 245 mm bio-assay plates (Thermo 
Scientific) under aseptic conditions. 
2.1.3 ZYP-0.8G broth 
ZY broth was made by dissolving tryptone (10 g/ L) and yeast extract (5 g/ L) in deionised water 
and autoclaving at 121 °C, 15 psi for 20 minutes. The following sterile solutions were added to 
46.5 ml ZY broth before use (final concentrations are shown in brackets): 100 μl 1 M MgSO4 (2 
mM), 1 ml 40% (w/ v) D-glucose (0.8%), 2.5 ml NPSC component (50 mM NH4Cl, 5 mM Na2SO4, 
25 mM KH2PO4, 25 mM Na2HPO4). 
2.1.4 8ZYM+5052+25 mM succinate broth 
8ZY broth was made by dissolving tryptone (80 g/ L) and yeast extract (40 g/ L) in deionised 
water and autoclaving at 121 °C, 15 psi for 20 minutes. The following sterile solutions were 
added to 400 ml 8ZY broth before use (final concentrations are shown in brackets): 800 μl 1 M 
MgSO4 (2 mM), 32 ml ‘5052 component’ (0.5% (v/ v) glycerol, 0.05% (w/ v) D-glucose, 0.2% (w/ 
v) α-lactose monohydrate), 20 ml NPSC component (50 mM NH4Cl, 5 mM Na2SO4, 25 mM 
KH2PO4, 25 mM Na2HPO4), 400 μl trace elements (50 µM FeSO4, 10 µM ZnSO4, 2 µM CuSO4, 10 
µM MnSO4, 2 µM Na2B4O7, 2 µM (NH4)6MO7O24), 20 ml 0.5 M succinate (25 mM). 
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2.1.5 BMMY broth 
YES component was made by dissolving yeast extract (1 g/ L) and soytone (2 g/ L) in deionised 
water and autoclaving at 121 °C, 15 psi for 20 minutes. The following sterile solutions were 
added to 80 ml YES component before use (final concentrations shown in brackets): 10 ml 1 M 
potassium phosphate, pH 6.0 (100 mM), 10 ml 13.4% (w/ v) yeast nitrogen base with 
(NH4)2SO4, without amino acids (1.34% (w/ v)), 200 µl 1 mM biotin (2 µM), 0.5 ml methanol 
(0.5% (v/ v)), 75 µl 100 mM CuSO4 (75 µM). 
2.1.6 SOC broth 
Tryptone (20 g/ L), yeast extract (5 g/ L) and NaCl (0.5 g/ L) were dissolved in deionised water 
and autoclaved at 121 °C, 15 psi for 20 minutes. The following sterile solutions were added to 
79 ml before use (final concentrations are shown in brackets): 10 ml 1 M MgCl2 (0.1 M), 10 ml 
MgSO4 (0.1 M), 1 ml 2 M D-glucose (20 mM). 
2.1.7 Antibiotics 
A 1000 x stock solution of each antibiotic was made up in deionised water, filter sterilised 
through a 0.2 µm syringe-end filter and stored in 1 ml aliquots at -20 °C. The final 
concentration used in cultures was 60 μg/ ml of carbenicillin or 50 μg/ ml kanamycin 
(Sambrook et al., 1989). Carbenicillin was used in place of ampicillin as it has the same 
resistance gene, is more stable, and the by-products generated upon its degradation are less 
toxic to cells, permitting denser cell growth. 
2.2 E. coli  
2.2.1 XL1 blue 
Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZΔM15 Tn10 
(Tetr)] 
Source: Stratagene (generated as detailed in Section 2.2.4) 
XL1 blue cells were used for replication, purification and storage of plasmid DNA as they have 
been optimised by a number of mutations: (i) the recA1 mutation maintains insert stability as 
unwanted recombination is reduced; (ii) non-specific digestion by endonuclease I is prevented 
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by incorporation of the endA1 mutation; (iii) the EcoK endonuclease system is prevented from 
cleaving cloned DNA by incorporation of the hsdR mutation; (iv) termination of translation is 
reduced by the supE44 mutation. The other mutations in the genotype were not necessary for 
the work presented here. 
2.2.2 BL21 Star (DE3) 
Genotype: F- ompT hsdSB (rB-mB-) gal dcm rne131(DE3) 
Source: Invitrogen (generated as detailed in Section 2.2.4) 
BL21 Star (DE3) cells were used for protein expression as they have been optimised by a 
number of mutations: (i) the ompT mutation in outer membrane protease VII as well as the 
absence of the lon protease reduces the proteolytic cleavage of the expressed protein; (ii) the 
hsdSB mutation reduces degradation of transformed plasmids which are ‘foreign’ to the host 
cell; (iii) mRNA degradation by ribonuclease E is reduced by the rne131 mutation thereby 
increasing the yield of the recombinant protein; (iv) the presence of the DE3 lysogen carrying 
the gene for T7 RNA polymerase is required for expression in a T7 promoter-based system (as 
in the pET vectors used here, Section 2.3) which synthesises mRNA more rapidly than E. coli 
RNA polymerases and so permits higher expression levels. 
2.2.3 Acella 
Genotype: F- ompT hsdSB (rB-mB-) gal dcm (DE3) ΔendA ΔrecA 
Source: Edge Bio (VH Bio) 
Acella cells are based on BL21 Star (DE3) but with the additional deletion of the endA and recA 
genes resulting in no non-specific digestion by endonuclease I and reduced recombination. 
This means the cells are suitable for replication, purification and storage of plasmid DNA as 
well as protein expression. 
2.2.4 Preparation of chemocompetent cells 
A 2TY agar plate containing no antibiotic was streaked with a glycerol stock of the appropriate 
strain and incubated overnight in a static incubator at 37 °C. A single colony was picked and 
used to inoculate 5 ml 2TY broth which was then incubated overnight in a shaking incubator at 
37 °C with shaking at 220 rpm. A 1 ml aliquot of the overnight culture was used to inoculate 50 
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ml pre-warmed 2TY broth which was then incubated in a shaking incubator at 37 °C with 
shaking at 220 rpm until an OD600 of ~0.4 was reached. The cells were then transferred to a 
sterile 50 ml Falcon tube and chilled on ice for 5 minutes. After centrifugation at 4 °C for 10 
minutes at 4000 x g in a Hermle Z400 K centrifuge with a 220 97 VO2 rotor, the cell pellet was 
resuspended in 20 ml ice-cold TFB1 buffer (3 mM potassium acetate, 100 mM RbCl2, 50 mM 
MnCl2, 10 mM CaCl2, 15% (v/ v) glycerol, pH adjusted to 5.8 with acetic acid, filter sterilised 
through a 0.2 µm membrane) and chilled on ice for 5 minutes. The cells were then centrifuged 
again for 10 minutes at 4000 x g, the supernatant discarded, and the tube wiped dry with 
tissue. The cells were resuspended in 2 ml ice-cold TFB2 buffer (10 mM RbCl2, 75 mM CaCl2, 10 
mM MOPS, 15% (v/ v) glycerol, pH adjusted to 6.5 with potassium hydroxide, filter sterilised 
through a 0.2 µm membrane), chilled on ice for 15 minutes and then 50 μl aliquots pipetted 
into sterile pre-chilled 1.5 ml microcentrifuge tubes. The aliquots were flash frozen in liquid 
nitrogen and stored at -80 °C. 
2.3 The pET vectors 
In this work the pET vectors pET101D (Invitrogen) and pET28c (Novagen) were used due to the 
presence of the T7 promoter upstream of the gene coding sequence. The BL21 Star (DE3) and 
Acella cells used for protein expression express T7 RNA polymerase which recognises the T7 
promoter, resulting in transcription of the gene of interest (Studier and Moffatt, 1986). The 
pET vectors also carry a copy of the lac repressor gene which, when expressed, binds the lac 
operator inhibiting transcription of the gene of interest. Expression of T7 RNA polymerase is 
inhibited in the same way. To induce expression of T7 RNA polymerase and the gene of 
interest, the non-hydrolysable lactose analogue isopropyl-β-D-thiogalactopyranoside (IPTG) is 
added and displaces the lac repressor.  
In the case of autoinduction, D-glucose is included in the broth as a primary carbon source as 
well as a repressor of induction until the culture has grown. Once levels of D-glucose are 
depleted, the lactose present in the broth can displace the repressor permitting protein 
expression without the requirement for monitoring of culture growth or addition of inducer 
(Studier, 2005). 
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2.4 DNA manipulation 
2.4.1 PCR 
In the majority of cases, PCR was carried out with Phusion DNA polymerase (New England 
Biolabs (NEB)) using the components supplied with the polymerase. Unless stated otherwise, 
the reaction was set up as detailed in Table 2.1 and thermal cycling carried out as detailed in 
Table 2.2 using a G-Storm GS2 thermal cycler. 
Table 2.1. The reaction components of a PCR with Phusion DNA polymerase 
Component Final concentration 
5 x HF buffer 1 x 
dNTPs 200 µM of each 
Forward primer 0.5 µM 
Reverse primer 0.5 µM 
Template DNA 1 ng/ µl 
DMSO 3% 
Deionised water Up to final volume of 50 µl 
Phusion DNA polymerase 0.02 U/ µl 
Components were added in the order shown. 
 
Table 2.2. The PCR reaction conditions 
Stage Temperature 
(˚C) 
Time 
(seconds) 
Hot start 98 120 
25 cycles:  
Denature 98 20 
Anneal 54 20 
Extend 72 Depends on expected product 
Final extension 72 600 
Store 4 ∞ 
 
When KOD DNA polymerase was used, the reaction conditions were the same except that no 
DMSO was used and 1.5 mM MgCl2 was added along with the 1 x KOD reaction buffer. 
2.4.2 Overlap extension 
The overlap extension reaction used all of the reaction components shown in Table 2.1 apart 
from the template DNA and primers. Equimolar quantities of the two DNA fragments to be 
spliced were added to a total DNA concentration of 40 ng/ µl. The reaction conditions are 
shown in Table 2.3. 
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Table 2.3. The overlap extension reaction conditions 
Stage Temperature 
(˚C) 
Time 
(seconds) 
Hot start 98 120 
10 cycles:  
Denature 98 20 
Anneal 54 20 
Extend 72 90 
Addition of a further 0.02 U/ µg Phusion DNA polymerase 
10 cycles:  
Denature 98 20 
Anneal 54 20 
Extend 72 90 
Final extension 72 600 
Store 4 ∞ 
 
2.4.3 Site-directed mutagenesis 
In order to introduce a point mutation two complementary oligonucleotide primers containing 
the mutation, and designed to bind to opposite strands of the plasmid, were synthesised. 
Using the plasmid as a template, linear amplification temperature cycling was carried out in 
the same way as PCR with KOD or Phusion DNA polymerase (Section 2.4.1) to extend the two 
primers. Following temperature cycling, the methylated template DNA which did not contain 
the mutation was digested by DpnI leaving the non-methylated nicked plasmid containing the 
introduced mutation on both strands. This was then transformed into XL1 blue cells, purified 
from transformants, and the mutation confirmed by DNA sequencing (Section 2.4.15). 
2.4.4 Agarose gel electrophoresis 
The agarose gel was prepared and run using a HU6 Mini (small gel) or HU10 Mini-Plus (large 
gel) horizontal gel unit (Scie-Plas, Harvard Bioscience). Agarose gels of the desired percentage 
were made by combining the appropriate volume of Tris-acetate ethylenediaminetetraacetic 
acid (TAE) buffer (40 mM Tris-acetate, 1 mM ethylenediaminetetraacetic acid (EDTA), made up 
as a 50 x stock, pH 8.0) with agarose in a 250 ml Duran bottle and heating in the microwave for 
approximately 2 minutes until the agarose completely dissolved and the solution was bubbling. 
The agarose solution was cooled in a 50 °C water bath for 30 minutes before addition of the 
appropriate volume of SYBRsafe DNA gel stain (Invitrogen). The molten agarose was then 
poured into the casting tray in a casting unit, a comb added and the gel left to set at room 
temperature. 
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To run, the casting tray containing the agarose gel was removed from the casting unit and 
placed into the running chamber. The comb was removed and TAE buffer was added until the 
gel was submerged. DNA samples were prepared by addition of 6 x gel loading dye (NEB) and 
then loaded into the wells of the agarose gel. A 1 μl aliquot of the appropriate DNA size ladder 
was also combined with 1 μl 6 x gel loading dye and added to a well: either 1 kb DNA size 
ladder or 100 bp DNA size ladder (NEB) were used (Figure 2.1). 
 
Figure 2.1. DNA size ladders used in agarose gel electrophoresis 
The 1 kb (left) and 100 bp (right) DNA size ladders were used to estimate the size of DNA 
analysed by agarose gel electrophoresis as well as confirm the concentration measured 
using the Nanodrop-1000 spectrophotometer by comparison of the band intensities 
(Section 2.4.14). 
 
Once samples were loaded the running chamber was connected to the power unit and a 
voltage of 100 V applied for 40 minutes, or longer if better resolution was required. DNA was 
either visualised under UV light and photographed using an AlphaImager system (Alpha 
Innotech) or if it was to be used for downstream applications, was visualised using a Safe 
Imager (Invitrogen) which is a blue light transilluminator and does not lead to DNA damage as 
UV light does. 
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2.4.5 Restriction digestion 
Restriction digestion was carried out with MfeI-HF™ and NotI-HF™ restriction enzymes (NEB). 
Each digestion reaction contained 1 x Buffer 4, 0.2 µg/ µl bovine serum albumin, 1 U/ µl of 
each of the restriction enzymes and 0.1 µg/ µl plasmid DNA and was incubated at 37 °C for >4 
hours. 
2.4.6 Dephosphorylation 
By dephosphorylating the digested plasmid, the 5’ phosphate is removed and self-ligation is 
prevented (Sambrook et al., 1989). Dephosphorylation was carried out by adding 0.1 U/ µl 
Antarctic Phosphatase and 1 x Antarctic Phosphatase reaction buffer (NEB) to the completed 
restriction digestion reaction (Section 2.4.5) and incubating at 37 °C for 15 minutes. The 
phosphatase enzyme was heat inactivated by incubation at 65 °C for 5 minutes in a G-Storm 
GS2 thermal cycler. 
2.4.7 Ligation 
Ligation of plasmid and insert was carried out using T4 DNA ligase from NEB or from Roche. 
The appropriate amounts of the digested, dephosphorylated plasmid and the digested insert 
were combined with the appropriate 1 x T4 DNA ligase reaction buffer and T4 DNA ligase and 
made up to a total reaction volume of 10 µl with deionised water. Incubations were carried out 
in 200 µl PCR tubes at 4 °C. 
2.4.8 Transformation into E. coli cells by heatshock 
A 50 μl aliquot of competent cells (Section 2.2.4) was defrosted on ice for at least 10 minutes 
before addition of 10-50 ng plasmid DNA in a total volume of no more than 5 μl. The mixture 
was gently mixed and incubated on ice for 30 minutes before transfer to a 42 °C water bath for 
45 seconds. The microcentrifuge tube was then transferred immediately to ice for a minimum 
of two minutes before addition of 1 ml 2TY broth, pre-warmed to 37 °C. The culture was then 
placed in a shaking incubator at 37 °C with shaking at 220 rpm to permit recovery and 
expression of the antibiotic resistance protein. After one hour, a 100 μl aliquot was plated 
onto an agar plate containing the appropriate antibiotic and the remaining culture was 
centrifuged at 4000 rpm for 4 minutes in a microcentrifuge. All but 100 μl of the supernatant 
was discarded and the remaining broth used to resuspend the bacterial pellet which was then 
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plated out onto a second agar plate containing the appropriate antibiotic. Both plates were 
inverted and incubated at 37 °C in a static incubator overnight. 
2.4.9 Transformation into E. coli cells by electroporation 
A 25 µl aliquot of electrocompetent cells was defrosted on ice for 5-10 minutes and then 
added to 40 ng plasmid DNA in 1.6 µl deionised water in a chilled microcentrifuge tube. The 
mixture was then carefully transferred to a chilled, sterile electroporation cuvette with a 0.2 
cm gap (BioRad). The samples were electroporated in a MicroPulser Electroporator (BioRad) at 
2.5 V and 2 x 750 µl SOC broth, at room temperature, was added immediately. The culture was 
transferred to a 14 ml round-bottomed tube and placed in a shaking incubator at 37 °C with 
shaking at 220 rpm to permit recovery and expression of the antibiotic resistance protein. 
After one hour the culture was plated out onto 245 x 245 mm bio-assay agar plates containing 
the appropriate antibiotic, inverted and incubated at 37 °C in a static incubator overnight. 
2.4.10  Colony PCR 
A 200 µl (yellow) pipette tip was used to collect a single colony and swirled gently in 100 μl 
sterile deionised water before being used to inoculate 3 ml 2TY broth containing the 
appropriate antibiotic. This culture was incubated overnight at 37 °C with shaking at 220 rpm 
to enable purification of the DNA by miniprep (Section 2.4.11). Meanwhile the inoculated 
water was heated to 99 °C for 5 minutes in a G-Storm GS2 thermal cycler, cooled to room 
temperature and centrifuged at 13000 rpm in a microcentrifuge to pellet cell debris leaving the 
DNA in suspension. A 1 μl aliquot of this suspension was added to 24 μl of PCR mastermix (1 x 
green GoTaq Flexi buffer, 2 mM MgCl2, 0.2 mM PCR nucleotide mix, 0.025 U/ μl GoTaq 
HotStart polymerase (Promega), 0.2 μM of each of the primers used), mixed and PCR carried 
out according to the parameters outlined in Table 2.4. The products were then analysed by 
agarose gel electrophoresis to confirm the presence or absence of the desired product. 
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Table 2.4. The reaction conditions for colony PCR 
Stage Temperature 
(˚C) 
Time 
(seconds) 
Hot start 95 300 
30 cycles:  
Denature 95 30 
Anneal 55 30 
Extend 72 Depends on expected product 
Final extension 72 300 
Store 4 ∞ 
 
2.4.11  Purification of DNA from E. coli by miniprep 
The QIAprep® Spin miniprep kit (Qiagen) was used to purify DNA from E. coli cultures. A single 
colony containing the plasmid to be purified was used to inoculate 5 ml 2TY broth containing 
the appropriate antibiotic and incubated overnight at 37 °C in a shaking incubator at 220 rpm. 
The cells were harvested by centrifugation at 7500 x g for 5 minutes in a Hermle Z400 K 
centrifuge with a 220 97 VO2 rotor and the supernatant drained by inverting the tube. The 
pellet was completely resuspended in 250 μl buffer P1 (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 
100 μg/ ml ribonuclease A, 1 μl/ ml LyseBlue reagent) using a vortex before transfer to a 1.5 ml 
microcentrifuge tube. 250 μl lysis buffer P2 (200 mM NaOH, 1% (w/ v) SDS) was added and the 
solution mixed by inversion until a homogeneous blue colour was achieved. 350 μl 
neutralisation buffer N3 (4.2 M guanidinium chloride, 0.9 M potassium acetate, pH 4.8) was 
then added and immediately mixed by inversion until all of the blue colour had disappeared 
indicating that the SDS had precipitated and the solution had been neutralised. The tube was 
then centrifuged at 13000 rpm in a microcentrifuge for 15 minutes to pellet all of the cell 
debris. The supernatant was applied to a QIAprep spin column, which contains a silica gel 
membrane which can bind up to 20 μg DNA in the presence of high concentrations of 
chaotropic salts such as guanidinium chloride, and centrifuged for 45 seconds. The flow-
through was discarded and the silica gel membrane was washed to remove impurities by 
addition of 750 μl buffer PE (10 mM Tris-HCl, pH 7.5, 80% (v/ v) ethanol) and centrifugation for 
45 seconds. The flow-through was discarded and the spin column with DNA adsorbed was 
spun for a further 60 seconds to remove any residual ethanol which would prevent loading of 
the sample onto an agarose gel and inhibit any future enzymatic reactions. The column was 
transferred to a sterile 1.5 ml microcentrifuge tube, 30 μl of deionised water was carefully 
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pipetted onto the membrane and after 60 seconds the column was centrifuged for 2 minutes 
to elute the DNA which was then stored at -20 °C. 
2.4.12  Purification of DNA from an agarose gel  
The QIAquick® Gel Extraction kit (Qiagen) was used to purify DNA from agarose gels. The DNA 
sample was first separated by agarose gel electrophoresis and visualised using a Safe Imager 
(Invitrogen) (Section 2.4.4). DNA was not visualised by UV light as this can cause damage which 
significantly reduces the efficiency of downstream applications such as overlap extension, and 
ligation (lifetechnologies.com). The band of interest was excised using a clean, sharp scalpel 
and placed in a 1.5 ml microcentrifuge tube or 7 ml bijou container depending on the size of 
the gel slice. The agarose gel was solubilised by addition of 3 gel volumes of buffer QG (5.5 M 
guanidine thiocyanate, 20 mM Tris-HCl, pH 6.6) at 50 ˚C, which contains high levels of the 
chaotropic salt guanidine thiocyanate to ensure binding of DNA to the QIAquick membrane. To 
ensure the highest efficiency binding the pH of the solution was brought below pH 7.5 by 
addition of 10 µl of 3 M sodium acetate, pH 5.0 and 1 gel volume of isopropanol was added. 
The sample was then applied to the QIAquick column and centrifuged for 1 minute at 13000 
rpm in a microcentrifuge. The flow-through was discarded and the column was washed to 
remove impurities by addition of 750 µl of buffer PE (10 mM Tris-HCl, pH 7.5, 80% (v/ v) 
ethanol) and centrifugation for 1 minute at 13000 rpm. To elute the DNA the column was 
placed in a clean 1.5 ml microcentrifuge tube and 30 µl sterile, deionised water added to the 
centre of the membrane. After 60 seconds at room temperature this was centrifuged for 2 
minutes at 13000 rpm, the spin column discarded and the DNA solution stored at -20 ˚C. 
2.4.13  Purification of PCR products 
The QIAquick® PCR Purification kit (Qiagen) was used to purify DNA products following PCR, 
overlap extension or ligation where separation from other DNA species was not necessary but 
removal of reaction components was required for the highest efficiency of downstream 
processes, such as digestion or transformation. The protocol was the same for that of the 
QIAquick® Gel Extraction kit except that the PCR reaction was mixed with 5 volumes of buffer 
PB (5 M guanidinium chloride, 30% (v/ v) isopropanol) containing pH indicator, rather than 
buffer QG, before being applied to the QIAquick column. 
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2.4.14  Determination of DNA concentration  
DNA concentration was determined using a Nanodrop-1000 spectrophotometer (Thermo-
Scientific). The spectrophotometer was initialised using 10 μl deionised water, then deionised 
water was used to take a blank reading. A 2 μl aliquot of the DNA solution was then applied to 
the sample pedestal and the concentration determined from the A260 reading according to the 
Beer-Lambert equation: A260 = εCl where ε is the extinction coefficient (50 (ng/ μl)
-1 cm-1), C is 
the DNA concentration in ng/ μl and l is the path length in cm. 
DNA concentration was also confirmed by comparing band intensity on agarose gels with that 
of the 1 kb or 100 bp DNA size ladders (NEB) (Figure 2.1). 
2.4.15  DNA sequencing 
DNA sequencing was carried out by GATC Biotech or Beckman Coulter Genomics. Plasmid DNA 
and sequencing primers (Table 2.5) were provided and sequencing data was returned as .ab1 
files. Results were analysed using BioEdit Sequence Alignment Editor v. 7.0.5.3 and Vector NTI 
Advance 11.5.2 (Invitrogen). 
Table 2.5. Primers used for sequencing GO 
Primer name Sequence 
T7F 5’ taatacgactcactataggg 3’ 
T7R 5’ ccgctgagcaataactag 3’ 
GOF1 5’ ccgacatcgggacgagtcc 3’ 
GOF2 5’ gccacaaccaacgcccac 3’ 
GOR1 5’ gtgggcgttggttgtggc 3’ 
GOR2 5’ ggactcgtcccgatgtcgg 3’ 
 
2.4.16  Preparation of glycerol stocks 
A single colony of XL1 blue cells containing the plasmid of interest was used to inoculate 5 ml 
of 2TY broth containing the antibiotic. This culture was incubated at 37 ˚C with shaking at 220 
rpm overnight. The following morning the culture was centrifuged at 4000 x g in a Hermle 
Z400 K centrifuge with a 220 97 VO2 rotor at 4 ˚C for 10 minutes to pellet the cells but not 
damage them. The pellet was then gently resuspended in 3 ml sterile 2TY broth containing 
80% (v/ v) glycerol and aliquoted into three cryovials. These were then flash frozen in liquid 
nitrogen and stored at -80 ˚C. 
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2.5 Protein expression and purification 
2.5.1 Expression by autoinduction 
A single colony of BL21 Star (DE3) cells containing the plasmid of interest was used to inoculate 
2 ml of ZYP-0.8G broth containing the appropriate antibiotic. This culture was incubated at 37 
˚C with shaking at 220 rpm for >6 hours after which time a 200 µl aliquot was used to inoculate 
400 ml 8ZYM+5052+25 mM succinate broth in a 2 L baffled flask. This autoinduction culture 
was then incubated at 25 ˚C with shaking at 220 rpm for 64 hours. 
2.5.2 Preparation of the crude extract 
Protein-expressing cells were harvested by centrifugation at 7500 x g at 4 ˚C for 15 minutes in 
a Sorvall RC-5B centrifuge and SLA-1500 rotor and the pellet stored at -80 ˚C. Lysis buffer was 
prepared by dissolving 50 mM HEPES pH 8.0, 25% sucrose (w/ v), 5 mM MgCl2 and 1% Triton X-
100 in deionised water, filter sterilising through a 0.2 µm membrane and chilling to 4 °C. 
Directly before use 1 mg/ ml hen egg white lysozyme, 20 U/ ml Omnicleave endonuclease 
(Epicentre, USA) and two cOmplete® protease inhibitor cocktail tablets (Roche) per 100 ml 
were added. The cells were lysed by dispersing the frozen pellet in 20 ml lysis buffer and 
stirring in the cold room for 45-60 minutes. The lysate was then centrifuged at 30000 x g at 4 
˚C for 45 minutes in a Sorvall RC-5B centrifuge and Fibrelite F21 8x50 rotor to separate the 
insoluble fraction (the pellet) from the soluble fraction (the supernatant). The soluble fraction 
was dialysed in 10 kDa MWCO dialysis tubing against 5 L phosphate buffered saline (PBS) (137 
mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) for 1 hour at 4 °C and then 5 L 
PBS for 2-3 hours at 4 °C and then centrifuged at 30000 x g at 4 ˚C for 20 minutes in a Sorvall 
RC-5B centrifuge and Fibrelite F21 8x50 rotor to remove any precipitate. Following 
centrifugation, the crude extract was filtered through a 0.2 µm syringe-end filter before 
loading onto the Strep-Tactin resin. 
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2.5.3 Strep-Tactin affinity chromatography 
The entire purification was carried out in the cold room. The four buffers used are shown in 
Table 2.6.  
Table 2.6. Buffers used in Strep-Tactin chromatography purification 
Buffer Components 
Wash buffer 1 (PBS) 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4 
Elution buffer wash buffer 1 containing 5 mM desthiobiotin, pH 7.4 
Regeneration buffer 100 mM Tris-HCl, pH 8.0, 150 mM NaCl,  
1 mM 2-(4-hydroxyphenylazo)benzoic acid 
Wash buffer 2 100 mM Tris-HCl, pH 10.5, 150 mM NaCl 
All buffers were filtered through a 0.2 µm membrane and chilled to 4 °C before use. 
 
A 0.5-2.0 ml aliquot of Strep-Tactin Superflow high capacity resin (IBA) was dispensed with a 
Pasteur pipette into a 2 ml disposable polystyrene column (Thermo Scientific) and equilibrated 
with >10 column volumes (CV) of wash buffer 1. The filtered crude lysate was then applied to 
the column and the flow-through collected. Unbound proteins were washed off the column 
with >10 CV of wash buffer 1 and the end cap of the polystyrene column was attached to 
pause the flow. Elution buffer was then added to fill the polystyrene column and the resin 
mixed with a Pasteur pipette to ensure maximal elution of the Strep II-tagged GO. After the 
Strep-Tactin resin had settled, the end cap was removed and elution fractions collected in 2 CV 
volumes. Extra elution buffer was added to the column and collected in the same way to yield 
a total elution volume of 12 CV. 
The following day, the six elution fractions were pooled and dialysed in 10 kDa MWCO tubing 
against 1 L 20 mM PIPES, pH 6.1 at 4 °C for 1 hour to remove the desthiobiotin. Dialysis was 
then carried out for 3 hours against 3 L 20 mM PIPES, pH 6.1 containing 1 mM Cu(NO3)2 at 4 °C 
to ensure complete incorporation of copper into the active site of the enzyme. The protein 
solution was finally dialysed against 5 L 100 mM sodium phosphate, pH 7.0 at 4 °C for 1 hour 
and then for a further 2-3 hours after a buffer change. 
The Strep-Tactin resin was regenerated by addition of >10 CV regeneration buffer which was 
removed by addition of 5 CV wash buffer 2 before equilibration with >10 CV wash buffer 1 
ready for the next purification. In order to avoid any potential contamination of one mutant 
with another, fresh resin was used for purification of each variant. 
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2.5.4 Concentration and storage of protein samples 
Following dialysis, protein samples were filtered through a 0.2 µm syringe-end filter and 
concentrated using a centrifugal concentrator (Vivaspin) with a polyethersulfone membrane 
and 10 kDa MWCO. Centrifugation was carried out at 8000 x g in a Hermle Z400 K centrifuge 
with a 220 97 VO2 rotor at 4 ˚C for 10 minutes at a time until the protein solution volume was 
less than 1 ml. The solution was then divided into aliquots of 50-200 µl, flash frozen in liquid 
nitrogen and stored at -80 °C. 
2.6 Protein analysis 
2.6.1 Determination of protein concentration 
Protein concentration was determined using a UV-2401PC spectrophotometer (Shimadzu) 
controlled by UV Probe v.2.2 software. A baseline reading was recorded with 100 mM sodium 
phosphate, pH 7.0 before a spectrum was recorded from 360 to 250 nm for a 10-fold dilution 
of the purified protein. A spectrum was recorded rather than a single wavelength reading at 
280 nm in order to confirm that the λmax was at 280 nm and not at another wavelength such as 
260 nm which would suggest DNA contamination. To determine the molar concentration of 
GO the Beer-Lambert equation was used: A280 = ε280Cl where ε is the extinction coefficient of 
GO at 280 nm (104900 M-1 cm-1) (Kosman et al., 1974), C is the molar protein concentration 
and l is the path length in cm. Therefore, for an absorbance of 1: 
[GO] = A280/ εl  
= 1/ (104900 M-1 cm-1 x 1 cm) 
= 9.53 x 10-6 M 
To convert to units of mg/ ml of enzyme this is multiplied by the molecular mass of the Strep II-
tagged protein (70435), as mass (g) = number of moles x molecular weight. As the Strep II-tag 
contains a Trp residue, the value then needs to be corrected as Trp residues have a significant 
effect on A280 measurements (Baron et al., 1994, Rannes et al., 2011). GO contains 16 Trp 
residues so the concentration was multiplied by a correction factor of 16/ 17. Therefore, the 
concentration in mg/ ml is determined by multiplying the absorbance reading by 9.53 x 10-6 x 
70435 x 16/ 17 = 0.63. 
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2.6.2 Analysis by SDS-PAGE 
Protein samples were separated according to their motility through a SDS-polyacrylamide gel 
by electrophoresis following the commonly used protocol developed by Laemmli (1970). 
2.6.2.1 Preparation of soluble samples 
To ensure visualisation, denaturation and easy loading, samples were mixed with 4 x loading 
buffer (200 mM Tris-HCl, pH 6.8, 20% (v/ v) glycerol, 8% (w/ v) SDS, 0.4% (w/ v) bromophenol 
blue, 20% (v/ v) β-mercaptoethanol) and heated at >70 °C for 5 minutes. 
2.6.2.2 Preparation of insoluble samples 
The insoluble fraction obtained from the lysis of the cell pellet in 20 ml lysis buffer (Section 
2.5.2) was resuspended in 20 ml 10% (v/ v) lysis buffer. A 1 ml aliquot of the resuspended 
mixture was then centrifuged at 13000 rpm in a microcentrifuge for 5 minutes, the 
supernatant was discarded and the pellet resuspended once more in 10% (v/ v) lysis buffer. 
This was repeated three more times to wash the insoluble pellet and remove any soluble 
proteins before the pellet was resuspended in enough 4 x loading buffer (Section 2.6.2.1) to 
make the total volume up to 1 ml. The resuspended pellet was then heated at >70 ˚C for 5 
minutes. 
2.6.2.3 Preparing and running the gel 
Using a Bio-Rad PROTEAN casting system a 15% resolving gel (15% (v/ v) acrylamide (Severn 
Biotech Ltd.), 375 mM Tris-HCl, pH 8.8, 0.1% (w/ v) SDS, 0.1% (w/ v) ammonium persulfate 
(APS), 0.04% (v/ v) N,N,N’,N’,-tetramethylethylenediamine (TEMED)) was poured between 
casting plates using a Pasteur pipette and allowed to polymerise overlaid with ethanol to 
ensure a flat interface. The ethanol was then removed by rinsing with deionised water and a 
stacking gel (5% (v/ v) acrylamide, 125 mM Tris-HCl, pH 6.8, 0.1% (w/ v) SDS, 0.1% (w/ v) APS, 
0.1% (v/ v) TEMED) poured using a Pasteur pipette before addition of a 10- or 15-well comb to 
create sample wells. Protein samples were loaded along with PageRuler™ Unstained Protein 
Size Ladder (Fermentas) (Figure 2.2) to permit estimation of the size of the protein bands. Gels 
were electrophoresed at 200 V in SDS-PAGE running buffer (25 mM Tris, 250 mM glycine, 0.1% 
(w/ v) SDS, pH 8.3) until the dye front had just run off the bottom of the gel (approximately 45 
minutes). The gel was stained with InstantBlue (Expedeon); bands were visible within about 10 
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minutes and the gel was photographed after 1 hour using an AlphaImager system (Alpha 
Innotech). 
 
Figure 2.2. PageRuler™ unstained protein size ladder used in SDS-PAGE 
 
2.6.3 Kinetic analysis of enzyme activity 
In order to measure the activity of GO, a coupled assay was carried out in which hydrogen 
peroxide generated by the GO-catalysed reaction is used by HRP to oxidise two molecules of 
ABTS to generate a coloured product. This product has a λmax of 414 nm so generation can be 
followed spectrophotometrically. The assay mix shown in Table 2.7 was equilibrated to 25 °C in 
a water bath before addition of 950 µl to a 1 ml plastic cuvette. 
Table 2.7. The assay mix used to measure GO activity spectrophotometrically 
Component Concentration in assay mix 
Sodium phosphate, pH 7.0 100 mM 
ABTS 1 mM 
HRP 30 U/ ml 
Sugar substrate varied 
 
A 50 µl aliquot of GO at an appropriate concentration to give a measurable rate was added. 
The cuvette was immediately covered with Parafilm and mixed by inversion and then 
immediately placed into the UV-2401PC spectrophotometer (Shimadzu). Absorbance at 414 
nm was typically measured for 30-60 seconds using the UV Probe v.2.2 software and the plot 
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of A414 against time was used to determine the rate in absorbance units per second. This rate 
was then divided by two as one molecule of hydrogen peroxide is used to generate two 
molecules of coloured product. According to the Beer-Lambert equation A414 = ε414Cl, where 
the extinction coefficient of ABTS radical at 414 nm is 31300 M-1 cm-1, the rate in absorbance 
units per second was divided by 31300 and then multiplied by 106 to convert the units to µM 
per second. 
Kinetic parameters were determined by measuring activity over a range of substrate 
concentrations and fitting the plot of rate against substrate concentration to the Michaelis-
Menten equation using non-linear regression in OriginPro 9.0: 
 Rate = (Vmax[S])/ (KM+[S]) 
Where Vmax (µM hydrogen peroxide/ second) is the maximum rate of the enzyme, [S] (mM) is 
the substrate concentration and the Michaelis constant, KM (mM) is the [S] at half Vmax and can 
give an indication of the affinity of the enzyme for the substrate. The turnover number, kcat (s
-1) 
was determined by dividing Vmax by the enzyme concentration (µM). 
2.6.4 Determination of specific activity 
The assay to determine specific activities of the variants with the different substrates was 
carried out in the same way as kinetic analysis (Section 2.6.3) except that activity was only 
measured at one substrate concentration (Table 2.8). The rate given in units of µM per minute 
was divided by the mg of GO added and then divided by 1000 ml to convert to units of µmol 
hydrogen peroxide per minute per mg GO. 
Table 2.8. Concentrations of substrates used to measure substrate specificity 
Substrate Concentrations used (M) 
D-galactose 0.6, 1.0 
D-arabinose 2.0, 1.0 
D-glucose 2.0, 1.0 
D-mannose 2.0, 1.0 
D-xylose 1.5, 1.0 
Glycerol 1.5, 1.0 
 
pH profiles were determined by measuring specific activities in buffers covering a range of pH. 
The protocol was the same except that the sodium phosphate, pH 7.0 was substituted for 
different buffers as detailed in Section 5.6. 
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2.6.4.1 Determination of specific activity at varied oxygen concentrations 
In order to measure the specific activities at different oxygen concentrations, the assay mixes 
were prepared differently. For measuring activity with a reduced oxygen concentration, the 
assay mix (Table 2.7), in a round bottomed flask sealed with a Suba Seal rubber septum, was 
degassed using a vacuum and nitrogen bubbled through overnight to remove all oxygen. The 
cuvette to be used for the activity measurement had a round opening and was sealed with a 
Suba Seal rubber septum before nitrogen was used to purge the cuvette of oxygen. The 
degassed assay mix was removed from the round bottomed flask with a Hamilton syringe and 
immediately transferred to the nitrogen-filled assay cuvette. The enzyme solution, which had 
been briefly bubbled with nitrogen to reduce the oxygen concentration, was transferred to the 
assay mix using a Hamilton syringe. After mixing by inversion, product generation was followed 
spectrophotometrically. 
In order to measure activity at increased oxygen concentration, the assay mix (Table 2.7) was 
transferred to a cuvette with a round opening and the cuvette sealed with a Suba Seal rubber 
septum. Oxygen was bubbled though the assay mix for a minimum of one hour, with an 
additional needle to permit exit of gases, before addition of the enzyme solution with a 
Hamilton syringe. After mixing by inversion, product generation was followed 
spectrophotometrically. 
2.6.5 NMR spectroscopy 
2.6.5.1 Preparation of samples 
The complete reaction mix, or 200 µl aliquots, were freeze-dried overnight to remove water. 
The dried samples were then redissolved in an appropriate volume of deuterium oxide (700 µl 
for the 200 µl aliquots) and transferred to 5 mm NMR tubes. 
2.6.5.2 Acquisition and analysis of 1H-NMR and 13C-NMR spectra 
1H and 13C NMR spectra were recorded on a Bruker Avance 500 instrument (at 500 MHz and 
125 MHz respectively) at 25 °C. The data were processed using MestReNova software 
(mestrelab.com). Signals were assigned by Dr Bruce Turnbull using a combination of COSY and 
HMQC 2D spectra. 
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3.1 Introduction 
In order to identify variants showing alterations in activity compared to WT it is necessary to 
screen libraries of mutants. Many examples of different assays exist to screen for changes in 
enzyme activities. In screening assays it is desirable to use selection techniques where the 
novel activity is essential for cell survival or growth. However, this is not possible in the 
majority of cases and therefore high-throughput screens must be developed. A number of 
factors must be considered when choosing or designing a screening method: 
 Reproducibility and accuracy so that results are reliable and minimal repeats are 
required. 
 Affordability of the assay components to reduce the financial impact of the process on 
laboratory budgets. For example, use of antibodies or expensive substrates will 
significantly increase the cost of screening. 
 Minimal use of expensive equipment such as NMR or LC-MS which can significantly 
reduce the feasibility of screening larger libraries. 
 Maximal throughput, for example, screening involving NMR or LC-MS can be 
considered very low-throughput compared to FACS or phage display methods which 
are ultra-high throughput. 
 Sensitivity of the screen so that small changes in activity can be detected. 
 Safety of the components and equipment used, for example avoiding use of 
radioactive or carcinogenic substances where possible to remove unnecessary risk of 
exposure to researchers. 
Unfortunately it is rarely possible to fulfil all of these criteria in development of an assay. For 
screening GO libraries an agar plate-based screen has already been used successfully by 
different groups (Delagrave et al., 2001, Escalettes and Turner, 2008). The basic screen uses 
the coupled assay detailed in Figure 1.6. The mutant library is transformed into an expression 
strain of E. coli which is plated out onto membranes and grown on agar plates containing the 
appropriate antibiotic. Cytoplasmic expression of the library variants is either induced by 
transfer of the membrane to an induction plate (Delagrave et al., 2001), or occurs by 
autoinduction during a longer growth period at lower temperature (Escalettes and Turner, 
2008). Unlike Delagrave et al. (2001), Escalettes et al. (2008) duplicated the plate of colonies 
onto an additional membrane. The duplicate colonies were used in later inoculations based on 
Chapter 3: Development and Optimisation of Screening Assays to Detect Oxidase Activity 
69 
 
the results of screening. Both protocols exposed the colonies to chloroform vapour in order to 
disrupt the cell membranes and release GO. The colonies, on the membrane support, were 
transferred to an assay mix containing the substrate of interest, CuSO4, HRP, and a 
chromogenic substrate which generates a coloured product when oxidised by HRP in the 
presence of hydrogen peroxide. Colour generation was then observed visually for colonies 
expressing variants active against the substrate provided. The bulk of this chapter details 
experiments to optimise the agar plate-based assay for maximal sensitivity as well as reducing 
the cost and improving the safety of the procedure. 
Optimisation of a microtitre plate-based screen for confirmation of novel activities identified in 
initial agar plate-based screening is also described. Microtitre plate-based screening is very 
widely used in various bioscience applications including drug discovery (Brik et al., 2006) and 
screening conditions required for different cellular processes (Tomasini-Johansson et al., 
2012). It also has the potential for automation if robotic systems are available. The basic assay 
involves growth of a different library variant in each well of the microtitre plate, followed by 
induction using IPTG and harvesting of the cell pellet by centrifugation. The pellet is then lysed 
and aliquots of the lysate added to different assay plates containing the same assay mix as 
used in the agar plate-based screen. Positive results can be detected visually, or 
spectrophotometrically. 
Some of the cloning described in this chapter (Section 3.2.3) is carried out using a method 
called Circular Polymerase Extension Cloning (CPEC) which was designed by Quan and Tian 
(2009). This sequence-independent method replaces the restriction digestion and ligation 
procedure commonly used to insert a coding sequence into a plasmid. It is convenient to use 
when it is not possible (or desirable) to engineer restriction sites at specific positions in a 
sequence. This relatively simple method extends overlapping regions between the insert and 
vector in much the same way as overlap extension (McPherson and Moller, 2006), but the 
overlaps occur at both ends of the linearised plasmid and insert resulting in a complete circular 
plasmid which can then be used to transform cells (Figure 3.1). This technique was selected to 
avoid the need to engineer restriction sites at the desired position.  
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Figure 3.1. Schematic illustrating CPEC 
Adapted from Quan and Tian (2009). Appropriate PCR primers are designed and used to 
generate the linear plasmid and insert with 20-30 bp overlapping regions (A). The 
plasmid and insert are denatured and annealed and the sequence is extended using a 
thermostable polymerase (B). This results in plasmids containing a single nick in each 
strand which are ready for transformation of E. coli (C). 
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3.2 Optimisation of the agar plate-based assay 
3.2.1 The best membrane for growth of colonies 
As the agar plate-based assay was to be used for large scale screening of multiple libraries, it 
was desirable to use cheap components where possible to reduce the overall cost of the 
process. Other groups using this format of assay have plated colonies onto polyester 
(Delagrave et al., 2001), nitrocellulose (Alexeeva et al., 2002) or nylon (Escalettes and Turner, 
2008) membranes. A trial was carried out to see if these membranes could be substituted with 
filter paper, which is significantly cheaper. Unfortunately it is clear from Figure 3.2 that filter 
paper is not an appropriate substitute as the coloured ABTS product diffused significantly 
across the membrane whereas with the nitrocellulose membrane the product remained 
localised, enabling identification of positive colonies. Filter paper would only be usable in 
screening if colonies were plated out at very low density and very few displayed colour change. 
 
Figure 3.2. Comparison of nitrocellulose membrane and filter paper for growth of colonies 
E. coli expressing WT GO-N6M1 were grown on A: nitrocellulose membrane or B: filter 
paper and the assay carried out. After 30 minutes, the coloured product has diffused 
across the filter paper to a significantly greater extent than the nitrocellulose 
membrane. 
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The sensitivity of the assay was compared when nitrocellulose membrane of two different 
thicknesses or nylon membrane was used. Nitrocellulose membrane is available from different 
suppliers at thicknesses of approximately 125 µm or 190 µm while the nylon membrane used 
(Hybond-N, GE LifeSciences) is between 100 and 200 µm according to the manufacturer. As 
shown in Figure 3.3, when the assay was carried out with nitrocellulose membrane of 125 µm, 
colour formation occurred much more rapidly than with the other two membranes implying a 
more sensitive assay with the thinner membrane.  
 
Figure 3.3. Effect on rate of colour formation with three different screening membranes 
The sensitivity of the assay was compared by measuring the rate of colour formation 
when nitrocellulose of two different thicknesses or nylon membrane was used for 
plating out the E. coli. 
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The final optimisation for the membrane used was to compare the sensitivity of nitrocellulose 
membrane with different pore sizes. Nitrocellulose membrane is available with different pore 
sizes due to its primary function in blotting experiments. Membranes with smaller pore sizes 
have a larger surface area and so show better retention of proteins. As shown in Figure 3.4, 
there was no significant difference in screen sensitivity when the pore size was 0.45 or 0.2 µm 
implying that the difference in surface area does not affect the retention of any assay 
components such as the protein HRP. 
 
Figure 3.4. Effect on rate of colour formation of nitrocellulose of different pore sizes  
The sensitivity of the assay was compared by measuring the rate of colour formation 
when nitrocellulose membranes with two different pore sizes were used for plating out 
the E. coli. 
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3.2.2 The most appropriate chromogenic peroxidase substrate for the 
assay 
Other published work using agar plate-based assays has used either 4-chloronaphthol (4-CN) 
(Delagrave et al., 2001, Escalettes and Turner, 2008, Rannes et al., 2011) or DAB (Alexeeva et 
al., 2002) as the substrate for HRP to generate a coloured product in the presence of hydrogen 
peroxide. ABTS is a highly sensitive chromogenic peroxidase substrate already used in GO 
assays for kinetic analysis (Baron et al., 1994). Assays were carried out with GO-N6M1-
expressing E. coli to compare ABTS or DAB and 4-CN. As shown in Figure 3.5, use of ABTS 
produced much better results than a combination of the other two substrates as limited 
colouration of the nitrocellulose membrane occurred and the two negative controls (with no D-
galactose and with no HRP) resulted in essentially no colour change. Additionally, DAB is a 
toxic compound which is carcinogenic so its use should be avoided if there is an alternative. 4-
CN is less stable than ABTS and is light sensitive which may explain the colouration of the 
membranes in the assays containing this compound. Overall, ABTS seems to be the most 
sensitive and safest chromogenic substrate for use in the agar plate-based assay. 
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Figure 3.5. Comparison of ABTS and DAB/ 4-CN as the coupled assay substrate 
The assay was carried out with GO-N6M1-expressing E. coli with ABTS (A, C and E) or 
DAB & 4-CN (B, D and F) as the chromogenic substrate. A and B show the complete 
assay; C and D show controls where no D-galactose was included in the assay mix; and E 
and F show controls where no HRP was included in the assay mix. 
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Trials were carried out to ensure that colonies expressing variants active against the substrate 
provided could be distinguished from those expressing inactive variants. A mixture of E. coli 
expressing GO-N6M1 or E. coli amine oxidase (ECAO) were mixed and plated onto the 
nitrocellulose membrane. ECAO shows no activity against D-galactose so no hydrogen peroxide 
would be produced by these colonies. Figure 3.6 clearly shows that colonies expressing active 
variants could be easily identified in the screen using ABTS. When DAB and 4-CN were used as 
coupled substrates it was more difficult to identify the colonies, but still possible. 
 
Figure 3.6. Distinguishing colonies expressing/ not expressing active GO  
Screens were carried out using a mixture of colonies expressing GO or ECAO (which 
shows no galactose oxidase activity). In the screen using ABTS (A) colonies expressing 
active GO are purple while those expressing ECAO remain white. In the screen using DAB 
& 4-CN (B) colonies expressing active GO are dark brown while those expressing ECAO 
are light brown. In each case, the inset shows a magnified view of part of the plate. 
 
3.2.3 Secretion of GO into the periplasm 
In all published examples of this screen except Alexeeva et al. (2002), where the E. coli were 
plated directly onto agar, after growing on the membrane colonies were duplicated and lysed 
by chloroform vapour before addition of assay components. Any colonies displaying the 
desired activity were then recovered from the duplicate plate. With the aim of reducing the 
number of steps in the screening process and also the chance of errors introduced by replica 
plating, cloning was carried out to generate a version of GO which is expressed in the 
periplasm. The hypothesis was that lysing cells would not be required as the assay mix 
components should be much more accessible to periplasmic GO. 
WT ECAO is expressed in the periplasm of E. coli due to a 31-residue secretion signal sequence 
at the N-terminus and had previously been cloned into the pET28c plasmid by Dr M. Smith, 
University of Leeds. Primers were designed to amplify the pET28c plasmid including the 
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secretion signal sequence, N-terminal Strep II-tag and a TEV cleavage site, but excluding the 
ECAO coding region. Another primer pair was designed to amplify the GO coding region from 
the pET101D-N6M1 plasmid and add overlaps of 23 and 26 nucleotides complementary to the 
appropriate regions of the pET28c construct (Figure 3.7) according to the CPEC method 
detailed in Quan and Tian (2009) (Section 3.1). Primer sequences are shown in Table 3.1. 
 
Figure 3.7. The two plasmids used in cloning to transfer the ECAO secretion signal sequence 
to the GO-N6M1 coding region 
The features of each plasmid are shown including the ribosome binding site (RBS), 
primer binding sites required for the cloning described here and the coding regions of 
interest 
 
Table 3.1. Primers used to transfer the GO coding region into the pET28c plasmid containing 
the ECAO secretion signal sequence, Strep II-tag and TEV cleavage site 
Primer name Sequence 
pET28c-fwd 5’ ggatccgaattcgagctccgtcg 3’ 
pET28c-rev 5’ accctggaagtacaggttttctttctc 3’ 
GOpET28c-fwd 5’ agaaagaaaacctgtacttccagggtgcatctgcacctattggaa 
   gcgcc 3’ 
GOpET28c-rev 5’ cgacggagctcgaattcggatccctgagtaacgcgaatcgtcgaa 
   gcc 3’ 
Overlapping regions are underlined. 
 
PCR (Section 2.4.1) was carried out to amplify the plasmid and insert using extension times of 5 
and 2 minutes, respectively. Following purification of the products using the QIAquick PCR 
Purification kit (Section 2.4.13), 200 ng of the plasmid and an equimolar quantity of the insert 
(72 ng) were combined with KOD polymerase reaction components and thermal cycling was 
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carried out for either 5, 10 or 15 cycles: denaturation at 98 °C for 30 seconds, annealing at 68 
°C for 30 seconds, extension at 72 °C for 8 minutes. The products (Figure 3.8) were 
transformed into XL1 Blue cells (Section 2.4.8) and plated out onto agar plates containing 
kanamycin which would only support growth of cells containing the pET28c plasmid, which 
contains the KanR gene. Correct incorporation of the insert into the plasmid was confirmed by 
DNA sequencing. Unfortunately the primers used to amplify the GO-N6M1 coding region from 
the pET101D plasmid did not include a stop codon at the 3’ end of the coding region which was 
necessary as the existing C-terminal Strep II-tag was not amplified. Site-directed mutagenesis 
was therefore carried out using KOD DNA polymerase to insert a stop codon using the primers 
shown in (Table 3.2). 
Table 3.2. Primers used to introduce a stop codon at the end of the GO-N6M1 coding region 
within the pET28c plasmid by site directed mutagenesis 
Primer name Sequence 
pET28c-GO-STOP-fwd 5’ cgcgttactcagtgatccgaattcgag 3’ 
pET28c-GO-STOP-rev 5’ ctcgaattcggatcactgagtaacgcg 3’ 
The mutated nucleotide is shown in red and bold. 
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Figure 3.8. Insertion of the GO-N6M1 coding region into pET28c by CPEC 
The pET28c plasmid including the ECAO secretion signal sequence, Strep II-tag and TEV 
cleavage site and the GO coding region were amplified by PCR. The CPEC reaction was 
carried out for 5, 10 or 15 cycles and the products transformed into XL1 Blue cells. 10 
cycles of CPEC appears to have generated the most of the desired product (indicated by 
the arrow). 
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Once the construct with the secretion signal sequence upstream of the GO coding region had 
been generated, it was used to transform BL21 Star (DE3) cells and a screen of colonies 
expressing secreted or cytoplasmic GO was performed (Figure 3.9). Secretion to the periplasm 
appears to have no significant impact on the rate of formation of the coloured product on 
those colonies giving rise to a coloured signal. However, with the periplasmically-expressed 
GO, all colonies on the plate showed colour change in the assay whereas for the 
cytoplasmically-expressed GO only approximately 20% of the colonies showed colour change 
(Figure 3.10), despite all colonies containing the same plasmid with no secretion signal 
sequence (as confirmed by DNA sequencing). This observation supported the view that the 
periplasmically-expressed version was the most appropriate for future screening. 
 
 
Figure 3.9. Rate of colour formation by GO expressed in the periplasm (red) or the cytoplasm 
(black) 
The sensitivity of the assay was compared by measuring the rate of colour formation 
when GO was expressed in the cytoplasm or in the periplasm. 
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Figure 3.10. The proportion of colonies showing colour change varies if GO is expressed in 
the cytoplasm or periplasm 
Left: when GO was expressed cytoplasmically, only the 14 colonies indicated with the 
red arrows showed colour change while the 63 other colonies did not. Right: when GO 
was expressed periplasmically, all colonies showed colour change. 
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3.2.4 Lysis of colonies by freeze-thaw 
When colonies were lysed by chloroform vapour (Delagrave et al., 2001, Alexeeva et al., 2002, 
Escalettes and Turner, 2008), duplicate plating was required to permit recovery of E. coli cells 
expressing the target variant to allow plasmid purification. It was hypothesised that freezing 
the membranes at -20 °C and then allowing them to thaw may be a less disruptive method and 
therefore only lyse a proportion of the cells within the colony. After the assay, the colony 
could then be used directly to inoculate a liquid culture for plasmid purification. 
Freezing overnight, or for 15 minutes (Figure 3.11) resulted in all colonies (expressing GO in 
the periplasm) subsequently used to inoculate liquid cultures successfully growing, confirming 
that not all cells in the colonies had lysed. 
 
Figure 3.11. The rate of colour formation when the membrane is frozen overnight versus for 
15 minutes 
The sensitivity of the assay was compared by measuring the rate of colour formation 
when colonies were frozen for 15 minutes, or overnight. 
 
Overall, it would appear that freezing the colonies overnight improved the sensitivity of the 
assay compared to freezing for just 15 minutes. However, as the increase in sensitivity was 
moderate and the addition of an extra day to the screening process would be quite 
inconvenient, it was decided to use the 15 minute freezing time in future screens. Further 
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trials were then carried out to determine if carrying out the freeze-thaw cycle multiple times 
led to further increases in assay sensitivity (Figure 3.12). Interestingly, performing multiple 
cycles reduced the assay sensitivity. This could be because the freeze-thaw process led to 
disruption of GO structure as well as the E. coli cells or that the extra time of the cell disruption 
process allowed degradation of the recombinant GO by proteolytic enzymes in the E. coli cells. 
 
 
Figure 3.12. The rate of colour formation when multiple rounds of freeze-thaw are carried 
out 
The sensitivity of the assay was compared by measuring the rate of colour formation 
when freeze-thaw was carried out 0, 1, 2 or 3 times. 
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3.2.5 Form of copper supplied in the assay 
Copper sulfate (CuSO4) is commonly added to GO during purification or in activity screens (Sun 
et al., 2001, Escalettes and Turner, 2008, Spadiut et al., 2010). The alternative copper (II) 
donating compound copper nitrate (Cu(NO3)2) is significantly more soluble than CuSO4: 145 g/ 
100 g H2O compared to 22 g/ 100 g H2O. This may affect the accessibility of the copper to GO 
and may have an effect on assay sensitivity. Excess copper may inhibit GO so it is important to 
determine an appropriate concentration of the copper compound to be used. Assays were 
carried out where copper was included in the induction mix in the two different forms and at 
two different concentrations (Figure 3.13). While no huge differences were seen in the 
sensitivity of the assay, 10 mM Cu(NO3)2 seemed to be slightly better and so was selected for 
future screens. 
 
Figure 3.13. The effect of different forms of copper and different concentrations on screen 
sensitivity 
The sensitivity of the assay was compared by measuring the rate of colour formation 
when copper (II) was provided in two different forms and at two different 
concentrations. 
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3.2.6 Optimisation of induction conditions 
Induction of GO expression in the colonies plated onto the membrane was based on the 
method used by Delagrave et al. (2001) where the membrane was transferred to ‘induction 
mix’ before exposure to the ‘assay mix’. While that method supplied the inducer (L-arabinose) 
in LB-agar, the screens detailed here were found to work when the membrane was placed 
onto filter paper soaked in the induction mix (containing IPTG). In order to ensure maximal 
expression and therefore maximal assay sensitivity, IPTG concentration (Figure 3.14) and the 
duration of induction (Figure 3.15) were varied. Surprisingly, no significant difference in assay 
sensitivity was seen at any IPTG concentration, including 0 mM. This implies that GO is being 
expressed without induction, a phenomenon known as ‘leaky expression’. As addition of IPTG 
appears to have no effect, it implies that the level of leaky expression is adequate for the 
screen, however as the effect of various factors on leaky expression is not known, it was 
decided to include 0.1 mM IPTG in the induction mix to ensure equal induction in all screens. 
 
Figure 3.14. The effect of varied IPTG concentrations on screen sensitivity 
The sensitivity of the assay was compared by measuring the rate of colour formation 
after induction with different IPTG concentrations. 
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Trials where induction time was varied (Figure 3.15) showed only small differences with 1 hour 
induction resulting in a slightly reduced assay sensitivity while there was no noticeable 
difference between 2 and 3 hour inductions. It was therefore decided to expose the colonies 
to the induction mix (containing 10 mM Cu(NO3)2 and 0.1 mM IPTG) for 2 hours. 
 
Figure 3.15. The effect of different induction times on screen sensitivity at 0.1 mM IPTG 
The sensitivity of the assay was compared by measuring the rate of colour formation 
after incubation with ‘induction mix’ for 1, 2 or 3 hours. 
 
In a separate experiment, the screen was carried out following a) incubation with ‘induction 
mix’ containing 0.1 mM IPTG but no copper and b) no incubation with ‘induction mix’. Even 
when 10 mM Cu(NO3)2 was included in the assay mix, no colour change was observed after 500 
seconds implying that the incubation with the ‘induction mix’ is perhaps most important for 
the copper-dependent processing of the enzyme (Section 1.6.1.2). 
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3.2.7 The concentration of substrate used 
In order to give a qualitative estimation of the sensitivity of the assay, screens were carried out 
at four different D-galactose concentrations. As shown in Figure 3.16, after 12 minutes some 
colour change was visible in screens where only 10 mM of D-galactose was supplied, at least 5-
fold lower than the KM of the enzyme. No significant difference was visible between the 
screens carried out at 100 and 600 mM D-galactose which was as expected as both 
concentrations are greater than the KM and therefore saturating. It was decided to carry out all 
future screens with substrate concentrations of 200 mM, regardless of which substrate was 
being screened. 
 
Figure 3.16. The sensitivity of the screen with different D-galactose concentrations 
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3.3 Optimisation of the microtitre plate-based screen 
In order to achieve the highest levels of expression of GO in the wells of the microtitre plate 
and thereby achieve the maximal screen sensitivity, a number of parameters were varied: IPTG 
concentration, induction time and whether the pelleted cells were resuspended in lysis buffer 
or in sodium phosphate buffer, pH 7.0, in case the lysis buffer interfered with the coupled 
enzyme reaction. As shown in Figure 3.17, the screen showed higher sensitivity when the cell 
pellets were dissolved in lysis buffer. This implies that, if the lysis buffer did interfere with the 
assay reaction, this effect was not as great as the effect of not lysing the cells. In contrast to 
the agar plate-based screen, addition of IPTG did seem to improve the microtitre plate-based 
screen, implying that the leaky expression was not adequate in this case. When IPTG was 
added, the length of the induction period had a variable effect on the screen with longer 
induction periods resulting in lower sensitivity at IPTG concentrations of 1.0 and 0.5 mM but 
with the opposite effect seen when 0.1 mM IPTG was added. Appropriate results were seen 
when induction was carried out overnight with 0.1 mM IPTG and these conditions were 
therefore selected as this reduces cost while overnight induction permits completion of the 
subsequent screening stage within the next working day. 
To determine whether the changes in activity observed in the screen correlated with 
expression of GO-N6M1, the cell lysates were analysed by SDS-PAGE (Figure 3.18). In most 
cases, it was not possible to visualise differences in expression levels and Western blot analysis 
may have been more appropriate. However, in some cases, expression levels did not seem to 
correlate with the screen results. An example of this is the trials at 2 and 4 hours of induction 
with 0.1 mM IPTG with lysis buffer; while the screen data were very similar, expression levels 
seem to be much lower after 2 hours of induction. 
Chapter 3: Development and Optimisation of Screening Assays to Detect Oxidase Activity 
89 
 
 
Figure 3.17. Trials to maximise the sensitivity of the microtitre plate-based assay 
 
 
Figure 3.18. SDS-PAGE gels of the lysates from the microtitre plate-based assay trials 
The lysates from one of the screens used to generate Figure 3.17 were analysed by SDS-
PAGE to visualise relative expression levels of GO. 
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Following these optimisations with D-galactose, screens were then carried out with GO-N6M1 
and alternative substrates. After 60 minutes, only screens with glycerol or D-xylose showed any 
visible colour change while screens with D-arabinose, D-glucose and D-mannose showed very 
small increases in absorbance, only detectable by plate reader (Figure 3.19). 
 
Figure 3.19. Typical A414 values in screens against the different substrates with GO-N6M1 
after 60 minutes 
Only screens with glycerol or D-xylose resulted in a visible colour change while the 
smaller changes in D-arabinose, D-glucose and D-mannose screens were detected by 
plate reader. 
 
In an attempt to increase the sensitivity of the screen, the amount of lysate added to the assay 
plate was increased for the glycerol screen. As shown in Figure 3.20, adding 20 or 40 µl of 
lysate had the same effect on screen sensitivity while higher volumes resulted in a lower level 
of colour change. It seems likely that this is due to inhibition of the coupled assay by 
component(s) of the lysis buffer but it was not considered necessary to explore which 
components are responsible for this. For all subsequent screening, 20 µl lysate was used. 
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Figure 3.20. The effect of adding different lysate volumes on rate of colour formation 
Adding lower amounts of lysate appeared to lead to greater screen sensitivity as the 
final degree of colour change was greater. 
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3.4 Removal of the secretion signal sequence and comparison 
of GO expression levels in the periplasm or cytoplasm  
Following screening, large scale expression and purification of any variants of interest is 
required to enable confirmation and characterisation of putative novel activities. Expression 
and purification from E. coli was optimised previously (Deacon and McPherson, 2011). As 
detailed in Section 3.2.3, expression of GO in the E. coli periplasm led to improvement of the 
agar plate-based screen. However, it was important to determine whether this had an effect 
on expression levels in large scale cultures. A comparison was therefore conducted of secreted 
versus cytoplasmic protein production and purification. Primers were designed to amplify the 
pET28c plasmid including the GO-N6M1 coding region, the Strep II-tag and TEV cleavage site 
but excluding the ECAO secretion signal sequence (Table 3.3). The forward primer 
incorporated a 20 nucleotide overlap so that, following amplification, the product would 
spontaneously circularise under the PCR conditions. 
Table 3.3. Primers used to remove the ECAO secretion signal sequence from the pET28c-
SSstrepTEVN6M1 construct 
Primer name Sequence 
GODelSS_F 5’ gaaggagatataccatgggttggagccatccg 3’ 
GODelSS_R 5’ catggtatatctccttc 3’ 
The overlapping region to permit re-circularisation is underlined. 
 
PCR was carried out with an extension time of 3 minutes and deletion of the secretion signal 
sequence was confirmed by colony PCR using the T7F and GOR2 primers and a 60 second 
extension time (Section 2.4.10). The original sequence containing the secretion signal 
sequence resulted in a 778 bp product, while successful removal of the secretion signal 
sequence resulted in a 682 bp product. Agarose gel electrophoresis was carried out to 
determine the size of the product generated (Figure 3.21). Plasmid DNA was purified from 
positive clones and the absence of the secretion signal sequence was confirmed by DNA 
sequencing. 
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Figure 3.21. Agarose gel of colony PCR products showing positive (+) and negative (–) results 
TOP: Following colony PCR with the T7F and GOR2 primers, plasmids still containing the 
secretion signal sequence (-) generated a 778 bp product while plasmids where removal 
of the secretion signal sequence was successful generated a 682 bp product (+). 
BOTTOM: the position of the primers with respect to the secretion signal sequence. 
 
Table 3.4. The three different constructs used in the project 
Construct Secretion signal 
sequence 
TEV cleavage site Strep II-tag 
pET101D-N6M1strep No None C-terminal 
pET28c-SSstrepTEVN6M1 Yes N-terminal N-terminal 
pET28c-strepTEVN6M1 No N-terminal N-terminal 
pET101D-N6M1strep was generated by Dr S. Deacon (Deacon and McPherson, 2011), 
pET28c-SSstrepTEVN6M1 was generated as described in Section 3.2.3. 
 
Each of the three constructs generated were expressed in BL21 Star (DE3) cells by 
autoinduction and purified by Strep-Tactin chromatography using 2 ml of Strep-Tactin resin 
(Section 2.5). The two constructs lacking the ECAO secretion signal sequence yielded 8-10 mg 
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purified protein per litre of culture while periplasmic expression yielded less than 3 mg per 
litre of culture. Comparison of the insoluble fractions from these purifications indicated that 
the reduced yield of the periplasmically expressed protein was due to reduced solubility of GO-
N6M1. The amount of GO-N6M1 in the insoluble fraction correlates inversely with the yield of 
soluble purified protein (Figure 3.22). 
 
Figure 3.22. SDS-PAGE gel of the insoluble fractions following purification of the three 
constructs 
Insoluble fractions from the purifications of the three different constructs: pET101D-
N6M1strep, pET28c-strepN6M1 and pET28c-SSstrepN6M1 were analysed by SDS-PAGE. 
The amount of GO (marked with an arrow) in the insoluble fraction increased when the 
Strep II-tag occurred on the N- rather than C-terminus, and was substantially greater in 
the presence of the ECAO secretion signal sequence (SS). 
 
Following screening and identification of hits the strategy adopted was to remove the 
secretion signal sequence before protein production and purification. To ensure maximal 
efficiency, this process was optimised by varying the annealing temperature of the reaction 
and the initial plasmid concentration (Table 3.5). 
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Table 3.5. Annealing temperature and plasmid concentration were varied in order to 
optimise the cloning to remove the secretion signal sequence 
Annealing temperature 
(°C) 
Plasmid concentration 
(ng/ µl) 
Number of colonies 
45 0.5 20 
45 1.0 70 
45 2.0 68 
55 0.5 27 
55 1.0 36 
55 2.0 26 
65 0.5 1 
65 1.0 7 
65 2.0 12 
The success of the reaction was determined by the number of colonies which grew 
following transformation of XL1 Blue cells. 
 
While varying the plasmid concentration only appears to have a minimal effect, an annealing 
temperature of 45 °C led to significantly more colonies than the other temperatures tested. 
The most appropriate conditions used to delete the secretion signal sequence from clones of 
interest were therefore: 
 Annealing temperature: 45 °C 
 Plasmid concentration: 1 ng/ µl 
3.5 Discussion 
When optimising a process there are normally multiple components which can be tested by 
sampling a variety of different conditions. In order to save time and resources, and as the two 
screens optimised here have already been successfully used by other groups, only limited 
optimisation was carried out. A number of further optimisation experiments are of course 
possible, but the improvements detailed above were deemed adequate for the screening 
strategy adopted in this project. 
There are a number of further immobilisation membranes available for plating out E. coli cells 
besides those sampled here. These include the polyester membranes used by Delagrave et al. 
(2001), the polyvinylidene difluoride used in Western blotting experiments, ceramic 
membranes and cellulose acetate. Each membrane displays different properties such as 
temperature or pressure resistance, thickness, pore size, hydrophobicity or chemical 
compatibility which are important for processes such as filtration, blotting experiments and 
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assaying mixtures. For the agar plate-based assay described here, most of these characteristics 
are not important and only five membranes were compared (filter paper, nylon membrane 
and nitrocellulose membrane of two thicknesses and pore sizes). The best membrane from this 
selection was identified as 125 m thick nitrocellulose membrane and shown to be adequate 
for the assay. 
The chromogenic peroxidase substrate used is an important component as it is essential in the 
identification of enzyme activity. Chromogenic peroxidase substrates are commonly used in 
immunoblotting procedures to identify HRP-conjugated antibodies as well as in other 
immunochemical techniques such as tissue staining. Previous screens by others have used 
either DAB or 4-CN as the chromogenic substrate. DAB displays relatively high sensitivity, 
essential for the assay, but is toxic; while 4-CN shows a lower sensitivity but the blue-purple 
colour generated is easily visible in screens. Combining these two substrates has been shown 
previously to result in high sensitivity and generation of a clearly visible black product (Young, 
1989) so this mixture was compared with ABTS. The most suitable was ABTS as DAB combined 
with 4-CN resulted in a brown product with high background levels. However, the trial was 
only done once and trials using DAB or 4-CN independently were not carried out so the data 
generated are not conclusive. The trial did however, confirm that ABTS is a suitable substrate 
for the screen and as this substrate is stable, safe and affordable it was selected for future 
screening. ABTS is also now used as the chromogenic peroxidise substrate in the Turner and 
Flitsch groups (Dr M. de Abreu, personal communication). Another chromogenic peroxidase 
substrate is 10-acetyl-3,7-dihydroxyphenoxazine (Amplex Red®) (Mohanty et al., 1997, Zhou et 
al., 1997) which is oxidised by HRP to form the fluorescent product resorufin in the presence of 
hydrogen peroxide. Amplex Red® is claimed to show much greater sensitivity than ABTS, 
although it is less stable, and it would be interesting in the future to see if the use of Amplex 
Red® results in increased sensitivity for both the agar plate- and microtitre plate-based assays. 
Development of further safe and ultrasensitive chromogenic substrates for HRP is still 
underway with the recent report of another fluorescent probe based on 4-amino-1,8-
naphthalimide (Groegel et al., 2011). 
Expression of GO in the E. coli periplasm was hypothesised to increase the rate of colour 
formation in the agar plate-based assay. Whilst this was not the case, assay sensitivity was 
improved by increasing the number of colonies showing colour change, compared to 
cytoplasmic expression which only led to colour change in a fraction of the colonies. A 
potential explanation is that these colonies were in fact expressing GO in the periplasm. 
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However, this explanation is difficult to rationalise as sequencing revealed that the secretion 
signal sequence was absent from all plasmids in the ‘cytoplasmic expression’ trial, regardless of 
the screen result. While the environment for the different colonies on the plate appears to be 
identical, subtle variations in hydration or nutrient levels may affect the colonies resulting in 
different levels of lysis, leading to the release of GO from the colonies; or secretion of GO into 
the periplasm, despite the absence of the secretion signal sequence. Further trials would be 
necessary to determine the reasons for this odd result but these were deemed unnecessary as 
the assay works adequately with the periplasmically-expressed GO. 
Whilst replica plating is a widely used technique, it is relatively easy to introduce errors into a 
library screening process. Some of the colonies on the first plate may not grow successfully on 
the replica plate, with the risk that variants of interest may not be recoverable. It is also 
sometimes difficult to identify corresponding colonies on the replica plate, leading to selection 
of the incorrect colony. In order to remove the need for replica plating, colonies were partially 
lysed by freeze-thaw rather than the more destructive chloroform vapour technique used by 
others. One round of freeze-thaw was shown to improve assay sensitivity, presumably by 
lysing a proportion of the cells in each colony due to the formation of ice crystals within the 
cells. Following freeze-thaw, sufficient cells remained viable as each colony could be used to 
inoculate liquid culture leading to culture growth. As well as adding to the simplicity of the 
assay, the freeze-thaw technique removed the safety concerns over use of chloroform, and the 
cost of the chloroform, making the assay safer and cheaper. 
Only limited trials were carried out to observe the effect of changing substrate concentration 
on the agar plate-based screen and the trials were only carried out with D-galactose. It would 
have perhaps been better to have determined the effect of varying the concentration of each 
of the substrates to be screened to identify the substrate concentration at which WT GO-
N6M1 shows colour change. However, it was known from initial experiments that the 
substrate concentrations required to observe activity against the alternative substrates 
(particularly D-arabinose, D-mannose and D-glucose) would be greater than 1 M which would 
result in the use of large quantities of substrates as well as potential issues with the viscosity of 
the assay mixes, particularly as some screens were to be carried out with mixtures of 
substrates. It is also important to consider the first law of directed evolution: ‘you get what 
you screen for’ (You and Arnold, 1996), as screening with high substrate concentrations is 
more likely to identify variants showing activity against these concentrations which are 
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important in potential downstream applications such as chemical synthesis. The issue of 
substrate concentrations used in screening is discussed further in Chapter 6. 
Interestingly, inclusion of IPTG as an inducer in the agar plate-based assay had no effect on the 
screen while it significantly increased the sensitivity of the microtitre plate-based screen. It 
would appear that the level of uninduced expression of GO is adequate for the agar plate-
based screen but not for the microtitre plate-based screen. Uninduced, or leaky expression is a 
common occurrence in expression of genes under the control of the lac operon and is 
primarily due to three factors: inefficiency in binding of the repressor protein to the lac 
operator (Glascock and Weickert, 1998); the use of high copy number plasmids which increase 
the number of promoters and operators requiring repression (Anthony et al., 2004); and the 
potential for read-through transcription from other promoters present on the plasmid 
(Krebber et al., 1996, Nishihara et al., 1994, Brown and Campbell, 1993). Leaky expression can 
be reduced with additional copies of the lacI (repressor) coding region or suppressed by 
inclusion of D-glucose in the growth medium; however this is only necessary if the 
recombinant protein is toxic to the host cell, which GO is not. Unfortunately it was not possible 
to determine the relative expression levels in the two screens so it is not possible to say 
whether the uninduced expression seen in the agar plate-assay occurs at the same level in the 
microtitre plate-based assay. It could be that the conditions of the agar plate-based assay 
result in a higher level of uninduced expression or it may be that the microtitre plate-based 
assay requires a higher expression level, above that generated without IPTG. 
As stated in Section 3.1, the ideal assay for identifying hits in a mutant library must be 
affordable, safe, sensitive, high-throughput, reproducible, accurate and minimise the use of 
expensive equipment. Where possible, both screens have been optimised to use the cheapest 
and safest components available such as the use of ABTS which replaces the carcinogenic DAB 
as a chromogenic substrate. Optimisations have been carried out to improve the sensitivity of 
both assays, although these optimisations could be continued if required; also neither assay 
requires the use of expensive equipment such as NMR in the screening process. If carried out 
on large agar plates (245 x 245 mm bio-assay plates (Thermo Scientific)) the agar plate-based 
assay can be used to screen up to 2 x 105 colonies per plate which can be considered high-
throughput screening. The microtitre plate-based screen can be used to screen 88 variants per 
plate (if eight wells are used for positive and negative controls) and can be considered medium 
throughput, although it has the added advantage of being quantifiable to an extent so that the 
relative levels of activity compared to WT can be observed. Unfortunately the screens do not 
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show as high reproducibility as desired, particularly the microtitre plate-based screen, as seen, 
for example, in the large error bars in Figure 3.17. This is most likely due to differences in 
growth of the cultures and expression of GO. Despite growing each culture to saturation, 
growth rates will vary in each well of the microtitre plate due to differences in the colonies 
used for inoculation. As a result, effective IPTG concentrations as well as the local environment 
will vary in each well affecting expression levels. As shown by Figure 3.18, increased expression 
of GO does not necessarily result in a higher level of activity in the screen. This could be 
because other components present in the cell lysate, which are not necessarily present in the 
same proportion as GO, may interfere with the assay components. It would be much easier to 
compare expression levels of GO if a Western blot was carried out on the samples used in 
Figure 3.18 as the other bands corresponding to other proteins in the lysate would not be 
visible. Because of the variation in the microtitre plate-based assay, the optimisations carried 
out may not be optimal as many more repeats may be required to generate reliable data. 
When screening against D-arabinose, D-mannose or D-glucose where only low levels of activity 
are initially expected, any increases in absorbance compared to WT may be within the error of 
the plate reader. It is therefore essential that repeats are carried out on the microtitre plate-
based screens, particularly for these three substrates, so that only genuine hits are taken 
forwards. 
Periplasmic expression often leads to improved solubility of recombinant proteins due to the 
oxidising environment and presence of chaperones which promote correct formation of 
disulfide bonds (Berkmen, 2012). However, in the case of GO-N6M1, it would appear that 
periplasmic expression results in generation of large quantities of insoluble enzyme. This could 
be because the periplasmic environment contains factors which promote aggregation of GO, 
however it seems more likely that the issue lies with the secretion process from the cytoplasm 
into the periplasm. Perhaps the levels of expression are too high for the secretion system used 
by the ECAO secretion signal sequence and so GO-N6M1 forms aggregates in the cytoplasm 
instead. Little work has been done on the secretion process of ECAO, however, analysis of the 
secretion signal sequence using the Signal P method (Nielsen et al., 1999) identified key 
features of a sec signal peptide: 31 residues long; hydrophilic N-terminal region containing two 
positively charged residues (lys and arg); central hydrophobic region composed of ten 
hydrophobic residues; and polar residues (his and gln) at the C-terminal region near the 
cleavage site. Sec-dependent secretion is often post-translational and so there is greater 
opportunity for the translated, unfolded protein to aggregate before translocation across the 
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membrane than if the process was co-translational. In order to improve expression of the 
periplasmically-expressed GO, the ECAO secretion signal sequence could be substituted for 
one which directs co-translational secretion such as DsbA (Schierle et al., 2003). However, as 
sufficient expression levels can be obtained by cytoplasmic expression this was not deemed 
necessary. 
 
Conclusions 
After various optimisation experiments, it was determined that the best membrane for the 
agar plate-based assay is nitrocellulose at a thickness of 125 µm and the best chromogenic 
peroxidase substrate is ABTS. Secretion of GO into the periplasm improves the reproducibility 
of the assay while colony lysis by freeze-thaw improves sensitivity without the need for replica 
plating. Induction of GO expression by IPTG is not required as leaky expression occurs at 
sufficient levels, but incubation with Cu(NO3)2 is essential for enzyme activity. The induction 
and lysis procedures for the microtitre plate-based assay were optimised and the screen tested 
with the substrates of interest. Unfortunately, expression of GO in the periplasm leads to 
significantly reduced yields upon scaled-up purification. Therefore the process for removal of 
the ECAO secretion signal sequence was optimised so that it can be efficiently carried out for 
each library variant to be taken forwards. 
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4.1 Introduction 
This chapter details the process of library generation where residues in loops surrounding the 
active site are selected for randomisation; oligonucleotides are designed which will be used to 
combine the randomisations in different combinations; and the range of libraries to be 
generated is described. The process of library generation and optimisation of the different 
steps involved is then described, followed by the results of library screening carried out using 
the assays developed in Chapter 3. Finally, the variants showing significant changes in activity 
are purified and the novel activities confirmed. 
Substrate specificity is often determined by residues occurring in loops, perhaps due to the 
inherent flexibility of these regions which is important in the ‘induced fit’ theory of enzyme 
specificity (Herschlag, 1988, Koshland, 1994). For many enzymes, however, the substrate-
induced conformational changes associated with this theory do not occur upon substrate 
binding (Johnson, 2008). For example, there is no evidence of a conformational change upon 
binding of substrate to the relatively rigid GO. Examples of loop regions determining substrate 
specificity include the ‘trigger loop’ in RNA polymerase which is responsible for the high 
specificity for the correct ribonucleotide during transcription (Wang et al., 2006); and the 
active site loops of D-hydantoinase which, when mutated, resulted in significant shifts in 
substrate specificity (Cheon et al., 2004). Loop regions are also frequently targeted in 
mutagenesis studies as they are likely to withstand mutation better than secondary structure 
elements such as α-helices and β-sheets, particularly when surface-exposed. In the case of GO, 
substrate modelling studies (Ito et al., 1994, Wachter and Branchaud, 1996) and previous 
mutagenesis projects (Section 1.6.2) (Sun et al., 2002, Delagrave et al., 2001, Deacon et al., 
2004) have identified several residues involved in substrate binding, all of which occur in loop 
regions surrounding the active site. 
The libraries created and screened in this chapter are generated using randomised 
oligonucleotides constructed using trimer phosphoramidites (Section 1.3.4). This rational 
design method was selected as GO has already been subjected to traditional directed 
evolution with only limited success (Sun et al., 2001) and there is a large body of research 
which can be used to select specific residues to target with the aim of altering substrate 
acceptance. Libraries generated using oligonucleotides generated in this way are generally of a 
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higher quality than similar methods such as use of degenerate codons (Section 1.3.4) due to a 
number of factors: 
 Each residue has an equal likelihood of being incorporated at each randomised 
position 
 The randomisation can include all 20 residues, all 19 excluding cysteine, or specific 
subsets as required 
 No stop codons are incorporated 
 The codons introduced are optimal for usage in E. coli 
 Neighbouring positions can be randomised independently 
The ability to randomise multiple positions in combination and independently of each other is 
particularly desirable as it allows for potential synergistic conformational effects brought about 
by the different residues in the different positions. This concept forms the backbone of the 
CASTing technique developed in the Reetz group (Reetz et al., 2005) (Section 1.3.6). In the 
work presented here, libraries were generated randomising between one and six residues in 
combination, some of which are in distinct regions of the active site. Targeting multiple regions 
of the active site simultaneously has the potential to alter activity in favour of very different 
substrates from those accepted by the WT enzyme. 
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4.2 Library design 
4.2.1  Selection of residues to mutate 
By visually analysing the crystal structure of GO, 13 loops surrounding the active site were 
identified (Figure 4.1). Two thirds of the residues on these loops point away from the active 
site copper or have their α-carbon atom at a distance of greater than 12 Å so were disregarded 
as these are unlikely to be involved in substrate binding.  
 
Figure 4.1. Loops surrounding the active site which appear likely to contain residues involved 
in substrate binding 
The 13 loops surrounding the active site are shown with the active site copper (cyan 
sphere) and D-galactose modelled in according to Wachter and Branchaud (1996). Loops 
shown in black are those on which no residues were selected for mutagenesis. Loops 
189-201 (red), 220-229 (light green), 243-249 (blue), 287-298 (yellow), 321-335 
(magenta), 370-384 (cyan), 400-413 (orange), 456-473 (dark green), 486-496 (brown) 
and 511-523 (purple) surround the active site. Figure created with PyMOL using .pdb file 
1GOF. 
 
Information from previous molecular modelling (Wachter and Branchaud, 1996) as well as 
mutagenesis studies (Deacon et al., 2004, Sun et al., 2002) was then used to identify residues 
likely to be involved in substrate interactions (Section 1.6.2): F194 and F464 interact with C4, 
C5 and C6, Y329 interacts with the C1 hydroxyl, R330 interacts with the C3 and C4 hydroxyls 
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and Q406 interacts with the C2 hydroxyl. The positions of other residues within the same loops 
and their chemical characteristics were then assessed in terms of their likelihood of being 
involved in substrate binding. In all cases the small non-polar residues, glycine and alanine, 
were thought to be less likely to form important interactions so were disregarded. This 
resulted in selection of Q326 and N333, two polar residues close to Y329 and R330; Y405, 
which may be involved in interactions close to Q406; and P463, which may affect the 
positioning of F464. In order to avoid potential disruption of the thioether linkage between 
C228 and Y272, residues in the loop containing Y272 were not selected. In the loop containing 
C228 however, F227 was selected for mutagenesis. This residue is close to the hydrophobic 
pocket formed by F194 and F464 which is thought to be an important binding surface in the 
active site. The two loops containing residues 431-442 and 577-587 are relatively buried within 
the enzyme structure and were not targeted as changes may disrupt the fold of the protein. 
Finally, residues N245, L514 and the disulfide bond-forming residues C515 and C518 were 
selected based on their positions close to the active site copper.  
Table 4.1. Loops of interest and residues selected for mutagenesis 
Loop Residue(s) selected 
189-201 F194 
220-229 F227 
243-249 N245 
263-273 
 
287-298 W290* 
321-335 Q326, Y329, R330, N333 
370-384 C383* 
400-413 Y405, Q406 
431-442 
 
456-473 P463, F464 
486-496 V494* 
511-523 L514, C515, C518 
577-587 
 
Loops are coloured according to Figure 4.1. Residues marked * were only randomised to 
a subset of residues based on previous studies. 
 
Most of the selected residues were randomised to any of the 19 amino acids excluding 
cysteine. Cysteine is commonly omitted from mutagenesis studies due to the potential 
formation of disulfide bonds which can result in oxidised forms, cause significant structural 
disruption, or aggregation of monomers. Residues 515 and 518 which are cysteines in the WT 
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structure were randomised to any of the 20 amino acids including cysteine. Three residues 
were selected to be mutated to a subset of residues due to previous characterisation of 
mutants. The stacking tryptophan Trp290 was randomised to only the small non-polar residue 
Ala and the aromatic residues Phe and Tyr. Histidine was also included at this position as the 
W290H mutation resulted in decreased KM in a previous study (Rogers et al., 2007) and His is 
present at the corresponding position in glyoxal oxidase (Whittaker et al., 1999). Trp290 was 
also identified as a target for mutation in a previous study where a mutant showing increased 
D-glucose activity contained, amongst others, the W290F mutation (Sun et al., 2002). Position 
383 was previously subjected to saturation mutagenesis as mentioned in Section 1.6.2 (Deacon 
and McPherson, 2011) which revealed a number of interesting variants, most notably 
mutations to Glu, Lys, Met and Ser which all reduced KM whilst having a limited effect on kcat 
and mutation to Thr which significantly increased kcat. Mutations at position C383 also had 
varied effects on the pH optimum of the enzyme. In this study therefore, C383 was 
randomised to these five residues, or Cys. Finally, position 494, which is sited close to the 
copper ligands Y495 and H496, was changed to valine (as in WT) or alanine (as in the M1 
mutant (Section 1.6.4) (Sun et al., 2001)). 
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4.2.2 Design of randomised oligonucleotides 
The positions of the residues selected for mutagenesis within GO are shown in Figure 4.2. A 
mutant oligonucleotide was designed for each loop so that some oligonucleotides contained 
only one mutated residue whereas others contained two, three or four residues. The 
oligonucleotides were designed so that the mutations occurred towards the centre of the 
sequence with 13-21 bases on each side. Each oligonucleotide also started and ended with at 
least one guanine or cytosine as these bases form stronger interactions due to the presence of 
three, rather than two hydrogen bonds as found in the adenine/ thymine interaction, and so 
improve specificity of binding. This is particularly important at the 3’ end of the 
oligonucleotide. The designed oligonucleotides were generated by Ella Biotech GmbH and are 
shown in Table 4.2. Their positions within the GO sequence are shown in Figure 4.3. 
 
Figure 4.2. Residues selected for mutagenesis 
Residues selected for mutagenesis are shown looking down on the substrate binding 
region from solvent (see inset for reference); colours correspond to the loops 
surrounding the active site (as in Figure 4.1). Copper ligands and thioether bond residues 
are shown in black, copper is shown as a cyan sphere and D-galactose (white) is 
modelled in according to Wachter and Branchaud (1996). Figure created with PyMOL 
using .pdb file 1GOF. 
  
1
0
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Table 4.2. Oligonucleotides for library construction 
Name Residues randomised Sequence 
F194X F194 5’ catatcgcaatgatgcaXXXgaaggatcccctgg 3’ 
F227X F227 5’ caccaagcatgatatgXXXtgccctggtatctcc 3’ 
N245X N245 5’ cgtagtcacaggtggcXXXgatgccaagaagacc 3’ 
W290AFHWY W290 (subset) 5’ ccattggaggctccXXXagcggtggcgtatttg 3’ 
QYRN326-333 Q326, Y329, R330, N333 
5’ caatgttgacggctgacaagXXXggattgXXXXXXtcagacXXXcacgcgtggctctttgga 
   tgg 3’ 
C383CEKMST C383 (subset) 5’ cccctgatgccatgXXXggaaacgctgtcatg 3’ 
Y405XQ406X Y405, Q406 5’ ggcggctccccagatXXXXXXgactctgacgccacaac 3’ 
P463XF464X P463, F464 5’ gccaacgacgtggaattXXXXXXgaggattcaaccccgg 3’ 
V494AMV V494 (subset) 5’ ctccattgttcgcXXXtaccatagcatttcc 3’ 
L514XC515XC518X L514, C515, C518 5’ cggtggtggtggtXXXXXXggcgatXXXaccacgaatcatttcg 3’ 
   
GOLibF1  5’ gattgttcctgcggctgcag 3’ 
GOLibR1  5’ tgcatcattgcgatatgaag 3’ 
GOLibR2  5’ catatcatgcttggtgac 3’ 
GOLibR3  5’ gccacctgtgactacg 3’ 
GOLibR4  5’ ggagcctccaatggtaaaaac 3’ 
GOLibR5  5’ cttgtcagccgtcaac 3’ 
GOLibR6  5’ catggcatcaggggctac 3’ 
GOLibR7  5’ atctggggagccgcc 3’ 
GOLibR8  5’ aattccacgtcgttggc 3’ 
GOLibR9  5’ gcgaacaatggagttgg 3’ 
GOLibR10  5’ accaccaccaccgttaaatac 3’ 
GOLibR11  5’ ggtggtggtgctcgagtg 3’ 
TOP: The ten oligonucleotides designed for library generation - colours correspond to the loops surrounding the active site. The codons to be 
randomised are shown as XXX. BOTTOM: The reverse primers required for generating the double stranded fragments.
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        GOLibF1  MfeI                     F194X 
    490 ACTATTGACT TACCGATTGT TCCTGCGGCT GCAGCAATTG AACCGACATC GGGACGAGTC CTTATGTGGT CTTCATATCG CAATGATGCA TTTGAAGGAT 
 TGATAACTGA ATGGCTAACA AGGACGCCGA CGTCGTTAAC TTGGCTGTAG CCCTGCTCAG GAATACACCA GAAGTATAGC GTTACTACGT AAACTTCCTA 
              GOLibR1 
 
                          F227X 
    590 CCCCTGGTGG TATCACTTTG ACGTCTTCCT GGGATCCATC CACTGGTATT GTTTCCGACC GCACTGTGAC AGTCACCAAG CATGATATGT TCTGCCCTGG 
 GGGGACCACC ATAGTGAAAC TGCAGAAGGA CCCTAGGTAG GTGACCATAA CAAAGGCTGG CGTGACACTG TCAGTGGTTC GTACTATACA AGACGGGACC 
              GOLibR2 
 
              N245X 
    690 TATCTCCATG GATGGTAACG GTCAGATCGT AGTCACAGGT GGCAACGATG CCAAGAAGAC CAGTTTGTAT GATTCATCTA GCGATAGCTG GATCCCGGGA 
 ATAGAGGTAC CTACCATTGC CAGTCTAGCA TCAGTGTCCA CCGTTGCTAC GGTTCTTCTG GTCAAACATA CTAAGTAGAT CGCTATCGAC CTAGGGCCCT 
         GOLibR3 
 
                  W290AFHWY 
    790 CCTGACATGC AAGTGGCTCG TGGGTATCAG TCATCAGCTA CCATGTCAGA CGGTCGTGTT TTTACCATTG GAGGCTCCTG GAGCGGTGGC GTATTTGAGA 
 GGACTGTACG TTCACCGAGC ACCCATAGTC AGTAGTCGAT GGTACAGTCT GCCAGCACAA AAATGGTAAC CTCCGAGGAC CTCGCCACCG CATAAACTCT 
            GOLibR4 
 
                      QYRN326-333 
    890 AGAATGGCGA AGTCTATAGC CCATCTTCAA AGACATGGAC GTCCCTACCC AATGCCAAGG TCAACCCAAT GTTGACGGCT GACAAGCAAG GATTGTACCG 
 TCTTACCGCT TCAGATATCG GGTAGAAGTT TCTGTACCTG CAGGGATGGG TTACGGTTCC AGTTGGGTTA CAACTGCCGA CTGTTCGTTC CTAACATGGC 
                 GOLibR5 
 
 
    990 TTCAGACAAC CACGCGTGGC TCTTTGGATG GAAGAAGGGT TCGGTGTTCC AAGCGGGACC TAGCACAGCC ATGAACTGGT ACTATACCAG TGGAAGTGGT 
 AAGTCTGTTG GTGCGCACCG AGAAACCTAC CTTCTTCCCA AGCCACAAGG TTCGCCCTGG ATCGTGTCGG TACTTGACCA TGATATGGTC ACCTTCACCA 
 
             
              C383CEKMST 
    1090 GATGTGAAGT CAGCCGGAAA ACGCCAGTCT AACCGTGGTG TAGCCCCTGA TGCCATGTGC GGAAACGCTG TCATGTACGA CGCCGTTAAA GGAAAGATCC 
 CTACACTTCA GTCGGCCTTT TGCGGTCAGA TTGGCACCAC ATCGGGGACT ACGGTACACG CCTTTGCGAC AGTACATGCT GCGGCAATTT CCTTTCTAGG 
            GOLibR6 
 
     Y405XQ406X 
    1190 TGACCTTTGG CGGCTCCCCA GATTATCAAG ACTCTGACGC CACAACCAAC GCCCACATCA TCACCCTCGG TGAACCCGGA ACATCTCCCA ACACTGTCTT 
 ACTGGAAACC GCCGAGGGGT CTAATAGTTC TGAGACTGCG GTGTTGGTTG CGGGTGTAGT AGTGGGAGCC ACTTGGGCCT TGTAGAGGGT TGTGACAGAA 
    GOLibR7 
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                         P463XF464X 
    1290 TGCTAGCAAT GGGTTGTACT TTGCCCGAAC GTTTCACACC TCTGTTGTTC TTCCAGACGG AAGCACGTTT ATTACAGGAG GCCAACGACG TGGAATTCCG 
 ACGATCGTTA CCCAACATGA AACGGGCTTG CAAAGTGTGG AGACAACAAG AAGGTCTGCC TTCGTGCAAA TAATGTCCTC CGGTTGCTGC ACCTTAAGGC 
                 GOLibR8 
 
                  V494AMV 
    1390 TTCGAGGATT CAACCCCGGT ATTTACACCT GAGATCTACG TCCCTGAACA AGACACTTTC TACAAGCAGA ACCCCAACTC CATTGTTCGC GCTTACCATA 
 AAGCTCCTAA GTTGGGGCCA TAAATGTGGA CTCTAGATGC AGGGACTTGT TCTGTGAAAG ATGTTCGTCT TGGGGTTGAG GTAACAAGCG CGAATGGTAT 
               GOLibR9 
 
              L514XC515C518X 
    1490 GCATTTCCCT TTTGTTACCT GATGGCAGGG TATTTAACGG TGGTGGTGGT CTTTGTGGCG ATTGTACCAC GAATCATTTC GACGCGCAAA TCTTTACGCC 
 CGTAAAGGGA AAACAATGGA CTACCGTCCC ATAAATTGCC ACCACCACCA GAAACACCGC TAACATGGTG CTTAGTAAAG CTGCGCGTTT AGAAATGCGG 
       GOLibR10 
 
 
    1590 AAACTATCTT TACGATAGCA ACGGCAATCT CGCGACACGT CCCAAGATTA CCAGAACCTC TACACAGAGC GTCAATGTCG GTGGCAGAAT TACAATCTCG 
 TTTGATAGAA ATGCTATCGT TGCCGTTAGA GCGCTGTGCA GGGTTCTAAT GGTCTTGGAG ATGTGTCTCG CAGTTACAGC CACCGTCTTA ATGTTAGAGC 
 
 
 
    1690 ACGGATTCTT CGATTAGCAA GGCGTCGTTG ATTCGCTATG GTACAGCGAC ACACACGGTT AATACTGACC AGCGCCGCAT TCCCCTGACT CTGACAAACA 
 TGCCTAAGAA GCTAATCGTT CCGCAGCAAC TAAGCGATAC CATGTCGCTG TGTGTGCCAA TTATGACTGG TCGCGGCGTA AGGGGACTGA GACTGTTTGT 
 
 
 
    1790 ATGGAGGAAA TAGCTATTCT TTCCAAGTTC CTAGCGACTC TGGTGTTGCT TTGCCTGGCT ACTGGATGTT GTTCGTGATG AACTCGGCCG GTGTTCCTAG 
 TACCTCCTTT ATCGATAAGA AAGGTTCAAG GATCGCTGAG ACCACAACGA AACGGACCGA TGACCTACAA CAAGCACTAC TTGAGCCGGC CACAAGGATC 
 
 
                  
    1890 TGTGGCTTCG ACGATTCGCG TTACTCAGTG ATCCGAATTC GAGCTCCGTC GACAAGCTTG CGGCCGCACT CGAGCACCAC CACCACCACC ACTGAGA    
 ACACCGAAGC TGCTAAGCGC AATGAGTCAC TAGGCTTAAG CTCGAGGCAG CTGTTCGAAC GCCGGCGTGA GCTCGTGGTG GTGGTGGTGG TGACTCT    
              NotI GOLibR11 
Figure 4.3. The positions of the oligonucleotides shown in Table 4.2 within the GO sequence 
Oligonucleotides containing randomisations are bold and underlined while the non-mutated reverse oligonucleotides are shown in green. 
Randomised positions are shown in magenta and the MfeI and NotI restriction sites are shown in red text. 
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The basic protocol for library construction is shown in Figure 4.4. The oligonucleotides 
containing the randomisation(s) (grey) were all designed as forward (coding strand) primers. 
For each of these primers, there is a corresponding reverse primer (blue) (Table 4.2) which, in 
conjunction with an upstream forward primer permits amplification of a region of DNA (Figure 
4.4A). The reverse primers are designed so that the neighbouring amplified fragments will 
overlap by 13-17 base pairs permitting joining of the fragments by overlap extension (Section 
2.4.2) (McPherson and Moller, 2006) (Figure 4.4B). The forward and reverse primers shown in 
red do not contain mutations and ensure that the randomised region (Figure 4.4C) can be 
digested by restriction enzymes MfeI (magenta) and NotI (cyan) (Section 2.4.5) and ligated into 
the digested plasmid (Section 2.4.7) ready for transformation into E. coli (Sections 2.4.8 and 
2.4.9). 
 
 
Figure 4.4. Schematic showing the protocol for construction of a library using two 
randomised oligonucleotides 
The randomised primers (grey) with mutations shown as green or yellow asterisks; 
reverse primers for generating each fragment are shown in blue; primers for amplifying 
from each end of the mutated region are shown in red; and the MfeI and NotI restriction 
sites are shown as magenta and cyan circles. 
 
With the ten different oligonucleotides that were designed, it is possible to generate a number 
of different libraries of varying sizes. Initially, it was decided to create 16 libraries which varied 
in complexity as well as the areas of the active site targeted (Table 4.3). 
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Table 4.3. Libraries generated using the randomised oligonucleotides 
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A Q326X/ Y329X/ R330X/ N333X/ P463X/ F464X 6 4.70 x 107 1.4 x 108 7047  
C W290AFHWY/ L514X/ C515X/ C518X 4* 38000 1.1 x 105 6  
D F194X/ P463X/ F464X 3 6859 20548 1  
E Q326X/ Y329X/ R330X/ N333X 4 1.30 x 105 3.9 x 105 20  
F F194X/ F227X/ W290AFHWY 3* 1805 5407 <1  
H F194X/ F227X/ Y405X/ Q406X/ P463X/ F464X 6 4.70 x 107 1.4 x 108 7047  
I F194X 1 19 57  <1 
J F227X 1 19 57  <1 
K N245X 1 19 57  <1 
L Y405X/ Q406X 2 361 1081 <1  
M P463X/ F464X 2 361 1081 <1  
N L514X/ C515X/ C518X 3 6859 20548 1  
O N245X/ C383CEKMST (n.b. same as R) 2* 95 285  3 
P F194X/ C383CEKMST 2* 95 285  3 
Q F227X/ C383CEKMST 2* 95 285  3 
R N245X/ C383CEKMST 2* 95 285  3 
The residues targeted in the 16 different libraries are shown along with the theoretical; 
number of different variants present in the library. Where the number of residues 
targeted is shown with an asterisk, one of the residues is only mutated to a subset of 
residues. The screening effort required is determined using the equation: T = -V ln (1-P) 
where T is the number of transformants to screen, V is the number of gene mutants in 
the library and P is the % completeness desired (in this case 95%) (Reetz et al., 2008). 
 
Library A was designed to target two areas on opposite sides of the active site. However, after 
generation, based on the assay approach used, it was determined that the screening effort to 
statistically cover even 5% of this library was unrealistic. The same was true for Library H 
which also randomised six residues. This library was designed to target an entire side of the 
active site as four neighbouring loops were selected. However, to statistically cover only 5% of 
the library would require screening of over 120 large agar plates. Library D was designed to 
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target the ‘hydrophobic surface’ (Sun et al., 2002) which potentially interacts with C4, C5 and 
C6 of the D-galactose molecule while Library E was made with a single randomised 
oligonucleotide to explore the effect of randomising four residues in the loop containing 
Arg330. Library F combined mutation of the stacking tryptophan W290 with randomisation of 
two nearby residues F194 and F227; while Library C also involved mutation of the stacking 
tryptophan but this time combined with the relatively uncharacterised L514, C515 and C518. 
Oligonucleotides which contained residues not previously subjected to mutagenesis studies 
(i.e. excluding W290, C383 and V494) were used individually to generate relatively small 
libraries which could easily be screened to 95% completeness: Libraries I – N. Libraries I, J and 
K were also combined with mutation at position 383 to produce Libraries P, Q and R, 
respectively. Library O, which was originally designed to mutate position 383 alone, actually 
included randomisation at position 245 as well (in error), effectively duplicating Library R. 
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4.3 Library generation 
Library generation was optimised with Library A (Q326X/ Y329X/ R330X/ N333X/ P463X/ 
F464X) and then repeated for generation of each of the other libraries. 
4.3.1  Generation of the mutant insert 
As the library uses two randomised oligonucleotides, three fragments were initially generated: 
fragment 1 using GOlibF1 and GOLibR5 primers, fragment 2 using QYRN326-333 and GOLibR8 
primers; and fragment 3 using P463XF464X and GOLibR11 primers (Figure 4.3 and Figure 4.4). 
PCRs were carried out using Phusion polymerase (Section 2.4.1) and an extension time of 20 
seconds. The expected fragment sizes from the three PCRs were 473 bp, 431 bp and 604 bp, 
respectively, and these were confirmed by agarose gel electrophoresis (Section 2.4.4) (Figure 
4.5). 
 
Figure 4.5. Amplification of fragments required for Library A 
The three fragments were generated by PCR using GOLibF1 and GOLibR5; QYRN326-333 
and GOLibR8; and P463XF464X and GOLibR11 primers, respectively, and then purified by 
gel extraction. 
 
In order to combine the fragments by overlap extension (Section 2.4.2), equimolar quantities 
of each fragment were combined to give a total amount of 2 µg. The online tool at 
www.encorbio.com/protocols/Nuc-MW.htm was used to determine the molecular mass and, 
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following gel extraction using the QIAquick Gel Extraction kit (Qiagen) (Section 2.4.12), 
appropriate volumes of each fragment were combined with Phusion PCR components and the 
overlap extension reaction carried out with an extension time of 1.5 or 3 minutes. As shown in 
Figure 4.6, the overlap extension successfully joined fragments 1 and 2 as well as fragments 2 
and 3, but there is no band corresponding to the combination of all three fragments. 
 
Figure 4.6. Attempts to combine all three fragments in a ‘one pot’ reaction 
Bands are clearly visible at sizes corresponding to each fragment individually as well as 
fragment 2 combined with each of the other fragments, however there is no band for all 
three fragments combined. 
 
It was therefore decided to combine the fragments in a stepwise manner, first combining 
fragments 1 and 2 to create fragment 1/2 (Figure 4.7A), then, following gel extraction, 
combining this with fragment 3 in a separate overlap extension. As shown in Figure 4.7B, two 
annealing temperatures were trialled in the second overlap extension and 64 °C resulted in 
more product than 54 °C. 
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Figure 4.7. Combining fragments by overlap extension 
Overlap extension was carried out with A: fragments 1 and 2 to create an 884 bp 
product and B: fragments 1/2 and 3 to create a 1474 bp product. For the second 
reaction two annealing temperatures were tested and 64 °C appeared to generate more 
of the desired product. Both products were purified by gel extraction. 
 
4.3.2 Ligation of the mutated insert into the pET28c-N6M1 plasmid 
In order to ligate the combined fragments (insert) into the rest of the GO-N6M1 gene within 
the pET28c plasmid, both were double digested with the same restriction enzymes (Section 
2.4.5). The plasmid DNA was double digested with MfeI and NotI for >4 hours. This was 
followed by dephosphorylation (Section 2.4.6) to prevent spontaneous re-ligation before 
separation from the smaller WT fragment by agarose gel electrophoresis (Section 2.4.4) (Figure 
4.8).  
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Figure 4.8. pET28c-N6M1 was double digested ready for insertion of the mutant insert 
The agarose gel shows the pET28c-N6M1 before and after digestion with MfeI and NotI 
to remove the 1474 bp region of the GO gene, which will be replaced by the mutated 
version upon ligation. The 5905 bp species was purified by gel extraction. 
 
In order to optimise ligation of the insert into the plasmid and not waste the mutated 
fragments, WT insert was generated by PCR using GOLibF1 and GOLibR11 primers and an 
extension time of 2 minutes (Section 2.4.1). The correct band (1474 bp) was purified from an 
agarose gel by gel extraction (Section 2.4.12). Double digestion was carried out with MfeI and 
NotI for >4 hours (Section 2.4.5) before removal of the restriction enzymes and the digested 
ends using the QIAquick PCR Purification kit (Qiagen) (Section 2.4.13). 
In optimising the ligation reaction, four conditions were varied: the incubation time, the 
plasmid to insert ratio, the amount of DNA present in the 10 µl reaction and the manufacturer 
of the T4 DNA ligase. Ligases from Roche and from NEB were selected; the instructions for the 
Roche ligase recommend total DNA amounts of 30 – 300 ng while NEB recommends 10 – 100 
ng. Amounts of 30, 100 and 300 ng were therefore selected for the Roche ligase and 10, 50 
and 100 ng for NEB. As recommended by the manufacturers, plasmid to insert ratios of 1:1 and 
1:2 were trialled for the Roche ligase while 1:2 and 1:4 were trialled for the NEB ligase. Finally, 
for both ligases, incubation times at 4 °C of 2 hours and overnight were compared. From each 
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reaction, 5 ng of DNA was transformed into E. coli (Section 2.4.8) and the number of colonies 
that grew used to measure the success of the ligation reaction (Figure 4.9). 
 
Figure 4.9. A comparison of different ligation conditions 
Different ligation reactions were carried out where the manufacturer of the T4 DNA 
ligase, the incubation time, the plasmid to insert ratio and the total amount of DNA 
present were varied. 5 ng of DNA from each reaction was transformed into E. coli and 
the number of colonies counted. 
 
In general incubating the ligation reaction for 2 hours is more efficient than incubating 
overnight, especially for the Roche enzyme; and smaller quantities of DNA in the reaction led 
to higher transformant colony numbers. A 1:2 ratio of plasmid to insert seemed slightly better 
than the other ratios trialled. However, in order to save materials it is desirable to use less of 
the mutant insert so a 1:1 ratio was selected as more optimal overall. The conditions selected 
for use in ligations of the mutant fragment into the plasmid were therefore: 
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 T4 DNA ligase: Roche 
 total DNA in 10 µl reaction: 10 ng 
 plasmid to insert ratio: 1:1 
 incubation time: 2 hours 
4.3.3 Transformation into an appropriate expression strain 
Following the ligation reaction the plasmid must be transformed into an appropriate strain of 
E. coli for the agar plate-based assay developed in Chapter 3. In order to permit screening of as 
many library variants as possible, very high transformation efficiencies are desirable. To this 
end, the transformation efficiencies of six different competent cell strains were compared 
(Table 4.4). Transformations were carried out according to the manufacturers’ protocols using 
40 ng of the ligated plasmid and 25 µl of cells (Section 2.4.8 and 2.4.9). 
Table 4.4. Comparison of different competent cell strains for transformation with the library 
construct 
Strain Supplier Electro-/ chemocompetent CFU/ µg 
Acella VH Bio Electrocompetent 6 x 107 
XL1 Blue Stratagene Electrocompetent 2 x 107 
ER2738 Lucigen Electrocompetent 9 x 106 
T7 Express NEB Chemocompetent 3 x 104 
BL21 Gold (DE3) Stratagene Chemocompetent 1 x 104 
BL21 Star (DE3) Invitrogen Chemocompetent 2 x 102 
40 ng of the ligated plasmid was transformed into six different strains of E. coli and 
plated out at an appropriate dilution. The number of colony forming units (CFU) was 
counted the following day. 
 
Acella cells from VH Bio showed the highest transformation efficiency. This was ideal as these 
are the only electrocompetent cells trialled which also carry a copy of the T7 RNA polymerase 
permitting expression of the GO protein. If either XL1 Blue or ER2738 were to be used, extra 
steps would have to be added to express the library variants. The chemocompetent cells 
trialled showed significantly lower transformation efficiencies, as expected with this 
transformation method.  
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4.3.4 Library construction and confirmation of diversity 
Despite scaling up the initial PCR to amplify the fragments and introduce mutations, due to 
loss of DNA in the gel extraction and PCR purification stages and inefficiencies in the overlap 
extensions, in some libraries there was inadequate insert produced for the ligation reaction 
and subsequent transformation. It was therefore necessary to amplify the insert by PCR before 
the double digestion. This was carried out using KOD polymerase, GOLibF1 and GOLibR11 
primers and an extension time of 20 seconds (Section 2.4.1). In order to reduce the possibility 
of bias being introduced into the library, only five cycles of PCR were carried out and this 
produced sufficient insert in each case for the ligation reaction. The final library construction 
procedure is shown in Figure 4.10 and was used to construct the 16 libraries shown in Table 
4.3. 
Before the large scale transformation of the library into Acella cells, a small aliquot was 
transformed into XL1 Blue cells (Section 2.4.8). Plasmids were purified from 10 colonies by 
DNA miniprep (Section 2.4.11) and sent for sequencing (Section 2.4.15) to assess library 
quality. While data from 10 variants is not adequate to confirm the expected diversity, it was 
sufficient to confirm that mutation(s) had been introduced at the correct position(s) and that 
there was not a significant level of errors such as frameshifts, insertions or deletions. In all 
cases, at least seven out of the 10 sequenced variants contained no errors and confirmed 
introduction of different residues at the desired position(s). 
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Figure 4.10. General protocol for library construction 
The protocol for construction of a library using two randomised oligonucleotides is 
shown. If only one randomised oligonucleotide is used, steps 3 and 4 would be omitted, 
if more than two oligonucleotides are used, additional overlap extensions would be 
carried out. 
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The primary limitation on sequencing more than 10 variants from every library produced was 
the cost of the sequencing reactions. However, in order to confirm that the expected diversity 
was being introduced and that the statistical approach to determining the screening effort 
required was appropriate, 88 variants from Library K (N245X) were sequenced (Figure 4.11). 
 
Figure 4.11. The results of sequencing 88 variants from Library K (N245X) 
In order to assess library diversity in an example library, 88 variants from Library K were 
sequenced. The dashed line at 5.33% shows the expected proportion of each residue if 
randomisation was perfect. The proportion of some residues shows significant variation 
from this value but all amino acids except Ile are represented. 
 
Unfortunately 12 of the variants failed to sequence which could be due to errors in the library 
construction which led to disruption of the primer binding site, but could also be due to issues 
in plasmid purification or the sequencing process. The sequencing data from the remaining 76 
variants revealed a diverse library with only Ile not represented at position 245. 
  
Chapter 4: Generation of Mutant Libraries and Screening to Identify Altered Enzyme Activities 
123 
 
4.4 Library screening 
4.4.1 Agar plate-based screening 
WT GO-N6M1 shows high enough levels of activity against glycerol and D-xylose that a colour 
change is visible with the agar plate-based assay. On the other hand, the level of activity with 
D-arabinose, D-mannose and D-glucose is so low that a colour change is not visible. When 
screening the different mutant libraries, the substrates were divided into two groups: a) 
glycerol & D-xylose and b) D-arabinose, D-mannose & D-glucose. In screening against the first 
set of substrates, any colonies showing a colour change could be expressing WT so sequencing 
was required to identify active mutants and confirmation of results by the quantifiable 
microtitre plate-based screen was essential to identify any enhancements in activity compared 
to WT. When screening against the substrate mix of D-arabinose, D-mannose and D-glucose 
however, any colony showing a colour change is likely to be expressing a mutant showing 
higher activity than WT against one or more of the substrates provided, unless the mutation 
has resulted in significant increases in expression levels as discussed later. 
The libraries screened using the agar plate-based assay are shown in Table 4.5. Due to the size 
of libraries and therefore the screening effort required, it was not always possible to screen to 
95% completeness and two of the libraries were not screened at all (Section 4.2.2). These are 
available for future screening efforts. It was also not possible to carry out microtitre plate-
based screening on all mutants identified in the agar plate-based screening but, again, these 
are available for future projects. 
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Table 4.5. The libraries screened using the agar plate-based screen 
Library Mutations introduced 
Number screened 
(approximately) 
Completeness 
(%) 
A Q326X/ Y329X/ R330X/ N333X/ P463X/ F464X 6.0 x 105 1.3 
C W290AFHWY/ L514X/ C515X/ C518X 0 0 
D F194X/ P463X/ F464X 2.0 x 105 >95 
E Q326X/ Y329X/ R330X/ N333X 4.0 x 104 27 
F F194X/ F227X/ W290AFHWY 2.0 x 105 >95 
H F194X/ F227X/ Y405X/ Q406X/ P463X/ F464X 0 0 
L Y405X/ Q406X 6.0 x 105 >95 
M P463X/ F464X 6.4 x 105 >95 
N L514X/ C515X/ C518X 6.0 x 105 >95 
The percentage completeness in the screening effort was determined using the 
equation: T = -V ln (1-P) where T is the number of transformants to screen, V is the 
number of gene mutants in the library and P is the % completeness (Reetz et al., 2008). 
Library D was screened by Ms Lito Paraskevopoulou; Library F was screened by Mr 
Ciaran Doherty. 
 
No enhancements in activities were identified upon screening of Library A. This could be due 
to the fact that a very small proportion of the library was screened, but it could also be that 
mutating these six residues in combination leads to a large number of deleterious mutations. 
The two oligonucleotides used to generate this library were used separately to generate two 
smaller libraries: Library E: Q326X/ Y329X/ R330X/ N333X and Library M: P463X/ F464X. 
Library E contained a number of mutants showing activity against glycerol and/ or D-xylose 
(Table 4.6) although whether these activities are greater than WT would have to be 
determined using the microtitre plate-based screen. However, no activity was seen against D-
arabinose, D-mannose or D-glucose. This could be because statistically, only 27% of the library 
was screened. From the sequencing data of the glycerol/ D-xylose hits it can be seen that the 
charged residues lysine and particularly arginine at position 333 are significantly favoured over 
other residues but no other trends are seen at the other three positions. 
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Table 4.6. Variants from Library E showing activity against glycerol and/ or D-xylose 
Active against glycerol and/ or D-xylose 
Q326 Y329 R330 N333 
Q N Y R 
V M F R 
S W M R 
M Q Q R 
R Q E K 
L L A R 
E Q S K 
Y V F R 
M A I R 
N K S S 
 
Library M, which was screened to greater than 95% completeness, revealed variants active 
against both sets of substrates (Table 4.7). The only trend visible in the mutants identified is 
that a hydrophobic residue (Ile, Val or Trp) seems to be favoured at position 463 in variants 
showing activity against glycerol and/ or D-xylose. As before, the microtitre plate-based screen 
would need to be carried out on these variants to determine if any show higher activity than 
WT against glycerol or D-xylose. 
Table 4.7. Variants from Library M showing activity against alternative substrates 
Active against 
glycerol and/ or D-
xylose 
 Active against 
D-arabinose, D-
mannose 
 and/ or D-glucose 
P463 F464  P463 F464 
I G  H Q 
V S  P E 
V Y    
W K    
W W    
 
Library L: Y405X/ Q406X was also screened to >95% using the agar plate-based screen. In an 
initial screen of 200 variants the only variants showing activity against D-galactose contained a 
tyrosine at position 405, as in the WT enzyme. Substitution at this position with a threonine, 
lysine or tryptophan appeared to abolish galactose oxidase activity, although sequencing of a 
number of active variants revealed substitutions at position 406. The screens of Library L 
against alternative substrates produced similar results with only two hits identified: Q406E 
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active against glycerol and/ or D-xylose and Q406K active against D-arabinose, D-mannose and/ 
or D-glucose. 
Screening of Library N: L514X/ C515X/ C518X to >95% completeness revealed five mutants 
with altered activities (Table 4.8). From this small dataset it appears that a hydrophobic 
residue is favoured at position 514 (Leu, Val or Met) in variants showing activity towards 
alternative substrates, and that the disulfide bond between Cys515 and Cys518 in the WT 
structure is not required for activity against these substrates as various substitutions were 
observed at these positions. 
Table 4.8. Variants from Library N showing activity against alternative substrates 
Active against 
glycerol and/ or D-xylose 
 Active against 
D-arabinose, D-mannose, 
and/ or D-glucose 
L514 C515 C518  L514 C515 C518 
V A A  V A A 
L G F  M M F 
L W E  W W A 
 
Approximately 2 x 105 colonies from Library D: F194X/ P463X/ F464X and from Library F: 
F194X/ F227W/ W290AFHWY were screened by Ms L Paraskevopoulou and Mr C Doherty, final 
year undergraduate project students under my supervision. 21 variants from Library D and 14 
variants from Library F showed activity against glycerol and/ or D-xylose while only one variant 
from each library was identified with activity against D-glucose, D-arabinose and/ or D-
mannose. These 38 variants were isolated and the screens repeated using the microtitre plate-
based assay (Section 3.3).  
4.4.2 Microtitre plate-based screening 
Data from the microtitre plate-based screens was analysed in different ways depending on 
which substrate was being screened. WT GO-N6M1 shows sufficiently high activity against 
glycerol and D-xylose that the colour change was clearly visible by eye (Figure 4.12). In the case 
of D-glucose, D-arabinose and D-mannose however, the colour change was much more subtle 
and thus a plate reader was used to measure A414 values. Blank readings were then subtracted 
and the A414 values ranked in order of magnitude and plotted against A414 (Figure 4.13). This 
clearly revealed any wells showing a higher level of absorbance than others, thus identifying 
mutants to be taken forward for further analysis. 
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Figure 4.12. Photographs of the microtitre plate-based screens of Library P: F194X/ 
C383CEKMST 
Screens against D-galactose (top left), glycerol (bottom left) and D-xylose (top right) are 
shown as an example of the screening methodology. Variants are numbered 1 to 88 with 
positive and negative controls in the final lane, where WT is WT GO-N6M1 enzyme with 
the full assay mix and B is WT GO-N6M1 with HRP excluded (bottom right).  
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Figure 4.13. Absorbance at 414 nm readings ranked according to magnitude  
The data show absorbance readings for variants from Library P: F194X/ C383CEKMST in 
a screen with D-glucose as the substrate. While no colour change was visible by eye, 
analysing the data by this method identified three potential hits: P72, P83 and P74 (red 
box). 
 
All microtitre plate-based assays were carried out on two separate days to ensure 
reproducibility of the results and that anomalous results (positive and negative) did not 
prevent identification of variants of interest. Plasmids encoding any variants showing 
increased activity compared to WT were purified by DNA miniprep and sent for DNA 
sequencing to identify the mutations present.  
Although the majority of sequencing reactions allowed identification of the mutations present, 
reactions for a number of the mutants failed, despite repeats, implying that the primer binding 
site was not present in the sample provided. In some cases, sequencing data revealed 
duplicates of mutants, which was reassuring as this confirmed the assay results. Almost 4% of 
variants were also shown to contain frameshifts, insertions, deletions and mutations at 
multiple positions, rather than just those which had been targeted. This is most likely due to 
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errors in the proof-reading mechanism of the polymerases used in library construction. Most 
of the mutants containing these errors displayed very low or no activity towards D-galactose, 
implying that the activity observed with other substrates may be an artefact of the screens. An 
example of this is the mutant P72 which appeared to have increased D-glucose activity (Figure 
4.13) but no D-galactose activity – sequencing revealed a frameshift mutation near the 
beginning of the gene. The observed D-glucose activity for this variant is possibly due to a 
screening artefact such as contamination with another variant. 
The libraries screened using the microtitre plate-based assay and the number of hits identified 
from each library are shown in Table 4.9. The seven smaller libraries were only screened using 
this assay, whereas hits from agar plate screening of Libraries D and F were confirmed using 
the microtitre plate-based screen. Unfortunately none of the variants from Libraries D and F 
which showed activity against D-arabinose, D-glucose and/ or D-mannose showed such 
activities in the microtitre plate-based screen. However, some of the other hits proved to be 
reproducible: P463V from Library D and F194W/ W290F from Library F both showed enhanced 
activity towards glycerol. 
Table 4.9. The libraries screened using the microtitre plate-based screen 
Library Mutations introduced 
Number 
screened 
Completeness 
(%) 
No. hits 
identified 
D F194X/ P463X/ F464X 
19 
(confirmation) 
n/a 1 
F F194X/ F227X/ W290AFHWY 
15 
(confirmation) 
n/a 1 
I F194X 88 >95 3 
J F227X 88 >95 1 
K N245X 88 >95 6 
O N245X/ C383CEKMST 88 60 2 
P F194X/ C383CEKMST 88 60 10 
Q F227X/ C383CEKMST 88 60 7 
R N245X/ C383CEKMST 88 60 6 
The percentage completeness in the screening effort was determined as before. The 
number of hits identified excludes duplicates and only includes those for which 
sequencing data was attainable. Library D was screened by Ms Lito Paraskevopoulou; 
Library F was screened by Mr Ciaran Doherty. 
 
In order to explore the basis for some of the failed sequencing reactions, analytical digests 
with MfeI and NotI were carried out on a selection of the plasmids for which sequencing 
reactions had failed. Analysis by agarose gel electrophoresis (Figure 4.14) revealed that, in all 
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but one case, the digestion did not result in fragments of the expected size. This suggests that 
a significant insertion or deletion has occurred during construction of these plasmids which 
may have deleted the binding site of the sequencing primer. Positive results seen in screens 
with these mutants seem to be artefacts. 
 
Figure 4.14. Analytical digests of a selection of plasmids for which sequencing reactions 
failed on more than one occasion 
Double digests were carried out with MfeI and NotI. The expected products for the intact 
pET28c-GO-N6M1 plasmid are 5857 and 1474 bp. Only the plasmid containing mutant 
J28 displays both of these bands. 
 
4.5 Confirmation of screen results 
4.5.1 Purification of the mutants 
Before large scale expression of variant proteins showing enhanced activities from Libraries D, 
F, I, J, K, O, P, Q and R it was necessary to delete the secretion signal sequence coding region 
to allow subsequent intracellular protein expression as detailed in Section 3.4. The resulting 
plasmids were used to transform BL21 Star (DE3) cells and the variant proteins were expressed 
by autoinduction before purification by Strep-Tactin chromatography. 
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Figure 4.15. SDS PAGE gels of samples taken during two different purifications of WT GO-
N6M1 
Samples taken at different stages of the purification process were analysed by SDS-
PAGE. The strepTEVN6M1 construct runs at approximately 70 kDa while the lower 
molecular weight bands seen in the elution fractions were unidentified. 
 
Despite an identical protocol being carried out each time, on several occasions multiple bands 
of lower molecular mass were visible by SDS-PAGE analysis of the purified GO (Figure 4.15). 
The presence or absence of the bands showed no correlation with activity and even two 
purifications of the same construct could show marked differences in the levels of 
‘contaminating’ bands. WT N6M1, which showed high levels of the lower molecular weight 
bands, still demonstrated kinetic behaviour within the range of published values. These bands 
could be a) contaminating proteins not removed during the purification process; b) 
degradation products of the GO protein; or c) due to errors in translation leading to truncated 
products. The first possibility seems unlikely due to the high affinity of the Strep-Tactin resin 
for the Strep II-tag present on GO (Voss and Skerra, 1997). There are no other proteins present 
in the cell lysate with a Strep II-tag so, unless these proteins are attached to GO itself, this does 
not explain how the low molecular weight bands elute at the same time as GO. The second 
possibility also seems unlikely as the cell lysate is filtered through a 0.2 µm filter to remove any 
bacterial contamination and protease inhibitor cocktail tablets are included in the lysis buffer 
to prevent proteolysis. The only way proteolysis could occur is if it is a) autocatalytic (which 
Chapter 4: Generation of Mutant Libraries and Screening to Identify Altered Enzyme Activities 
132 
 
only occurs in the WT enzyme to cleave the pro-region (Section 1.6.4) (Rogers et al., 2000); or 
b) catalysed by a protease not inhibited by the protease inhibitor cocktail used, which is 
unlikely. The final possibility also seems unlikely due to the maintenance of galactose oxidase 
activity (see below) which would not be expected in a version of GO lacking large amounts of 
the C-terminal end of the protein. 
When carrying out analyses on the purified protein, concentration was determined from the 
A280 reading. If the ‘contaminating’ bands were not part of the GO protein, the A280 readings 
would be inaccurate as this method measures total protein in the solution, not just the protein 
of interest. As kcat values for the WT enzyme, where these bands are also observed, are within 
the range of published values, and the relative proportion of these bands show no correlation 
with activity, it implies that the bands are not contaminants and are in fact part of GO. The 
most reasonable explanation is that the bands are products of cleavage of the protein 
backbone but when folded, the protein is held together with intramolecular interactions such 
as hydrogen bonds. When the protein is denatured to be analysed by SDS-PAGE these 
intramolecular interactions are disrupted causing the fragments to dissociate. This hypothesis 
would be most easily explored by native PAGE, however due to the high negative charge on its 
surface, it is not possible to analyse GO in this way. The only remaining question is what causes 
the cleavage in the first place but as the presence of the low molecular weight bands does not 
appear to affect activity, exploration of this problem was not considered a priority. In future, 
the gel bands could be identified using trypsin digestion and MALDI mass spectrometry in 
order to try and identify the cause of the proposed cleavage and try to prevent it. 
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4.5.2 Determination of specific activities 
Following purification, specific activities were determined for the 37 variants identified by 
screening against the substrates with which enhanced activities had been detected, as well as 
D-galactose (Table 4.10, Table 4.11, Table 4.12 and Table 4.13). Substrate concentrations were 
selected for D-galactose (0.6 M), glycerol (1.5 M) and D-xylose (1.5 M) based on concentrations 
which appear to be saturating for the WT enzyme with these substrates. D-arabinose, D-
mannose and D-glucose were used at 2 M as, whilst this does not appear to be saturating for 
WT GO, concentrations higher than this are likely to be inhibitory due to viscosity and reduced 
solubility of the sugars. Each variant is labelled with a letter and a number whereby the letter 
refers to the library number (I, J, K, P, Q or R) as detailed in Table 4.3, and the number refers to 
the position of the variant in the microtitre plate as shown in the bottom right of Figure 4.12. 
In the case of Libraries D and F, as only one variant was identified from each library, no 
number was used. 
 
 
 
1
3
4 
Table 4.10. Specific activities of mutants from Libraries D and F 
Variant Mutations 0.6 M D-GALACTOSE 1.5 M GLYCEROL 
 
WT 550 ± 25 64 ± 4.5 
D P463V 370 ± 50 95 ± 10 
F F194W/ W290F 28 ± 1.8 140 ± 10 
For each variant, specific activity values were compared to WT activity with that substrate (100%): values <25% are coloured dark blue, 25-90% are 
pale blue and 110-1000% are yellow. 
Table 4.11. Specific activities of mutants from Libraries I and P (containing mutations at position 194) 
Variant Mutations 
0.6 M  
D-GALACTOSE 
1.5 M  
GLYCEROL 
1.5 M  
D-XYLOSE 
2.0 M  
D-MANNOSE 
2.0 M  
D-ARABINOSE 
2.0 M  
D-GLUCOSE 
 
WT 550 ± 25 64 ± 4.5 3.3 ± 0.14 89 ± 4.6 1.2 ± 0.04 0.15 ± 0.02 
P19 F194D/ C383E 28 ± 0.84 
 
3.5 ± 0.16 
  
0.51 ± 0.03 
P28 F194E/ C383S 69 ± 2.4 
   
0.62 ± 0.02 
 
I8 F194G 29 ± 0.73 
 
0.78 ± 0.03 
   
P88 F194G/ C383S 52 ± 0.85 
 
5.2 ± 0.21 
 
3.9 ± 0.16 2.0 ± 0.07 
P76 F194H/ C383E 74 ± 5.2 
 
12 ± 0.74 
 
6.0 ± 0.20 0.02 ± 0.01 
P74 F194I/ C383S 76 ± 2.6 
 
12 ± 0.23 
 
13 ± 0.39 2.4 ± 0.08 
P60 F194K/ C383M 8.2 ± 0.38 
 
2.1 ± 0.14 
   
P20 F194Q/ C383S 200 ± 5.5 68 ± 2.2 19 ± 1.0 
 
13 ± 1.4 
 
P83 F194T/ C383E 72 ± 1.1 
  
8.6 ± 0.00 
 
3.8 ± 0.12 
I5 F194V 19 ± 0.72 
   
0.51 ± 0.03 0.30 ± 0.00 
P7 F194W/ C383S 470 ± 24 230 ± 7.6 32 ± 1.1 85 ± 8.7 12 ± 0.29 0.47 ± 0.01 
P77/ I81 F194Y 470 ± 29 69 ± 1.9 15 ± 0.29 37 ± 3.1 0.49 ± 0.01 0.09 ± 0.00 
For each variant, specific activity values were compared to WT activity with that substrate (100%): values <25% are coloured dark blue, 25-90% are 
pale blue, 90-110% are green, 110-1000% are yellow and >1000% (i.e. greater than 10-fold increase) are red. 
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Table 4.12. Specific activities of mutants from Libraries J and Q (containing mutations at position 227) 
Variant Mutations 
0.6 M  
D-GALACTOSE 
1.5 M  
GLYCEROL 
1.5 M  
D-XYLOSE 
2.0 M  
D-MANNOSE 
2.0 M  
D-ARABINOSE 
2.0 M  
D-GLUCOSE 
 
WT 550 ± 25 64 ± 4.5 3.3 ± 0.14 89 ± 4.6 1.2 ± 0.04 0.15 ± 0.02 
J16 F227D 0.99 ± 0.03 0.20 ± 0.01 0.01 ± 0.00 
  
not detectable 
Q16 F227G/ C383E 0.33 ± 0.01 
   
0.01 ± 0.00 
 
Q48 F227L/ C383E 2.9 ± 0.05 2.4 ± 0.08 
 
1.1 ± 0.36 not detectable 
 
Q61 F227M/ C383E 18 ± 1.1 14 ± 0.62 2.7 ± 0.23 
  
0.26 ± 0.02 
Q75 F227N/ C383E 0.98 ± 0.00 
    
not detectable 
Q20 F227P/ C383S 0.65 ± 0.01 0.19 ± 0.00 
   
not detectable 
Q3 F227Q/ C383K 1.5 ± 0.09 0.22 ± 0.00 0.02 ± 0.00 
   
Q14 F227W/ C383E 18 ± 1.6 18 ± 1.3 12 ± 0.56 
 
5.9 ± 0.30 0.73 ± 0.02 
For each variant, specific activity values were compared to WT activity with that substrate (100%): values <25% are coloured dark blue, 25-90% are 
pale blue and 110-1000% are yellow. 
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Table 4.13. Specific activities of mutants from Libraries K and R (containing mutations at position 245) 
Variant Mutations 
0.6 M  
D-GALACTOSE 
1.5 M  
GLYCEROL 
1.5 M  
D-XYLOSE 
2.0 M  
D-MANNOSE 
2.0 M  
D-ARABINOSE 
2.0 M  
D-GLUCOSE 
 
WT 550 ± 25 64 ± 4.5 3.3 ± 0.14 89 ± 4.6 1.2 ± 0.04 0.15 ± 0.02 
R24 N245A/ C383M 170 ± 17 110 ± 3.8 43 ± 0.69 
 
7.0 ± 0.36 1.1 ± 0.04 
K64 N245F 600 ± 20 98 ± 5.8 28 ± 2.2 
  
0.28 ± 0.01 
K50 N245G 480 ± 33 83 ± 5.6 12 ± 1.7 
   
K58 N245H 490 ± 33 87 ± 2.4 14 ± 0.45 
   
R38 N245H/ C383E 130 ± 14 140 ± 3.6 67 ± 13 
   
R69 N245H/ C383M 110 ± 3.8 84 ± 6.1 33 ± 2.2 49 ± 1.1 5.4 ± 0.19 1.2 ± 0.11 
R85 N245H/ C383S 410 ± 7.8 250 ± 16 62 ± 3.1 110 ± 1.9 7.5 ± 0.32 0.88 ± 0.03 
R28 N245L/ C383S 520 ± 12 180 ± 12 30 ± 2.2 
 
6.8 ± 0.49 0.59 ± 0.02 
K72 N245P 500 ± 32 
 
12 ± 0.41 87 ± 7.8 1.8 ± 0.05 0.24 ± 0.02 
K60 N245R 600 ± 37 140 ± 9.9 22 ± 2.6 
   
R62 N245R/ C383E 100 ± 6.1 97 ± 12 77 ± 6.0 9.7 ± 2.0 12 ± 0.57 3.0 ± 0.08 
O62 N245R/ C383S 460 ± 21 270 ± 12 91 ± 1.8 
 
8.9 ± 0.36 1.0 ± 0.03 
K21 N245S 510 ± 5.9 
 
3.5 ± 0.22 
  
0.19 ± 0.01 
O52 N245W/ C383S 430 ± 10 280 ± 6.9 93 ± 3.7 120 ± 20 8.5 ± 0.32 1.2 ± 0.31 
For each variant, specific activity values were compared to WT activity with that substrate (100%): values <25% are coloured dark blue, 25-90% are 
pale blue, 90-110% are green, 110-1000% are yellow and >1000% (i.e. greater than 10-fold increase) are red. 
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As the data are grouped by library, it is easy to visualise trends. For example, mutations at 
positions 194 or 227 almost always lead to significant reductions in D-galactose activity while 
this is not the case for most mutations at position 245. Mutations at position 245 generally 
increase the activity against most of the alternative substrates screened, particularly D-xylose. 
In some cases, enhanced activities seen during the initial screens were not observed with the 
purified protein. For the eleven examples of this in libraries containing F194 or N245 
mutations, this is most likely due to errors in the screening. These could include pipetting 
errors, contamination between wells of the microtitre plate, or contamination with another 
microorganism, such as fungus, which can catalyse one of the reactions in the coupled assay. It 
is also possible that the mutation(s) have resulted in increased expression levels rather than 
increased activity which would not be detected with the purified proteins. This was observed 
by the Ollis group when evolving a bacterial phosphotriesterase (McLoughlin et al., 2005). 
In the case of libraries containing mutations at position 227 however, only four of the 19 
observed enhancements in activity were confirmed with the purified protein (Table 4.12). F227 
is a large hydrophobic residue which occurs directly next to the thioether bond-forming 
residue C228 in the active site of the enzyme. When the residue was selected it was thought 
that it may play a role in substrate binding through the hydrophobic surface with F194 and 
F464. This may be the case, given the enhancement in activities seen with two of the mutants 
(F227M/ C383E and F227W/ C383E, Table 4.12). However, it also seems likely that mutating 
this residue has, in some cases, had a negative impact on the environment around the 
thioether bond, which is essential for the enzyme mechanism. Most of the variants taken 
forward from these screens were selected because they showed the highest change in 
absorbance. However, it now seems likely that many of these absorbance readings may have 
been within the error of the plate reader used to measure the absorbance as the relative 
increases compared to WT GO-N6M1 were smaller than in other screens. Nevertheless, these 
screens have still proved worthwhile as two variants showing enhancements in activity were 
confirmed: F227M/ C383E with enhanced D-glucose activity and F227W/ C383E with enhanced 
activity towards D-xylose, D-arabinose and D-glucose. 
In some potential applications of variants generated in this project, the specificity of the 
enzyme for the new substrate will be an important factor. In order to help the selection of 
variants to take forward for further characterisation, the shifts in specificity away from D-
galactose and towards the new substrate were determined (Table 4.14). While some variants 
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stand out due to large increases in specific activity, others stand out due to shifts in specificity 
towards the new substrate. In all cases where the specificity has shifted by over 100-fold, apart 
from Q14: F227W/ C383E, activity towards D-galactose is reduced by more than 4-fold at the 
same time as activity against the alternative substrate(s) is increased more than 10-fold. 
Table 4.14. Shifts in specificity away from D-galactose and towards the alternative substrate 
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P19 F194D/ C383E 
 
21 
  
64 
P88 F194G/ C383S 
 
17 
 
32 127 
P76 F194H/ C383E 
 
27 
 
37 1 
P74 F194I/ C383S 
 
27 
 
77 108 
I39 F194K 
 
9 
 
10 
 
P60 F194K/ C383M 
 
44 
   
P20 F194Q/ C383S 3 16 
 
29 
 
P83 F194T/ C383E 
    
183 
I5 F194V 
   
12 56 
P7 F194W/ C383S 4 12 1 11 3 
Q16 F227G/ C383E 
   
17 
 
Q61 F227M/ C383E 7 25 
  
50 
Q14 F227W/ C383E 8 113 
 
145 139 
R24 N245A/ C383M 6 42 
 
18 22 
K64 N245F 1 8 
  
2 
R38 N245H/ C383E 9 88 
   
R69 N245H/ C383M 7 51 3 23 39 
R85 N245H/ C383S 6 25 2 7 7 
R28 N245L/ C383S 3 10 
 
6 4 
K60 N245R 2 6 
   
R62 N245R/ C383E 8 129 
 
53 103 
O62 N245R/ C383S 5 34 
 
9 8 
O52 N245W/ C383S 6 36 2 9 10 
C383E C383E 8 33 
 
16 21 
C383S C383S 4 7 2 5 5 
F F194W/ W290F 42 
    
Only variants displaying a shift in specificity of greater than 5-fold towards at least one 
substrate are shown. Shifts in specificity were determined by multiplying the shift away 
from D-galactose by the shift towards the alternative substrate, for example if there is no 
overall shift, the value would be 1. 
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The nine variants showing the most interesting changes in activity and which were taken 
forward for further characterisation are shown in Table 4.15. Full analysis of activity increases 
and specificity shifts is carried out in Chapter 5. 
Table 4.15. The nine variants to be taken forwards for further characterisation 
Variant Mutations Substrate towards 
which activity is altered 
Increased 
activity? 
Shift in 
specificity? 
P88 F194G/ C383S D-glucose   
P74 F194I/ C383S D-arabinose   
P74 F194I/ C383S D-glucose   
P83 F194T/ C383E D-glucose   
Q14 F227W/ C383E D-arabinose   
Q14 F227W/ C383E D-glucose   
Q14 F227W/ C383E D-xylose   
R38 N245H/ C383E D-xylose   
R62 N245R/ C383E D-arabinose   
R62 N245R/ C383E D-glucose   
R62 N245R/ C383E D-xylose   
O62 N245R/ C383S D-xylose   
O52 N245W/ C383S D-xylose   
F F194W/ W290F Glycerol   
 
4.6 Discussion 
Deciding which residues to randomise in projects such as this is crucial. Until more is known 
about the precise roles of each residue, designing libraries will always be a form of educated 
guess work. Fortunately, each project which aims to alter the substrate specificity of GO, 
regardless of its success, provides information on the effects of different residues at different 
positions which can then feed into future projects (Delagrave et al., 2001, Sun et al., 2002). 
Selecting the residues for randomisation in this project was done with great care, following 
analysis of all the previous studies on GO. It was reassuring that another group working on a 
similar project simultaneously selected very similar residues (Rannes et al., 2011). There are, 
no doubt, other residues within GO which play a role in determining substrate specificity which 
have not been included here. C383 was identified by epPCR and it is still unclear how this 
residue, ~12 Å from the active site copper, can have the observed significant effects on 
catalysis. Perhaps further studies like the one by Delagrave et al. (2001) would identify 
additional residues which would not be considered important upon simple structural analysis, 
although no mutants displaying enhanced activity were identified in a directed evolution study 
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by the Arnold group (Sun et al., 2001). This is perhaps a consequence of the proposed rigidity 
of the GO structure (Section 1.6.1). As our knowledge of enzyme structures increases, in silico 
tools will also prove invaluable in design of mutant libraries. 
Designing the mutant oligonucleotides and the libraries is another important step. Due to the 
nature of the library generation method selected for this project, it was necessary to include 
multiple randomisations on one oligonucleotide. In some cases this proved advantageous as 
generation of Libraries L (Y405X/ Q406X) and M (P463X/ F464X) was very straightforward. 
However, in the case of the oligonucleotide QYRN326-333 where four residues were 
randomised in combination, this meant any library with one of these mutations also had to 
include the other three, instantly increasing the size of the library and screening effort 
required. 
As some of the substrates used in screening seem to structurally differ quite considerably from 
D-galactose, it is easy to make the mistake of assuming that a large number of mutations must 
be required to enhance this activity. However, this can lead to significant disruption of the 
active site meaning no catalysis of any substrates can occur. There is also the requirement for 
an increased screening effort in order to stand a chance of finding the mutant(s) with the 
desired activity. In this project, similar numbers of variants showing enhanced activity were 
observed in small and large libraries implying that it may have been better to focus only on 
small libraries initially and use the data gathered to design the larger libraries by more rational 
approaches. 
As noted in Chapter 3, it is easy to spend large amounts of time optimising a process beyond 
what is necessarily required. If a process is adequately efficient for its purpose it is often wise 
to cease optimisation experiments. In the case of library generation, it would have avoided 
extra purification and overlap extension steps if the DNA fragments containing the different 
mutations could have been combined in a ‘one pot’ reaction. It is not clear why this did not 
work but it was more efficient to simply combine the fragments in multiple steps than spend 
an unknown amount of time exploring why the ‘one pot’ reaction did not work. Likewise with 
optimisation of the ligation reaction and transformation into E. coli; various additional 
conditions such as incubation times longer than 2 hours, different incubation temperatures 
and a wider choice of cells to transform into could have been included. However, the 
conditions selected from the optimisations carried out were completely adequate for the 
library generation here, as demonstrated by the diverse libraries generated. 
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Testing a variety of different conditions is often required to optimise ligation of an insert and 
plasmid as the kinetics of the ligation reaction are very sensitive to the molecular weight of the 
two species and the reaction conditions. In the conditions sampled here it was found that a 
low plasmid to insert ratio, a low DNA concentration and an incubation time of 2 hours gave 
the best results. However, there may have been additional conditions which were not sampled 
which would have improved the efficiency of the ligation further. Ligation of different inserts 
into different plasmids may proceed most efficiently under totally different conditions than 
those used here and further optimisation should be carried out if a higher efficiency is 
required. 
A large number of variants were screened for altered activities using the agar plate-based 
screen. While it was not possible to confirm many of the hits using the microtitre plate-based 
screen, a useful set of initial data is now available for future studies. However, without further 
analysis of the hits from the agar plate-based screening and confirmation of the new activities, 
it is necessary to be cautious when analysing these datasets. In most cases, the number of hits 
is so small that any trends seen in the residues represented could easily be down to 
coincidence. However, two conclusions can be drawn from the agar plate screens with some 
confidence. A charged residue at position 333 (arginine or lysine) is significantly favoured in 
variants showing enhanced glycerol and/ or D-xylose activity (Library E); and the disulfide bond 
between C515 and C518 in the WT enzyme is not essential for structural integrity or catalytic 
activity as removal of this bond has not inactivated the enzyme (Library N). The substitution of 
an Asn residue at position 333 with Arg or Lys not only introduces a charge at this position, but 
also introduces a larger residue. This may reduce the size of the active site to permit more 
efficient binding of the smaller glycerol molecule or introduce a charge at an optimal position 
to promote binding of glycerol or D-xylose. Without confirmation of the enhanced activity this 
mutation was not explored further here, but this is a potential target for future work. 
The identification and confirmation of 27 variants showing at least some enhancement in 
activity towards one or more of the substrates screened is a valuable achievement. It is, 
however, impossible to fully characterise all of the variants in order to understand the basis for 
the altered activity so the most promising subset of variants was selected for more in-depth 
characterisation. As well as showing an enhancement in activity towards the new substrate, it 
is often desirable to reduce the activity towards the native substrate at the same time. Specific 
activities were therefore determined at different substrate concentrations, depending on the 
substrate used due to the different saturation kinetics of WT GO with each substrate. While 
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this data is not ideal for identifying shifts in specificity, it still provides an indication of which 
variants show the greatest shifts. Calculation of specificity shifts using the same substrate 
concentrations is shown in Section 5.3. Only nine of the variants were taken forwards for 
further characterisation. However, those not selected may still be helpful in analysis of the 
new activities. All nine of the variants are double mutants so it will, of course, be important to 
analyse the effect of each mutation individually. Unselected variants which contain one of the 
same mutations, but show different activities will help in the analysis. For example, combined 
with Cys383Ser, substitution of Phe194 with smaller hydrophobic residues Gly or Ile results in 
reduced D-galactose activity but increased activity with other substrates. Substitution with the 
larger hydrophobic residue Trp however, leads to similar increases in D-xylose and D-arabinose 
activities but a much smaller loss in D-galactose activity. Screening of Library R (N245X/ 
C383CEKMST) identified multiple mutants containing His at position 245 combined with 
different residues at position 383. While N245H/ C383S (R85) showed higher activities against 
D-galactose and glycerol than the N245H/ C383E (R38) mutant, activities against D-xylose were 
about the same. With a Met at position 383 the results were different again. Only N245H/ 
C383E (R38) was selected for further characterisation but initial data from the two similar 
mutants may help in analysis of this data. The two similar variants N245R/ C383E (R62) and 
N245R/ C383S (O62) were both selected for further characterisation so the differences in 
activity will be explored in more detail. 
 
Conclusions 
Based on analysis of previous data, 17 residues surrounding the active site of GO were selected 
for randomisation. Libraries were designed to randomise different combinations of these 
residues and, following optimisation of the library generation procedure, 16 libraries were 
produced. The two screens developed in Chapter 3 were used effectively to identify a number 
of variants showing altered activities and 37 of these variants were purified by Strep-Tactin 
chromatography. Specific activities were measured against the different substrates and 27 
variants were shown to display enhanced activities. Using this data, nine variants were 
selected for further characterisation. 
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5.1 Introduction 
In the previous chapter, 27 variants of GO were identified with enhanced activity towards one 
or more substrates (Table 4.15). Many of these variants also displayed shifts in specificity 
towards the alternative substrate and away from D-galactose. Other studies which have 
introduced novel activities into GO have presented further data, either detailing 
characterisation of the activities, or demonstrated the use of the variant(s) in a targeted 
application. For example, Arnold and co-workers characterised the products of D-glucose 
oxidation by the W290F/ R330K/ Q406T variant using thin-layer chromatography and 13C- and 
1H-NMR, and demonstrated that oxidation occurs on the C-6 hydroxyl of the D-glucose 
molecule (Sun et al., 2002). Turner and co-workers successfully demonstrated labelling of 
mannosylated glycoproteins on the surface of P. pastoris cells using a GO variant with 
increased activity towards mannose (Rannes et al., 2011). 
In this chapter, the nine variants selected during this study were subjected to more extensive 
analysis and characterisation with the aim to further understand the enhanced activities, and 
to determine more optimal reaction conditions for the variants for potential future 
applications. As each of the nine variants contains two mutations, the contribution of each 
single mutation on activity towards D-galactose and the alternative substrates was also 
assessed. Determination of the specific activities at pH 7.0 with D-galactose and the alternative 
substrates all at the same concentration makes it possible to determine the shift in specificity 
more accurately than in Chapter 4, where activities were measured at different substrate 
concentrations depending on the substrate used. The simplest way to visualise changes in 
specificity is by a graphical method which can demonstrate the true extent to which any 
enzyme substrate specificity switch has been achieved. As WT GO-N6M1 displays such a high 
level of activity towards D-galactose (kcat = 889 ± 23) and such low levels of activity towards D-
arabinose (kcat = 1.87 ± 0.08) and D-glucose (kcat = 0.39 ± 0.01) it is a major challenge to 
generate a variant displaying higher activity towards D-arabinose or D-glucose than D-
galactose. WT GO-N6M1 displays a higher level of activity towards D-xylose (kcat = 6.76 ± 0.17) 
than the other substrates and so generation of a ‘D-xylose oxidase’ showing a preference for D-
xylose over D-galactose does seem more feasible. Values for KM are not considered in this 
project due to the high substrate concentrations used which are likely to be higher than the KM 
for all substrates, this is discussed further in Section 6.3. 
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Determination of kinetic parameters is carried out in many enzyme evolution projects 
(Delagrave et al., 2001, Deacon et al., 2004) as the different parameters provide specific 
information on the catalysed reaction. kcat represents the number of turnovers catalysed by 
the enzyme per unit time. In the case of WT GO with D-galactose, kcat is around 1000 s
-1. KM 
represents the substrate concentration at which the enzyme rate is half the maximum rate 
(Vmax) and is often interpreted as an indication of the affinity of the enzyme for the substrate – 
a high KM indicates a lower affinity. However, it is important to realise that KM and affinity are 
not necessarily directly correlated as the value of KM is also dependent on the rate of product 
release. A standard one-substrate enzyme reaction is shown below where E is enzyme, S is 
substrate, ES is the enzyme-substrate complex and P is product: 
 
Here KM is defined as, 
KM = (k-1 + k2)/ k1 
while the dissociation constant (KS) of the first step of the reaction (formation/ dissociation of 
ES) defines the affinity of the enzyme for the substrate and is defined as, 
KS = k-1/ k1 
Therefore, KM is only a direct measure of the enzymes affinity for substrate when k2/ k1 is very 
small i.e. k2 < k1. This is not always the case in enzyme catalysed reactions and the relative rate 
constants may be altered by the mutations introduced so comparison of KM values as a 
measure of affinity should be treated with caution. For WT GO with D-galactose, the KM is very 
high at around 50-70 mM. 
The analysis of activity towards different forms of the substrate can provide valuable 
information on the binding of substrate within the active site. The activities of the GO variants 
towards methylated versions of the substrates were investigated and the products of some of 
the reactions were analysed by 1H-NMR in order to determine the regioselectivity of the 
variants. pH can have a significant effect on important characteristics of certain substrates and 
products such as solubility, oligomeric state and stability. The pH optima of the different 
variants were measured for two reasons: 
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 to identify shifts in the pH profile and optima which may help explain the altered 
activity 
 to identify the pH range over which the variants are most active, an important 
consideration for potential future development. 
The final characterisation aimed to observe changes to the oxidative half reaction as 
measurements so far have focussed on changes in the reductive half reaction. As detailed in 
Section 1.6.3.2, following oxidation of the alcohol group and release of the aldehyde product, 
the enzyme undergoes an oxidative half reaction whereby dioxygen binds, the Cu2+ centre and 
thioether bond radical is regenerated with hydrogen peroxide released. This regeneration 
process is essential for continued use of the enzyme over long periods and it is important to 
consider whether catalytic rate could be improved by increasing the oxygen concentration in 
the reaction. This is not necessarily desirable in industrial processes as addition of oxygen can 
greatly increase the cost of the process as well as adding extra safety concerns. 
A single variant showing significant change in activity towards glycerol, F194W/ W290F, was 
discovered towards the end of the project and so complete characterisation was not possible, 
but further investigation of this variant would be of value. The bulk of this chapter focuses on 
variants showing enhanced activity towards D-arabinose, D-glucose or D-xylose while Section 
5.9 presents the preliminary characterisation of variant F194W/ W290F. 
5.2 Alignments with galactose oxidases from other species 
While structural alignments with similar proteins can greatly aid the generation of so-called 
‘smart’ libraries (Jochens and Bornscheuer, 2010), they can also prove very useful in 
rationalising the results of screening more diverse libraries, as created here. The BLAST tool at 
www.uniprot.org was used to identify GO-like sequences from 50 different species (42 fungal 
and eight bacterial) that show the highest levels of sequence identity to the WT F. 
graminearum GO sequence (Table 5.1).  
 
Table 5.1 (Next page). Details of the 50 sequences showing highest identity to GO from F. 
graminearum 
Fungi are shown in orange, bacteria are shown in yellow. Entries shown in bold were 
used in the alignment shown in Figure 5.2. 
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Entry  Protein name Organism  
Identity 
(%) 
I1S2N3  Galactose oxidase Fusarium graminearum 100 
K3VPS0  GAOA Fusarium pseudograminearum 98 
E6PBN5  Galactose oxidase Fusarium oxysporum 79 
E6PBN6  Galactose oxidase Fusarium verticillioides 79 
C7YSK0  Putative uncharacterized protein Fusarium solani 68 
E6PBN7 Galactose oxidase Fusarium verticillioides 68 
E6PBN9 Galactose oxidase Fusarium graminearum 66 
C0KZ93  Putative galactose oxidase Epichloe festucae 61 
E7CHE7  Galactose oxidase Fusarium subglutinans 60 
G3JJG5  Galactose oxidase Cordyceps militaris 60 
J5K2D6  Galactose oxidase Beauveria bassiana 60 
E6PBN4 Galactose oxidase Fusarium oxysporum 59 
E6PBP1  Galactose oxidase Fusarium graminearum 59 
E9E9T3  Putative galactose oxidase Metarhizium acridum 58 
B8MVM2 Galactose oxidase, putative Aspergillus flavus 55 
I8ACL7  Galactose oxidase Aspergillus oryzae 55 
Q0TYM4  Putative uncharacterized protein Phaeosphaeria nodorum 53 
A1DD28  Galactose oxidase, putative Aspergillus fischerianus 52 
E3RTD1  Putative uncharacterized protein Pyrenophora teres 52 
F8N1M2  Galactose oxidase Neurospora tetrasperma 52 
Q1K6D3  Galactose oxidase Neurospora crassa 52 
Q4WH00  Galactose oxidase, putative Aspergillus fumigatus 52 
A7F712  Putative uncharacterized protein Sclerotinia sclerotiorum 51 
B6HHT0  Pc21g18600 protein Penicillium chrysogenum 51 
F9XG69  Putative uncharacterized protein Mycosphaerella graminicola 51 
G2XTJ0  Carbohydrate-Binding Module family 32 Botryotinia fuckeliana 50 
F7WCC9  WGS project CABT0000 data, contig 2.115 Sordaria macrospora 49 
A1C8B2  F5/8 type C domain protein Aspergillus clavatus 48 
B2W528  Galactose oxidase Pyrenophora tritici-repentis 48 
E5AB94  Galactose oxidase domain protein Leptosphaeria maculans 48 
B6QHP5  Galactose oxidase, putative Penicillium marneffei 47 
E3QHV8 Kelch domain-containing protein Colletotrichum graminicola 47 
G8S9Z0  Putative uncharacterized protein Actinoplanes sp. 47 
H1VE61  Kelch domain-containing protein Colletotrichum higginsianum 47 
Q0CJ74  Galactose oxidase Aspergillus terreus 47 
C9SWV4  Galactose oxidase Verticillium albo-atrum 46 
D5WMI0  Galactose oxidase Burkholderia sp. 46 
G2XFJ0  Galactose oxidase Verticillium dahliae 46 
B2AU87  Predicted CDS Pa_1_18310 Podospora anserina 45 
C5CYJ5  Galactose oxidase Variovorax paradoxus 45 
G4NG45  Galactose oxidase Magnaporthe oryzae 45 
J3PC95  Galactose oxidase Gaeumannomyces graminis 45 
A2S3I5  Galactose oxidase-related protein Burkholderia mallei 44 
C0Y524  Galactose oxidase domain protein Burkholderia pseudomallei 44 
B5WUJ3  Galactose oxidase Burkholderia sp.  43 
B8MB95  Galactose oxidase, putative Talaromyces stipitatus 43 
I2N9Q4  Galactose oxidase domain protein Streptomyces tsukubaensis 43 
K1XJ48  Galactose oxidase Marssonina brunnea 42 
Q2T7C2  Lectin repeat domain protein Burkholderia thailandensis  42 
Q4PAQ4  Putative uncharacterized protein Ustilago maydis 42 
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An alignment was carried out using the Vector NTI program and the residues occurring at each 
of the randomised positions was assessed. As shown in Figure 5.1, of the 16 residues 
randomised in libraries, the majority show relatively high levels of conservation. Position 227, 
for example contains Phe in all 50 sequences while positions 405 and 514 only differ from the 
input sequence in one case. Some of the other randomised positions, however, show greater 
variation, such as position 326 where 11 different residues occur. Indeed, only 11 of the 50 
sequences contain Gln at this position as in the WT F. graminearum sequence. 
Residues showing high levels of conservation are more likely to play an important role within 
the enzyme, such as substrate binding or catalysis. However, it is important to remember that 
the engineering carried out here aims to introduce binding to an alternate substrate to D-
galactose. Indeed, when initial screening data from many of the libraries (Chapter 4) is 
compared with the alignment data shown here the results do not always correlate. In the case 
of Library E (Q326X/ Y329X/ R330X/ N333X) for example, the range of residues seen in the first 
three positions for variants showing enhanced glycerol or D-xylose activity is not limited to 
those residues shown in the alignments. At position 333, the prevalence of the charged 
residues Lys and Arg bears no resemblance to the uncharged polar residues Asn or Ser seen in 
the alignment. Screening of Library M (P463X/ F464X) revealed a preference for hydrophobic 
residues at position 463 which was also displayed in the alignments. However, the high 
conservation of Phe at position 464 is not seen in screening data. It would be interesting to see 
the effect of mutations at position 464 on activity against D-galactose. Screening of Library L 
(Y405X/ Q406X) showed that mutation of Y405 had a negative effect on activity against D-
galactose. This is in agreement with the alignment data which shows a high level of 
conservation at this position. Tyr405 is obviously an important residue and will no doubt be 
the subject of future studies on GO. 
Mutation of F194 in Library I led to significant reductions in D-galactose activity in most cases 
which is in agreement with the relatively high conservation of this residue in the different 
species. The absolute conservation of F227 in the GO sequences from the 50 organisms 
combined with the deleterious effect on enzyme activity towards all substrates seen upon 
screening Libraries J (F227X) and Q (F227X/ C383X) implies an essential role for this residue in 
the enzyme. 
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Figure 5.1. Pie charts showing the prevalence of different residues at the positions selected 
in this study 
 
Figure 5.2 shows an alignment of the sequences showing highest identity to GO from F. 
graminearum from ten different organisms (Table 5.1). All of the sequences share over 55% 
sequence identity with GO from F. graminearum and Domain 1 appears to be slightly less 
highly conserved than domains 2 and 3. This is unsurprising given the role of these two 
domains in enzyme activity. 
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Figure 5.2. Sequence alignment of the sequences from ten different organisms showing 
highest identity to GO from F. graminearum  
Residues identical to those in GO from F. graminearum are coloured while other 
residues are shown in grey. The relative identity for each residue is shown as a bar chart 
above the alignment: 100% conserved (green), >50% conserved (lime), <50% conserved 
(red). Figure created using Geneious 7.0.6 software. 
 
5.3 Contributions of single mutations to the altered activities 
5.3.1 Generation of single mutants 
As all of the variants selected at the end of Chapter 4 are double mutants, analysing the 
activity of each mutation individually is likely to provide information on the contribution of 
each mutation towards the altered activity. The single mutants F194G, N245H and N245R had 
already been isolated from library screening, but the other single mutants needed to be 
generated. Each double mutant combined a mutation at position 194, 227 or 245 with a 
mutation at position 383 so the single mutants at positions 194, 227 and 245 were easily 
created by site-directed mutagenesis using primers which introduced a Cys at position 383, as 
in the WT enzyme. The primers are shown in Table 5.2 and Phusion DNA polymerase was used 
for the primer extension (Section 2.4.3). Initial attempts to introduce the tgc codon were 
unsuccessful; however, following optimisation of annealing temperature, number of cycles and 
buffer, success was achieved using 16 cycles and the ‘GC buffer’ provided with the Phusion 
DNA polymerase. The C383E and C383S mutants had been generated previously (Deacon and 
McPherson, 2011). 
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Table 5.2. Primers used to reverse the C383 mutation to WT by site directed mutagenesis 
Primer name Sequence 
C383Xreversal_fwd 5’ ctgatgccatgtgcggaaacgctgtc 3’ 
C383Xreversal_rev 5’ gacagcgtttccgcacatggcatcag 3’ 
The mutated codon is shown in red and bold. 
 
All single and double mutant proteins were expressed, purified and had their specific activities 
determined with the relevant substrates (D-galactose, D-xylose, D-arabinose or D-glucose) at 1 
M substrate concentrations (Sections 2.5 and 2.6.4). 
5.3.2 Analysis of activity towards D-galactose 
As shown in Figure 5.3, at pH 7.0 all of the double mutants showed reduced D-galactose 
activity compared to WT GO-N6M1 or the relevant C383 single mutant; however the 
magnitude of this reduction varied.  
C383S displayed similar activity to WT, while C383E activity was reduced about two-fold. 
However, the four double mutants containing C383E displayed a greater than ten-fold 
reduction in D-galactose activity compared to WT, with F227W/ C383E showing >40-fold 
reduction.  
N245R and N245W combined with C383S showed much smaller reductions in D-galactose 
activity compared to WT of two- and three-fold, respectively. By contrast F194G and F194I 
with C383S showed activity reduction of 27- and nine-fold, respectively.  
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Figure 5.3. Specific activities at pH 7.0 of double and single mutants with 1 M D-galactose 
The F194X, F227X or N245X single mutant is the same colour as the relevant double 
mutant. Double mutants containing the C383E mutant are shown  while those 
containing C383S are shown . 
 
For F194X, F227X and N245X double mutants compared with single mutants, the results can be 
divided into two groups. When combined with C383S, neither F194X nor N245X single mutant 
activity was significantly different from the double mutant. However, with C383E, the F194X, 
F227X and N245X single mutant activity was significantly greater than for the double mutants. 
F227W displayed two-fold greater activity than F227W/ C383E while the other three single 
mutants displayed five- to nine-fold greater activity than their respective double mutant. The 
N245X single mutants all showed a two-fold reduction in D-galactose activity compared to WT 
while F227W showed a reduction of >20-fold compared to WT. Mutation of F194 to the polar 
residue Thr resulted in a three-fold reduction in activity while the non-polar residues Gly or Ile 
resulted in much greater reduction in activity of 45- and 13-fold, respectively. 
In summary, the F194X, F227X and N245X single mutations all led to a reduction in D-galactose 
activity compared to WT. Addition of C383E led to a further reduction in activity while C383S 
had a more limited effect on D-galactose activity. 
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5.3.3 Analysis of activity towards D-glucose 
Figure 5.4 shows the specific activities, at pH 7.0, of the double mutants which exhibited 
enhanced activity towards D-glucose, and the corresponding single mutants. F194T/ C383E 
showed a four-fold enhancement while F194G/ C383S and F194I/ C383S showed smaller 
enhancements of two- to three-fold. N245R/ C383E also showed a four-fold enhancement and 
F227W/ C383E was double that seen with WT GO-N6M1. These enhancements in activity are 
smaller than those measured in Chapter 4 as the D-glucose concentration was different at 2 M 
(Chapter 4) and 1 M (Chapter 5). The specific activities for all of the mutants are consequently 
reduced by approximately 50%, whereas the specific activity of the WT enzyme doubles, 
resulting in a less significant enhancement at 1 M D-glucose. 
 
Figure 5.4. Specific activities at pH 7.0 of double and single mutants with 1 M D-glucose 
The F194X, F227X or N245X single mutant is the same colour as the relevant double 
mutant. Double mutants containing the C383E mutant are shown  while those 
containing C383S are shown . 
 
The most significant increase in D-glucose activity compared to WT was seen with the C383E 
single mutant which displayed a five-fold increase. However as this mutant retained ~50% of 
the D-galactose activity (Figure 5.3), the shift in specificity towards D-glucose is much smaller 
than for some of the double mutants. C383S activity towards D-glucose was enhanced three-
fold – within a similar range to the four double mutants, excluding F227W/ C383E, although 
C383S displayed no reduction in D-galactose activity. 
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All of the F194X, F227X and N245X single mutants showed significantly lower activity towards 
D-glucose than their respective double mutants and, with the exception of N245R, activity was 
also reduced compared to WT.  
In summary, C383E and C383S mutations led to significant increases in D-glucose activity but, 
as outlined in Section 5.3.2, only limited or no loss in D-galactose activity. Combining the C383 
mutation with an additional mutation at position 194, 227 or 245 resulted in a moderate 
decrease in activity towards D-glucose but a significant reduction in activity towards D-
galactose, compared to the C383 mutation alone.  
As shown in Figure 5.5, despite significant reductions in D-galactose activity and increases in D-
glucose activity it is not possible to visualise any activity towards D-glucose on the same scale 
as D-galactose activity. All variants still show significantly higher activity towards D-galactose 
than D-glucose. 
 
Figure 5.5. Graphical representation to visualise any shift in specificity towards D-glucose 
Specific activities at pH 7.0 towards 1 M D-galactose are shown in red on the left of the 
axis. Specific activities at pH 7.0 towards 1 M D-glucose are shown in yellow on the right 
of the axis – as the activities are so small relative those of D-galactose they are not 
possible to visualise on the same axis. 
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5.3.4 Analysis of activity towards D-xylose 
Specific activities against D-xylose are shown in Figure 5.6. As seen with D-glucose, the double 
mutant F227W/ C383E only showed a moderate increase in D-xylose activity compared to WT. 
However, as the reduction in D-galactose activity was so great, a significant shift in specificity 
was observed and the variant is almost as active towards D-xylose as D-galactose (Figure 5.7). 
The double mutants N245H/ C383E, N245R/ C383E and N245W/ C383S showed increases in D-
xylose activity compared to WT of five- to eight-fold; while N245R/ C383S displayed a much 
greater increase of 20-fold.  
 
Figure 5.6. Specific activities at pH 7.0 of double and single mutants with 1 M D-xylose 
The F227X or N245X single mutant is the same colour as the relevant double mutant. 
Double mutants containing the C383E mutant are shown  while those containing 
C383S are shown . 
 
The variant showing the greatest potential is N245R/ C383E which couples a ten-fold reduction 
in D-galactose activity with an eight-fold increase in D-xylose activity. 
As seen with D-glucose, the C383E mutation led to a significant (10-fold) increase in activity 
against D-xylose. When C383E was combined with F227W, N245H or N245R, the activity 
towards D-xylose was reduced compared to C383E alone but the specificity for D-xylose was 
increased compared to C383E or WT (Figure 5.7). In fact with activity towards 1 M D-xylose of 
54.5 µmol H2O2/ min/ mg and towards 1 M D-galactose of 82.9 µmol H2O2/ min/ mg, the 
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double mutant N245R/ C383E almost represents a non-selective enzyme in terms of activity 
with these two substrates. The three single mutants (F227W, N245H or N245R) showed 
increased or equal D-xylose activity to WT but lower activity than the double mutants 
containing the C383E mutation. 
The C383S mutation increased D-xylose activity five-fold compared to WT, however when 
combined with the N245W mutation, which alone reduced D-xylose activity by 2.5-fold, 
actually displayed seven-fold higher activity than WT. A similar effect was seen with N245R, 
which displayed 2.6-fold greater D-xylose activity than WT, but when combined with C383S, 
enhanced activity by 20-fold. 
In summary, as seen with D-glucose, C383E and C383S mutations led to significant increases in 
D-xylose activity but, as outlined in Section 5.3.2, only limited or no loss in D-galactose activity. 
Combining C383E with F227W, N245H or N245R resulted in decreased D-xylose activity, but a 
greater reduction in D-galactose activity, compared to the C383E single mutant. Combining 
C383S with N245R or N245W resulted in larger increases in D-xylose activity but less of an 
effect on D-galactose activity. 
 
Figure 5.7. Graphical representation to visualise any shift in specificity towards D-xylose 
Specific activities at pH 7.0 towards 1 M D-galactose are shown in red on the left of the 
axis. Specific activities at pH 7.0 towards 1 M D-xylose are shown in blue on the right of 
the axis. 
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5.3.5 Analysis of activity towards D-arabinose 
Figure 5.8 shows the specific activity measurements towards D-arabinose compared to WT. 
F227W/ C383E showed a two-fold increase in D-arabinose activity compared to WT while 
F194I/ C383S and N245R/ C383E showed a three-fold increase. As seen with the D-glucose 
data, the enhancement in activity is reduced compared to previous measurements at 2 M D-
arabinose (Chapter 4) due to the different effect of changing substrate concentration on WT 
versus the mutants. As also observed with D-glucose, the C383E mutation led to the greatest 
enhancement in D-arabinose activity of over six-fold. Combination with an additional mutation 
(F227W or N245R) reduced this activity but, due to the effect on D-galactose activity, 
specificity was increased. The F194I single mutant displayed a 2.5-fold reduction in D-arabinose 
activity compared to WT but, when combined with the C383S mutation, the double mutant 
retained the D-arabinose activity of the C383S mutant while the D-galactose activity was 
reduced nine-fold compared to WT (Figure 5.3). 
 
Figure 5.8. Specific activities at pH 7.0 of double and single mutants with 1 M D-arabinose 
The F194X, F227X or N245X single mutant is the same colour as the relevant double 
mutant. Double mutants containing the C383E mutant are shown  while those 
containing C383S are shown . 
 
As shown in Figure 5.9, as with the data for D-glucose, for many of the variants it is not 
possible to visualise activity towards D-arabinose on the same scale as D-galactose activity. All 
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variants displaying increased activity towards D-arabinose activity still show greater levels of 
activity towards D-galactose. 
 
 
Figure 5.9. Graphical representation to visualise any shift in specificity towards D-arabinose 
Specific activities at pH 7.0 towards 1 M D-galactose are shown in red on the left of the 
axis. Specific activities at pH 7.0 towards 1 M D-arabinose are shown in green on the 
right of the axis – some variants do not display high enough levels to visualise on the 
same axis as D-galactose activity. 
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5.4 Kinetic analysis of variants  
5.4.1 Analysis with D-galactose 
In order to further characterise the oxidation of D-galactose and the alternative substrates by 
the different variants, activity was measured over a range of substrate concentrations with the 
aim of determining the kinetic parameters kcat and KM. While kinetic parameters with D-
galactose were determined in all but one case (Table 5.3), very few of the reactions with the 
alternative substrates followed a hyperbolic rate equation. It was therefore not possible to 
determine meaningful kinetic parameters for the reactions with alternative substrates. 
Table 5.3. Kinetic parameters for each single and double mutant with D-galactose at pH 7.0 
Mutant kcat (s
-1) KM (mM) kcat/ KM (s
-1 M-1) 
WT 1000 ± 16 47 ± 6.1 22000 ± 1200 
 
F194G/ C383S 69 ± 4.2 160 ± 25 420 ± 70 
F194G 33 ± 0.3 260 ± 5.5 130 ± 3.0 
 
F194I/ C383S 130 ± 4.8 120 ± 12 1100 ± 110 
F194I 110 ± 4.0 480 ± 32 230 ± 18 
 
F194T/ C383E 97 ± 13 160 ± 54 590 ± 210 
F194T 510 ± 16 40 ± 4.5 13000 ± 1500 
 
F227W/ C383E ND ND ND 
F227W 50 ± 4.5 21 ± 8.6 2400 ± 1000 
 
N245H/ C383E 160 ± 4.1 7.9 ± 1.4 21000 ± 3700 
N245H 1300 ± 39 35 ± 3.9 38000 ± 4300 
 
N245R/ C383E 140 ± 0.8 5.6 ± 0.3 25000 ± 1300 
N245R/ C383S 570 ± 24 18 ± 3.8 32000 ± 6900 
N245R 560 ± 8.2 37 ± 2.1 15000 ± 880 
 
N245W/ C383S 460 ± 26 27 ± 6.3 17000 ± 4000 
N245W 600 ± 9.6 48 ± 2.6 123000 ± 710 
 
C383E 730 ± 11 10 ± 1.0 71000 ± 7100 
C383S 1100 ± 26 15 ± 1.8 72000 ± 8600 
Kinetic parameters were determined with D-galactose for each double and single mutant 
and compared to WT (100%): values <25% are coloured dark blue, 25-90% are pale blue, 
90-110% are green and 110-1000% are yellow. It was not possible to generate 
reproducible data for F227W/ C383E so kinetic parameters could not be determined. 
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Enzyme efficiency is measured by kcat/ KM and therefore higher values for kcat and lower values 
for KM indicate a more efficient enzyme for the reaction measured. As expected, the value 
determined for kcat correlates with the previously determined specific activities with D-
galactose (Section 5.3.2) in all cases except N245H, which displays a slightly increased value for 
kcat compared to WT. However, the enzyme efficiency with D-galactose does not always 
correlate with the specific activity measurements due to the values determined for KM. Apart 
from the F194T single mutant, all of the mutants containing a mutation at position 194 show 
significant increases in KM for D-galactose. However, all of the other single and double mutants 
show similar or decreased values for KM, some of which result in increased enzyme efficiency. 
If it were possible to determine kinetic parameters for the alternative substrates, the 
specificity of the enzyme for each substrate could be determined by comparing the values for 
kcat/ KM. 
5.4.2 Analysis with alternative substrates 
The plot of rate versus substrate concentration took on different forms with the different 
variants and substrates. As seen in the examples shown in Figure 5.10, these included 
sigmoidal plots (N245R/ C383E with D-arabinose and possibly F194I/ C383S with D-glucose); 
linear plots (F194G/ C383S with D-glucose); and plots where the rate increased, and then 
decreased and levelled off (N245R/ C383E with D-xylose). In order to explain the non-
hyperbolic nature of the plots, further kinetic characterisation would be required which was 
beyond the scope of this project. 
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Figure 5.10. Examples of kinetic plots at pH 7.0 which do not follow a hyperbolic rate 
equation 
Kinetic plots took on various different forms for the different substrates and variants. 
Four examples are shown: F194I/ C383S with D-glucose may be the beginning of a 
sigmoidal plot, F194G/ C383S with D-glucose is almost linear, N245R/ C383E with D-
arabinose is sigmoidal, and N245R/ C383E with D-xylose shows increasing rate which 
then decreases slightly and levels off as substrate concentration was increased. 
  
Chapter 5: Characterisation of Altered Enzyme Activities 
165 
 
5.5 Activities of the variants against methyl glycosides 
When dissolved in water, the hemiacetal ring of the monosaccharides D-galactose, D-glucose, 
D-xylose and D-arabinose opens and reforms to give up to five different isomers: α-pyranose 
(six-membered ring), β-pyranose, α-furanose (five-membered ring), β-furanose and the acyclic 
carbonyl form (Isbell and Pigman, 1968, Isbell and Pigman, 1969) (Figure 5.11).  
     
      D-galactose α-D-galactopyranose  β-D-galactopyranose α-D-galactofuranose β-D-galactofuranose 
Figure 5.11. The five forms of D-galactose 
 
The mechanism of interconversion of α- and β-D-galactopyranose is shown in Figure 5.12; 
interconversion of the other sugars occurs by a similar mechanism. 
 
Figure 5.12. The mechanism of interconversion of α- and β-D-galactopyranose 
Adapted from Collins and Ferrier (1995). 
 
In general, the six-membered pyranose rings are more stable than the five-membered 
furanose rings and the acyclic form and so exist at higher proportions at equilibrium (Table 
5.4). 
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Table 5.4. The percentage compositions of sugars in aqueous solution at equilibrium at 31 °C 
Sugar α-pyranose β-pyranose α-furanose β-furanose Acyclic form 
D-arabinose 60 35.5 2.5 2 0.03 
D-galactose 30 64 2.5 3.5 0.02 
D-glucose 38 62 - 0.14 0.02 
D-xylose 36.5 63 < 1 < 1 0.02 
Taken from Collins and Ferrier (1995).  
 
In order to prevent isomerisation a different group can be added to C-1 of the hemiacetal ring, 
such as a methyl group to form the methyl glycoside. In order to determine the relative 
activities of each mutant against the different isomers and observe the effect (if any) of a 
methyl group at position C-1, specific activities at pH 7.0 were determined with the methyl 
glycosides. Unfortunately, the methyl D-galactofuranosides, methyl D-glucofuranosides and 
methyl D-xylofuranosides were not commercially available and the only methyl D-
arabinoglycosides available were methyl α-D-arabinofuranoside and methyl β-D-
arabinopyranoside. Specific activities were determined with those glycosides which were 
commercially available (Figure 5.13) and compared with the activity with the isomeric mixture 
of the unmethylated form. 
    
Methyl α-D-
galactopyranoside 
 
Methyl β-D-
galactopyranoside 
 
Methyl α-D-
glucopyranoside 
 
Methyl β-D-
glucopyranoside 
 
   
 
Methyl α-D-
xylopyranoside 
Methyl β-D-
xylopyranoside 
Methyl α-D-
arabinofuranoside 
Methyl β-D-
arabinopyranoside 
Figure 5.13. The eight commercially available methyl glycosides 
  
Chapter 5: Characterisation of Altered Enzyme Activities 
167 
 
5.5.1 D-Galactopyranosides 
When analysing the specific activities of each mutant with D-galactose and the methyl D-
galactopyranosides (Table 5.5) most show a slight reduction in activity compared to the 
isomeric mixture. This implies that the presence of the methyl group may have a minor effect 
on substrate binding. A proportion of the mutants show a slight preference for methyl β-D-
galactopyranoside over methyl α-D-galactopyranoside but not more than two-fold. There are 
no obvious trends linking the mutation(s) with the different activities. 
The C1-hydroxyl of D-galactose is predicted to act as a hydrogen bond donor to Tyr329 
(Wachter and Branchaud, 1996) so replacement of the hydroxyl with a methoxy group would 
disrupt this interaction. This may result in a lower binding affinity for methyl D-
galactopyranoside compared to D-galactose, thus reducing the overall efficiency of catalysis. It 
is possible that new enzyme-substrate interactions may be made with the methyl D-
galactopyranoside and that these interactions are modestly more favourable with the β-
anomer than the α-anomer. Further structural analysis would be required to predict these 
potential interactions. 
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Table 5.5. Specific activities at pH 7.0 of all selected mutants and corresponding single 
mutants against 1 M D-galactose and the methyl D-galactopyranosides 
Variant 
D-galactose 
(isomeric mixture) 
Methyl α-D-
galactopyranoside 
Methyl β-D- 
galactopyranoside 
Anomer 
preference 
F194G/ C383S 32 ± 2.2 31 ± 1.0 30 ± 1.5 None 
F194G 20 ± 1.2 20 ± 0.5 20 ± 1.2 None 
F194I/ C383S 97 ± 2.3 48 ± 2.1 66 ± 4.0 β 
F194I 69 ± 1.9 50 ± 1.3 52 ± 2.5 None 
F194T/ C383E 45 ± 5.1 21 ± 0.3 19 ± 0.0 None 
F194T 320 ± 17 150 ± 12 330 ± 0.0 β 
F227W/ C383E 20 ± 1.9 8.5 ± 0.13 12 ± 0.0 β 
F227W 41 ± 4.3 21 ± 0.9 25 ± 0.0 β 
N245H/ C383E 60 ± 3.5 66 ± 1.4 63 ± 1.6 None 
N245H 520 ± 42 250 ± 40 310 ± 5.4 β 
N245R/ C383E 83 ± 4.0 51 ± 1.3 61 ± 0.0 β 
N245R/ C383S 470 ± 9.8 270 ± 16 350 ± 14 β 
N245R 450 ± 41 240 ± 17 280 ± 0.0 β 
N245W/ C383S 260 ± 17 270 ± 12 260 ± 0.5 None 
N245W 370 ± 31 320 ± 28 370 ± 22 β 
    
 
C383E 410 ± 7.3 220 ± 15 340 ± 20 β 
C383S 830 ± 27 420 ± 5.4 640 ± 58 β 
WT 890 ± 23 410 ± 5.2 620 ± 8.8 β 
Values are given in units of µmol H2O2/ min/ mg GO. For each mutant, specific activity 
values for the methyl D-galactopyranosides were compared to the value for the isomeric 
mixture (100%): values 25-90% are pale blue while those within 10% of the isomeric 
mixture are green. 
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5.5.2 D-Glucopyranosides 
Analysis of the specific activities of each of the D-glucose hits, and respective single mutants, 
against the isomeric D-glucose mixture and the methyl D-glucopyranosides revealed some 
interesting trends (Table 5.6). The methyl D-glucopyranoside activities of the F194G and F194I 
single mutants were only 6-15% of the isomeric D-glucose mixture activities. When combined 
with the C383S mutation, these activities were reduced even further to 0.6-3.2%. The F194T/ 
C383E mutant shows only 0.7-1.0% of the isomeric D-glucose mixture activity against the 
methyl D-glucosides but the F194T single mutant shows essentially no difference in activity. It 
is possible that the F194T data is incorrect due to contamination or incorrect labelling of the 
protein sample. 
Table 5.6. Specific activities at pH 7.0 of all selected mutants and corresponding single 
mutants against 1 M D-glucose and the methyl D-glucopyranosides 
Variant 
D-glucose 
(isomeric mixture) 
Methyl α-D-
glucopyranoside 
Methyl β-D- 
glucopyranoside 
Anomer 
preference 
F194G/ C383S 0.90 ± 0.04 0.006 ± 0.000 0.005 ± 0.000 None 
F194G 0.09 ± 0.00 0.005 ± 0.000 0.006 ± 0.000 None 
F194I/ C383S 1.08 ± 0.02 0.035 ± 0.007 0.030 ± 0.005 None  
F194I 0.08 ± 0.00 0.009 ± 0.000 0.012 ± 0.001 β 
F194T/ C383E 1.5 ± 0.27 0.011 ± 0.003 0.015 ± 0.002 β 
F194T 0.29 ± 0.01 0.26 ± 0.003 0.21 ± 0.015 α 
F227W/ C383E 0.47 ± 0.07 1.0 ± 0.05 0.037 ± 0.003 α 
F227W 0.19 ± 0.02 0.20 ± 0.01 0.10 ± 0.000 α 
N245R/ C383E 1.5 ± 0.09 2.0 ± 0.13 0.48 ± 0.024 α 
N245R 0.42 ± 0.02 0.81 ± 0.003 0.22 ± 0.000 α 
    
 
C383E 2.1 ± 0.16 2.9 ± 0.25 1.3 ± 0.03 α 
C383S 1.2 ± 0.05 1.0 ± 0.04 1.2 ± 0.13 β 
WT 0.39 ± 0.01 0.32 ± 0.01 0.35 ± 0.011 None 
Values are given in units of µmol H2O2/ min/ mg GO. For each mutant, specific activity 
values for the methyl D-glucopyranosides were compared to the value for the isomeric 
mixture (100%): values < 25% are dark blue, 25-90% are pale blue, 90-110% are green 
and >110% are yellow. 
 
The F227W mutant displays similar activity for methyl α-D-glucopyranoside as the isomeric 
mixture but activity towards the β-anomer is 2-fold lower. When combined with the C383E 
mutation, this preference for the α-anomer is greatly enhanced. 
In the case of N245R, the C383E mutation increases the moderate preference for the α-
anomer by increasing activity towards the α-anomer while reducing activity towards the β-
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anomer. This appears to be a cumulative effect as the C383E single mutant also shows a 
moderate preference for the α-anomer. 
Without the structure of an enzyme-substrate complex, it is difficult to explain the different 
observations with sugars other than D-galactose. However, it is clear from the data presented 
for D-glucose and the methyl D-glucopyranosides that variants containing mutations at position 
194 bind D-glucose in a different way from the WT enzyme or F227 or N245 mutants as 
addition of a methyl group at position C-1 led to significant loss of activity for F194 mutants. 
WT GO-N6M1 shows no anomeric preference while F227W, N245R and C383E all showed a 
modest preference for the α-anomer. This implies that position C-1 of the sugar ring influences 
substrate binding in some minor manner in the mutants which may lead to a slight 
improvement in the efficiency of catalysis compared to WT. The major disruption observed 
upon addition of a methyl group to the sugar ring with the variants containing the F194 
mutation suggests that D-glucose may bind in a very different orientation in these mutants, 
perhaps with the C1 position facing into the active site and making more contacts with the 
enzyme. It is, of course, possible that the activity observed with the isomeric mixture is 
actually activity against β-D-glucofuranose. However, as this isomer only exists as 0.14% at 
equilibrium, this seems very unlikely. 
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5.5.3 D-Xylopyranosides 
The specific activity measurements against D-xylose and the methyl D-xylopyranosides (Table 
5.7) revealed the surprising result that WT and mutant GO is active against the methyl D-
xylopyranosides as these substrates only contain secondary alcohol groups against which it has 
previously been reported GO does not show activity (Escalettes and Turner, 2008). If the 
methyl group indeed has no effect on catalysis, the specific activities recorded for each of the 
methyl D-xylopyranosides multiplied by the proportions of each anomer in solution (Table 5.4) 
should generate a value close to the activity recorded for the isomeric mixture (as less than 1% 
of D-xylose exists in the furanose or acyclic species at equilibrium). This is the case for the WT 
enzyme, the N245W single mutant and the three mutants containing the N245R mutation, 
implying that binding of the methyl D-xylopyranosides to the other mutants is affected by the 
methyl group. Most of the mutants show a preference for one or other of the anomeric forms, 
although the difference in values is no more than two-fold in all cases. Variants containing the 
F227W mutation show a slight preference for the α-anomer while those containing mutations 
at N245 show a slight preference for the β-anomer. This implies that substrate binding is 
different in the two cases, which is not surprising given the nature of the mutated residues. 
Table 5.7. Specific activities at pH 7.0 of all selected mutants and corresponding single 
mutants against 1 M D-xylose and the methyl D-xylopyranosides 
Variant 
D-xylose 
(isomeric mixture) 
Methyl α-D-
xylopyranoside 
Methyl β-D- 
xylopyranoside 
Anomer 
preference 
F227W/ C383E 12 ± 0.23 22 ± 0.62 13 ± 0.32 α 
F227W 6.2 ± 0.29 15 ± 0.58 12 ± 0.70 α 
N245H/ C383E 31 ± 2.7 33 ± 2.4 43 ± 0.03 β 
N245H 11 ± 0.73 11 ± 0.07 14 ± 0.84 β 
N245R/ C383E 55 ± 4.0 62 ± 2.0 55 ± 1.3 None 
N245R/ C383S 130 ± 6.3 120 ± 5.0 170 ± 7.9 β 
N245R 17 ± 1.3 14 ± 0.77 22 ± 1.5 β 
N245W/ C383S 48 ± 1.5 50 ± 0.43 110 ± 2.0 β 
N245W 2.7 ± 0.12 2.4 ± 0.00 2.6 ± 0.01 None 
    
 
C383E 68 ± 2.5 93 ± 2.1 100 ± 6.2 None 
C383S 35 ± 2.5 38 ± 0.88 57 ± 0.94 β 
WT 6.8 ± 0.17 6.2 ± 0.06 6.9 ± 0.00 None 
Values are given in units of µmol H2O2/ min/ mg GO. For each mutant, specific activity 
values for the methyl D-xylopyranosides were compared to the value for the isomeric 
mixture (100%): values 25-90% are pale blue, 90-110% are green and >110% are yellow. 
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5.5.4 D-Arabinosides 
When analysing the specific activity measurements for D-arabinose and the two methyl D-
arabinosides (Table 5.8), the data cannot be compared in the same way as for the other sugars 
as the α-anomer used is the furanoside while the β-anomer used is the pyranoside. WT GO-
N6M1 and both of the C383 single mutants show a moderate preference for methyl α-D-
arabinofuranoside over methyl β-D-arabinopyranoside. The F194I variant shows 18-fold 
greater activity towards methyl β-D-arabinopyranoside compared to the α-furanoside. When 
this is combined with the C383S mutation, the overall activity towards both species increases 
but the relative preference is unchanged. A similar trend was observed with N245R and its 
combination with C383E although the difference in activity between the two D-arabinosides is 
not as great and the preference is for methyl α-D-arabinofuranoside. When F227W and C383E 
are combined, both of which display a preference for the α-furanoside, the specificity shifts to 
the β-pyranoside. This is difficult to rationalise without knowing where oxidation is occurring 
on the two substrates. It is surprising that in a number of cases, the enzyme shows similar 
levels of activity towards the D-arabinofuranoside and the D-arabinopyranoside. This implies 
that the enzyme is either oxidising a secondary alcohol group in both cases, or that the 
mechanisms are different with the two substrates as only the furanoside contains a primary 
alcohol group. 
Table 5.8. Specific activities at pH 7.0 of all selected mutants and corresponding single 
mutants against 1 M D-arabinose, methyl α-D-arabinofuranoside and methyl β-D-
arabinopyranoside 
Variant 
D-arabinose 
(isomeric mixture) 
Methyl α-D-
arabinofuranoside 
Methyl β-D- 
arabinopyranoside 
Preference 
F194I/ C383S 5.7 ± 0.39 0.45 ± 0.02 7.7 ± 0.10 β-pyr 
F194I 0.74 ± 0.01 0.037 ± 0.000 0.68 ± 0.032 β-pyr 
F227W/ C383E 3.9 ± 0.18 9.8 ± 0.82 14 ± 1.3 β-pyr 
F227W 3.1 ± 0.15 2.0 ± 0.038 1.0 ± 0.076 α-fur 
N245R/ C383E 5.6 ± 0.20 37 ± 0.14 7.8 ± 0.043 α-fur 
N245R 3.0 ± 0.15 3.4 ± 0.036 0.58 ± 0.063 α-fur 
    
 
C383E 12 ± 1.4 60 ± 0.44 13 ± 0.89 α-fur 
C383S 4.7 ± 0.14 11 ± 0.40 4.1 ± 0.032 α-fur 
WT 1.9 ± 0.08 1.5 ± 0.079 0.66 ± 0.016 α-fur 
Values are given in units of µmol H2O2/ min/ mg GO. For each mutant, specific activity 
values for the methyl D-arabinosides were compared to the value for the isomeric 
mixture (100%): values < 25% are dark blue, 25-90% are pale blue, 90-110% are green 
and >110% are yellow. 
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5.6 pH dependence of the enhanced activities 
5.6.1 Determination of an appropriate three-component buffer system 
for pH profile measurements 
When measuring the effect of pH on enzyme activity, it is important to ensure that the effect 
seen is solely due to the variation in pH and not another factor such as ionic strength or buffer 
composition (Ellis and Morrison, 1982). With this in mind, it was decided to determine the pH 
profile of GO activity using a three-component buffer system designed so that ionic strength is 
maintained across the pH range. Three-component buffer systems also use the same buffer 
mix across the pH range so errors will not be introduced by using different buffers for different 
pH values. 
The first three-component buffer trialled was 0.05 M acetic acid, 0.05 M 2-(N-morpholino) 
ethanesulfonic acid (MES) and 0.1 M Tris and covered a pH range of 3.7 to 9.0 (Ellis and 
Morrison, 1982). The specific activity of WT GO-N6M1 with 600 mM D-galactose was measured 
in this buffer at pH 7.0 and found to be within 10% of the activity measured in 100 mM sodium 
phosphate, pH 7.0. However, when specific activities with 600 mM D-galactose were measured 
over a pH range of 4.0 to 9.0 with WT GO-N6M1, it was not possible to identify the highest pH 
at which the enzyme is active as pH 9.0 does not appear to inhibit activity (Figure 5.14, red 
line). For pH values above 9.0, specific activities were determined using 100 mM 3-
(cyclohexylamino) ethanesulfonic acid (CHES) (Figure 5.14, blue line), however it is not clear 
whether the rapid drop off in activity above pH 9.0 is due to the pH of the solution, or 
inhibition by CHES, or a combination. 
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Figure 5.14. pH profile of WT GO-N6M1 with D-galactose determined using Tris-MES-acetic 
acid and CHES as buffers 
 
A different three-component buffer was therefore trialled: 0.1 M N-(2-acetamido)-2-
aminoethanesulfonic acid (ACES), 0.052 M Tris and 0.052 M ethanolamine which covers a pH 
range of 5.6 to 10.4 (Ellis and Morrison, 1982). Again, the specific activity with 600 mM D-
galactose of WT GO-N6M1 in this buffer at pH 7.0 was found to be within 10% of the activity 
measured in 100 mM sodium phosphate, pH 7.0 so activity over the full pH range of the buffer 
was measured. As can be seen in Figure 5.15, this three-component buffer is much more 
suitable as activity clearly goes down towards the lowest and highest pH values measured 
allowing visualisation of the pH profile. 
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Figure 5.15. pH profile of WT GO with D-galactose determined using ACES-Tris-ethanolamine 
as a buffer 
 
5.6.2 The effect of high pH on D-xylose and D-arabinose 
The ACES-Tris-ethanolamine buffer was then used to make up solutions of 1 M D-glucose, D-
xylose or D-arabinose across the pH range in order to observe the effect of pH on oxidation of 
these substrates. However, with the pentoses D-xylose and D-arabinose, a coloured substance 
was generated upon dissolving in the buffer which was more pronounced at higher pH values 
(Figure 5.16). Colour was visible after a few hours and increased over the course of several 
days. 
 
Figure 5.16. D-xylose dissolved in ACES-Tris-ethanolamine buffer at different pH values 
Similar colour changes were observed for D-arabinose. 
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Without further analysis such as gas-liquid chromatography or thin-layer chromatography, it is 
not possible to identify the coloured substance. The instability of sugars in alkaline solutions, 
and subsequent conversion or degradation to a number of other products, has been previously 
reported (Forsskahl et al., 1976, Shaffer and Friedemann, 1930).  
Despite the obvious presence of something other than the pentose in the D-xylose and D-
arabinose solutions, activity was measured with WT GO-N6M1 across the pH range. As shown 
in Figure 5.17, the measurements showed a marked shift in pH optimum of the enzyme 
towards lower pH compared to the reaction with D-galactose (Figure 5.15); activity was barely 
detectable above pH 8.0. However, it is unclear whether this shift in pH optimum is solely due 
to the pH of the buffer, or if the coloured substance (or another substance also present in the 
higher pH solutions) inhibits the oxidation reaction. Without the further analysis and perhaps 
comparing the effect of yet more three-component buffers, the pH profiles with D-xylose and 
D-arabinose could not be reliably measured. 
 
Figure 5.17. pH profile of WT GO with D-xylose determined using ACES-Tris-ethanolamine as 
a buffer 
The corresponding pH profile with D-arabinose showed a similar shift in pH optimum 
towards acidic pH. 
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5.6.3 pH profiles of D-glucose activity 
As no colour change was observed upon dissolution of 1 M D-glucose in ACES-Tris-
ethanolamine across the pH range, and the pH profile with WT GO-N6M1 appeared similar to 
that with D-galactose, pH profiles were measured for each of the variants showing enhanced D-
glucose activity as well as the corresponding single mutants.  
Figure 5.18 shows the pH profiles of variants containing mutations at position 194. When the 
hydrophobic residues Gly or Ile were introduced the pH optimum shifted from pH 7.0-8.0 for 
WT to pH 6.0-7.0 for the mutants; meanwhile the C383S single mutant displays a pH optimum 
of pH 9.0-9.5. The double mutant in each case seemed to take on much more of the character 
of the C383S mutation than the F194 mutation as, compared to WT, activity was reduced at 
low pH and increased at high pH with a pH optimum of pH 8.5-9.0 in both cases. In the case of 
the F194T/ C383E double mutant, similar trends were observed: the F194T single mutant has a 
pH optimum of pH 7.0-7.5 and a narrower pH profile while C383E has a pH optimum of 9.5-
10.0 and greatly reduced activity at low pH compared to WT. The double mutant took on much 
more of the C383E character with a pH optimum of 8.5-9.0 and reduced activity at low pH. 
As shown in Figure 5.19, the pH profile for the F227W mutant revealed a very similar pH 
optimum to WT of pH 7.5, but as activity dropped off drastically as pH was increased or 
decreased the profile is very different. The F227W/ C383E double mutant also displayed a 
relatively narrow pH profile but with a pH optimum of pH 9.5, the same as the C383E single 
mutant. Again the C383X mutation had the greatest effect on the pH profile. 
Measurement of the pH profiles for the N245R/ C383E variant and associated single mutants 
(Figure 5.20) did not reveal such dramatic variation as with variants containing F227W: the 
N245R single mutant has a pH profile almost identical to WT and the double mutant has a pH 
profile almost identical to C383E. 
Overall, it would seem that mutations at positions 194 or 227 in a WT background had a 
significant effect on the pH profile of the enzyme while the same mutations in the background 
of the C383E or C383S mutations had a much less significant effect. This implies that the C383X 
mutations may induce change(s) in the active site which make it less sensitive to mutation at 
position 194 or 227. The N245R mutation had a very limited effect on the pH profile regardless 
of the background into which it was introduced.   
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Figure 5.18. pH profiles of double and single mutants from F194X libraries with D-glucose 
For each variant, activities are presented as a percentage of the highest activity to 
permit comparison of the pH profiles regardless of relative activities towards D-glucose. 
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Figure 5.19. pH profiles of F227W/ C383E, WT and single mutants with D-glucose 
For each variant, activities are presented as a percentage of the highest activity to 
permit comparison of the pH profiles regardless of relative activities towards D-glucose. 
 
 
Figure 5.20. pH profiles of N245R/ C383E, WT and single mutants with D-glucose 
For each variant, activities are presented as a percentage of the highest activity to 
permit comparison of the pH profiles regardless of relative activities towards D-glucose. 
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5.7 The effect of the mutations on the oxidative half reaction 
By measuring the effect of varying sugar substrate concentration (Section 5.4.2), only the 
effect of the mutations on the reductive half reaction was measured. In order to see whether 
the oxidative half reaction (where oxygen binds, the copper (II) and thioether bond cofactors 
are regenerated and hydrogen peroxide is released (Section 1.6.3.2)) is affected by the 
mutations, specific activities at pH 7.0 were measured for some of the variants at three 
different oxygen concentrations: air saturated, ‘increased oxygen’ and ‘decreased oxygen’. The 
measurements only represent initial data as molar oxygen concentrations were not 
determined. While oxygen was bubbled through the ‘increased oxygen’ samples for over an 
hour, it was not confirmed that the solution was saturated with oxygen. Likewise, while every 
effort was made to purge the ‘decreased oxygen’ samples of oxygen, small quantities of 
oxygen no doubt entered the assay mix during transfer to the reaction cuvette and upon 
addition of the enzyme solution, which was only partially degassed (Section 2.6.4.1). 
As shown in Figure 5.21, in the case of WT GO-N6M1 with D-arabinose, increased or decreased 
oxygen levels had essentially no effect on the activity of the enzyme. This implies that the very 
low level of oxygen present in the ‘decreased oxygen’ sample was adequate for maximal 
activity. When the C383E or C383S mutations were introduced however, the effect was quite 
different. Increasing the oxygen concentration resulted in a small increase in activity, while in 
the ‘decreased oxygen’ sample activity was barely detectable. This could imply that the 
KM(oxygen) for the mutants is higher than for WT as the oxygen concentration in the air saturated 
samples was not saturating for the enzyme. However, the observed effect could also be 
explained by the more rapid turnover of the variant which depletes local oxygen 
concentrations faster than the WT, making it more sensitive to overall oxygen availability. A 
similar effect was observed for the F227W/ C383E variant while F194I/ C383S displayed no 
difference in D-arabinose activity between air saturated and ‘increased oxygen’ samples 
implying that the KM(oxygen) may lie somewhere in-between the oxygen concentrations of the 
oxygen depleted and air saturated samples. 
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Figure 5.21. Specific activities at pH 7.0 with 1 M D-arabinose at three different oxygen 
concentrations 
Specific activities were measured in three different assay mixes: i) air saturated, ii) 
increased oxygen concentration and iii) decreased oxygen concentration for a selection 
of variants, as detailed in Section 2.6.4.1. Note the different y-axis scales. 
 
When oxygen levels were varied in the measurement of activity with 1 M D-glucose (Figure 
5.22), more moderate effects were observed. For WT GO-N6M1, increasing the oxygen 
concentration had no effect on activity towards 1 M D-glucose whereas reducing the oxygen 
concentration reduced activity compared to the air saturated level. This implies that the 
KM(oxygen) for activity with D-glucose as the other substrate is higher than with D-arabinose 
(Figure 5.21). For the C383E, F194G/ C383S and F194I/ C383S variants, increasing oxygen 
concentration increased activity slightly, although reducing oxygen concentration had a 
smaller effect than for WT. The C383S single mutation resulted in an enzyme which showed 
equal activities at all three oxygen concentrations trialled. All four of the variants display 
changes in the effect of oxygen concentration compared to WT; however these changes are 
small in all cases. Given the limited accuracy of the measurements due to variation in oxygen 
concentrations, the observed differences between the variants are unlikely to be significant. 
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Figure 5.22. Specific activities at pH 7.0 with 1 M D-glucose at three different oxygen 
concentrations 
Specific activities were measured in three different assay mixes: i) air saturated, ii) 
increased oxygen concentration and iii) decreased oxygen concentration for a selection 
of variants, as detailed in Section 2.6.4.1. Note the different y-axis scales. 
 
As observed for 1 M D-arabinose, altering the oxygen concentration had no effect on WT GO-
N6M1 activity against 1 M D-xylose (Figure 5.23). The C383E mutation led to a reduction in 
activity when oxygen levels were depleted and this effect was enhanced by addition of the 
F227W or N245H mutations. The N245H/ C383E variant also showed increased activity when 
oxygen concentration was increased, implying that the level of oxygen in the air saturated 
sample was not saturating for the enzyme. C383S also showed a reduction in activity towards 1 
M D-xylose when oxygen was reduced, but to a lesser extent than for C383E. When combined 
with the N245R or N245W mutations however, activity was significantly reduced when oxygen 
levels were reduced and increased at higher oxygen concentrations. The data imply that 
mutations at position 245 may increase KM(oxygen), although analysis of the single mutants would 
have to be carried out to confirm this. 
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Figure 5.23. Specific activities at pH 7.0 with 1 M D-xylose at three different oxygen 
concentrations 
Specific activities were measured in three different assay mixes: i) air saturated, ii) 
increased oxygen concentration and iii) decreased oxygen concentration for a selection 
of variants, as detailed in Section 2.6.4.1. Note the different y-axis scales. 
 
In summary, many of the mutations do appear to have an effect on the oxidative half reaction. 
However, without more detailed analyses, including accurate determination of the oxygen 
concentrations, it is difficult to confidently identify the effect(s). The different trends observed 
with the different sugar substrates support the possibility of different catalytic mechanisms for 
the three substrates. If the mechanisms were the same, altering oxygen concentration would 
be expected to have similar effects.  
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5.8 Determination of the regioselectivity of some variants 
The oxidation of methyl D-galactopyranoside to the corresponding aldehyde can be followed 
by proton NMR spectroscopy (Parikka and Tenkanen, 2009). 1D and 2D NMR experiments 
were carried out by Parikka and Tenkanen (2009) with methyl α-D-galactopyranoside in order 
to assign the 1H chemical shifts of the aldehyde product, which exists as a hydrate when 
dissolved in D2O (Figure 5.24). If a mixture of isomeric forms of the sugars was used it would be 
very difficult to assign the chemical shifts as many would overlap. It is therefore essential to 
use only one isomer, such as the methyl α-pyranoside used for D-galactose. 
 
             1                  2                       3 
Figure 5.24. Oxidation of methyl α-D-galactopyranoside to form the aldehyde 
Methyl α-D-galactopyranoside (1) is oxidised by GO to form the aldehyde (2) which 
occurs as a hydrate (3) in H2O (or D2O). Adapted from Parikka and Tenkanen (2009). 
 
Figure 5.25 shows the assignments of 1H chemical shifts. The percentage conversion can be 
estimated from the relative sizes of the peaks corresponding to H-4 in the substrate (1) and 
product (3) as these peaks are clearly distinct from other chemical shifts. 
 
Figure 5.25. Chemical shift assignments determined by Parikka and Tenkanen (2009) 
The molecule numbers 1 and 3 refer to the structures shown in Figure 5.24. 
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The initial aim of the NMR study was to characterise the reaction over several days, to provide 
information on enzyme stability and rate of conversion over time. This information is 
important for development of any of the variants for use in industrial scale syntheses. The 
hydrogen peroxide generated is known to inactivate the enzyme at high concentrations 
(Cooper et al., 1959) so catalase was included in the reaction to convert this to water. The 
inclusion of HRP in the reaction mixture maintains GO in the fully oxidised form (Section 
1.6.3.1) and therefore enhances activity. The reaction conditions were optimised by Parikka 
and Tenkanen (2009): 7.5 ml water containing 70 mM methyl α-D-galactopyranoside, 45 U 
HRP, 11200 U catalase and 5.2 U GO, stirred vigorously at room temperature for up to 96 
hours.  
When the water was substituted with 25 mM sodium phosphate buffer, pH 7.0, it was 
reported by Parikka and Tenkanen (2009) that generation of the aldehyde product was 
significantly reduced. However, when this optimisation was repeated here, this was not the 
case. In water 76% conversion was observed in 24 hours, while in sodium phosphate, pH 7.0 
79% conversion was observed. It was therefore decided to carry out all future reactions in 
buffer as maintenance of a constant pH is most likely to maintain enzyme activity. When a 
similar reaction was carried out by Sun et al. (2002), copper was included in the reaction mix. 
Addition of 0.1 mM Cu(NO3)2 to the 7.5 ml reaction was therefore trialled and resulted in a 5-
10% increase in product generation over 24 hours. Neither Sun et al. (2002) or Parikka and 
Tenkanen (2009) give any information on the reaction vessel used for the reaction. The 7.5 ml 
reaction was therefore carried out in either a 10 ml beaker or a 14 ml glass bijou container, 
both with vigorous stirring. Surprisingly, this made a significant difference to the progression of 
the reaction as after 24 hours, the reaction carried out in the beaker had reached >80% 
conversion while the reaction in the bijou had only reached 34% conversion. This implies that 
the level of oxygenation of the reaction is important as the most significant difference 
between the two reaction vessels is the diameter which determines the surface area of the 
reaction mix. It was decided not to further optimise the reaction vessel or explore the effect of 
oxygenation as any use of the GO variants in industrial processes would be carried out in much 
larger volumes than 7.5 ml, so the reaction vessel and associated conditions would need to be 
optimised in a different way. Accurate determination of oxygen kinetics would also be useful 
for this optimisation. 
Oxidation of D-galactose by GO has already been well characterised and is exploited in a 
number of commercial applications (Section 1.6.5.1). The oxidation of D-arabinose, D-glucose 
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and D-xylose by the variants showing enhanced activities was therefore of interest. 
Unfortunately, the reaction conditions optimised for oxidation of methyl α-D-
galactopyranoside did not result in any generation of product in the oxidation of methyl β-D-
xylopyranoside by 5 U of WT, C383E or N245R/ C383S. Only when 28 U of N245W/ C383S was 
used was a change in the NMR spectrum observed. Unfortunately, as shown in Figure 5.26, a 
large number of peaks were present in the spectrum of the product mixture and it was not 
possible to identify the position(s) of oxidation. This could imply oxidation at multiple positions 
to generate a number of different products, or the product could have undergone degradation 
before analysis by NMR. 
 
 
Figure 5.26. The structure of methyl β-D-xylopyranoside and NMR spectra before and after 
oxidation 
Chemical shifts for each of the protons in methyl β-D-xylopyranoside have been assigned 
for the reaction before oxidation. However, after oxidation a large number of additional 
chemical shifts have appeared which were not possible to assign (marked *). These 
could indicate the presence of multiple oxidation products, or degradation of the 
product(s) before NMR analysis. 
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With methyl β-D-arabinopyranoside, it was not possible to add 5 U of the variant GO as the 
number of units per mg was too low. A reaction with 0.8 U C383E resulted in no detectable 
product after 72 hours, however 1.2 U of F227W/ C383E resulted in formation of product 
which was analysed by 1H-NMR, 13C-NMR (Figure 5.27 and Figure 5.28) and 2D correlation 
spectroscopy (COSY) experiments (Figure 5.29). 
The data were analysed by Dr W. B. Turnbull. 2D COSY spectra (Figure 5.29) were used to 
assign signals in the 1H-NMR spectra (Figure 5.27) to specific atoms in the starting material and 
product. The presence of cross-peaks correlating H-1, H-2 and H-3 implied that the oxidation 
reaction had occurred at position 4. This hypothesis was further supported by the lack of 
couplings from H-5 to an H-4 proton signal. The 13C-NMR spectrum (Figure 5.28) showed an 
extra signal at 92.8 ppm which is consistent with the formation of a hydrate at the oxidised 
carbon as a ketone would be expected to have a chemical shift above 200 ppm. 
The same changes in spectra were observed upon oxidation by F194I/ C383S and N245R/ 
C383S implying that all three variants oxidise methyl β-D-arabinopyranoside at the same 
position. 
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                1                     2                         3 
   
 
Figure 5.27. The proposed oxidation of methyl β-D-arabinopyranoside at the C-4 position and 
1H-NMR spectra before and after the reaction 
The data support the reaction shown at the top where the GO variant oxidises methyl β-
D-arabinopyranoside (1) specifically at the C-4 position. The insets show an expansion of 
the region 3.84-3.54 ppm. 
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Figure 5.28. 13C-NMR spectra after oxidation of methyl β-D-arabinopyranoside 
Molecule numbering refers to the scheme shown at the top of Figure 5.27. The signal at 
92.8 ppm is consistent with formation of a hydrate at position 4. 
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Figure 5.29. 2D COSY spectra after oxidation of methyl β-D-arabinopyranoside 
The spectra were used to assign assign signals in the 1H-NMR spectra (Figure 5.27). 
 
As with methyl β-D-arabinopyranoside, it was not possible to add 5 U of the GO variants in the 
reaction with methyl α-D-glucopyranoside as the number of units per mg was too low, 
therefore 1.4 U of N245R/ C383E was used. As shown in Figure 5.30, the NMR spectrum after 
oxidation shows appearance of a chemical shift at approximately 5.2 ppm which corresponds 
to the proton at C-6 in the species with an aldehyde group at C-6 (2) (Sun et al., 2002). As this 
is the only difference in the spectra, it would appear that the N245R/ C383E variant oxidises 
specifically at the C-6 position of D-glucose, the same position that is oxidised by WT GO in the 
reaction with D-galactose. 
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                1                     2                         3 
   
 
Figure 5.30. The proposed oxidation of methyl α-D-glucopyranoside at the C-6 position and 
NMR spectra before and after the reaction 
Appearance of the chemical shift at ~5.2 ppm after oxidation supports the reaction 
shown at the top where the GO variant oxidises methyl α-D-glucopyranoside (1) 
specifically at the C-6 position. The insets show an expansion of the region 3.66-3.37 
ppm. 
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5.9 The F194W/ W290F variant: a glycerol oxidase 
The F194W/ W290F variant displayed a non-hyperbolic relationship between reaction velocity 
and substrate concentration for activity towards D-galactose and glycerol, so it was not 
possible to determine kinetic parameters. However, the activity measurements taken over a 
range of substrate concentrations revealed that the mutant displayed two- to three-fold higher 
activity towards glycerol than D-galactose (Table 5.9). As the WT enzyme is already saturated 
at 200 mM D-galactose, the decrease in D-galactose activity at lower substrate concentrations 
upon addition of the two mutations is much more significant than at higher substrate 
concentrations: D-galactose activity is reduced 92-fold at 200 mM compared to 23-fold at 800 
mM. When combined with the four- to five-fold increase in glycerol activity the shift in 
specificity is around 100-fold at 800 mM substrate but over 200-fold at 400 mM substrate 
(Figure 5.31), the largest shift in specificity of any variant identified. 
Table 5.9. Specific activities at pH 7.0 of WT and F194W/ W290F towards D-galactose and 
glycerol 
Substrate 
concentration (mM) 
Specific activity (µM H2O2/ sec/ µM GO) 
WT F194W/ W290F 
D-galactose Glycerol D-galactose Glycerol 
200 830 ± 50 Not measured 9.1 ± 1.0 29 ± 0.50 
400 790 ± 71 12 ± 0.88 19 ± 0.94 63 ± 6.0 
600 880 ± 33 Not measured 28 ± 1.8 82 ± 2.7 
800 930 ± 59 25 ± 2.5 41 ± 0.86 100 ± 1.6 
 
 
Figure 5.31. Graphical representations to visualise the substrate specificity of F194W/ W290F 
compared to WT at 400 mM 
 
Unfortunately it was not possible to assign the chemical shifts of the oxidation reaction 
followed by 1H-NMR (Figure 5.32). This is an important consideration for future continuation of 
this project as the product generated will determine the industrial potential of this variant. 
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Figure 5.32. NMR spectra before and after oxidation of glycerol by the F194W/ W290F 
variant 
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5.10  Attempts to crystallise E. coli-expressed GO for structural 
analysis of variants 
Previous attempts in the group to crystallise the E. coli-expressed N6M1 version of GO using 
the published conditions for the P. pastoris-expressed WT were unsuccessful. This could be 
due to a number of different factors, including effects of the M1 mutations (S20P, M70V, 
G195E, V494A and N535D), the Strep II-tag, or perhaps some unidentified factor which is 
essential for crystallisation picked up by the protein during expression and purification.  
The process of protein crystallisation is still poorly understood and it is common to trial a large 
number of buffers, precipitants and additives in order to identify conditions which promote 
formation of crystals of suitable quality for diffraction experiments. Crystallisation trials were 
carried out with the C-terminally Strep II-tagged N6M1 (Deacon and McPherson, 2011) using 
crystallisation screens from Hampton Research: Crystal Screen 1, Crystal Screen 2, MembFac 
and SaltRx2. A number of crystals grew in the different screens but following analysis by UV 
light and diffraction experiments on the University of Leeds home X-ray source diffractometer, 
were identified as salt crystals containing no protein. 
WT GO has been successfully crystallised following expression in P. pastoris (Wilkinson et al., 
2004) or A. nidulans (Baron et al., 1994) and purification by ammonium sulfate precipitation 
followed by chromatography using cellulose phosphate or Sepharose 6B resin. The C-
terminally Strep II-tagged N6M1 was expressed and purified as detailed in Section 2.5 and then 
incubated in the P. pastoris induction medium BMMY at 4 °C overnight. In order to purify the 
protein from the BMMY medium the mixture was applied to a cellulose phosphate column 
pre-equilibrated with 10 mM sodium phosphate, pH 7.3. To elute the GO from the column, the 
concentration of sodium phosphate, pH 7.3 was gradually increased to 500 mM. However, GO 
appeared exclusively in the column flow-through implying that it had not adsorbed to the 
cellulose phosphate resin. 
The presence of the Strep II-tag could be responsible for the lack of binding to the cellulose 
phosphate column and also the lack of crystallisation. As detailed in Section 3.2.3, a TEV 
cleavage site was added to the construct in the pET28c plasmid to permit cleavage of the Strep 
II-tag following purification. This construct is available for further crystallisation studies if 
required.  
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Following the failure of the initial screening for crystallisation conditions using the Hampton 
screens, trials were carried out using crystallisation conditions based on the different 
published conditions (Table 5.10) (Firbank et al., 2001, Rogers et al., 2007, Deacon et al., 2004, 
Ito et al., 1991, Wilkinson et al., 2004). The N6M1strep, strepTEVN6M1 and SSstrepTEVN6M1 
constructs were each dialysed against 20 mM MES, pH 7.0 and crystallisation trials set down 
using the sitting drop method. Drops containing 0.5 µl protein solution at 2, 4 or 6 mg/ ml and 
0.5 µl mother liquor were used. Needle-like crystals grew in the screen using SSstrepTEVN6M1 
at 4 mg/ ml in 10-24% polyethylene glycol (PEG) 8000, 100 mM MES, pH 5.8-6.4 and 100-200 
mM calcium acetate (Figure 5.33). The crystals were confirmed to contain protein by analysis 
under UV light and following transfer to mother liquor containing 20% (v/ v) glycerol as a 
cryoprotectant and flash cooling in liquid nitrogen, were used in diffraction experiments at 
Diamond Light Source, Oxfordshire. Unfortunately none of the crystals showed diffraction to 
high resolution so further optimisation will need to be carried out. 
After the trials detailed above were completed, another group published a study including a 
crystal structure of E. coli-expressed GO containing the M1 mutations as well as W290F, 
R330K, Q406T and P463I (Rannes et al., 2011). The structure of this variant, which contained 
multiple mutations around the active site, and the C383S structure from P. pastoris-expressed 
protein solved previously (Wilkinson et al., 2004), revealed no noticeable changes in the 
structure compared to the WT enzyme apart from the substituted residues. Neither structure 
provided an explanation for the observed changes in activity. It was therefore decided in this 
project not to focus further on obtaining crystal structures of the variants. However, if this 
were to be carried out in the future, the crystallisation conditions used by Rannes et al. (2011) 
would be used as a starting point. 
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Figure 5.33. Some of the GO crystals grown under different conditions 
In each photo the bar indicates 100 µm. The crystallisation conditions were as follows: A: 
16% PEG8000, 100 mM MES, pH 6.0, 200 mM calcium acetate; B: 20% PEG8000, 100 mM 
MES, pH 6.0, 100 mM calcium acetate; C: 18% PEG8000, 100 mM MES, pH 6.0, 150 mM 
calcium acetate; D: 10% PEG8000, 100 mM MES, pH 5.8, 100 mM calcium acetate. 
 
 
 
 
 
Table 5.10 (Next page). Crystallisation trials based on published conditions 
The 96 different combinations of precipitant (PEG8000, PEG4000 or ammonium sulfate), 
buffer (MES, pH 5.8-6.4 or sodium acetate, pH 4.4-5.0) and additive (100-200 mM 
calcium acetate or 100-200 mM ammonium sulfate) were based on previous published 
conditions from Firbank et al. (2001) and Deacon et al. (2004): green; Wilkinson et al. 
(2004): white; or Ito et al. (1991) and Rogers et al. (2007): blue. Conditions shown in bold 
are those which resulted in crystal growth. 
 
 
 
 
1
9
7 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 
10% PEG8000 
100 mM MES 
pH 5.8 
100 mM 
Ca(OAc)2 
10% PEG8000 
100 mM MES 
pH 6.0 
150 mM 
Ca(OAc)2 
10% PEG8000 
100 mM MES 
pH 6.2 
200 mM 
Ca(OAc)2 
10% PEG8000 
100 mM MES 
pH 6.4 
100 mM 
Ca(OAc)2 
20% PEG4000 
100 mM NaOAc 
pH 4.4 
100 mM 
(NH4)2SO4 
20% PEG4000 
100 mM NaOAc 
pH 4.6 
150 mM 
(NH4)2SO4 
20% PEG4000 
100 mM NaOAc 
pH 4.8 
200 mM 
(NH4)2SO4 
20% PEG4000 
100 mM NaOAc 
pH 5.0 
100 mM 
(NH4)2SO4 
1.0 M (NH4)2SO4 
100 mM NaOAc 
pH 4.4 
1.0 M (NH4)2SO4 
100 mM NaOAc 
pH 4.6 
1.0 M (NH4)2SO4 
100 mM NaOAc 
pH 4.8 
1.0 M (NH4)2SO4 
100 mM NaOAc 
pH 5.0 
B 
12% PEG8000 
100 mM MES 
pH 5.8 
150 mM 
Ca(OAc)2 
12% PEG8000 
100 mM MES 
pH 6.0 
100 mM 
Ca(OAc)2 
12% PEG8000 
100 mM MES 
pH 6.2 
150 mM 
Ca(OAc)2 
12% PEG8000 
100 mM MES 
pH 6.4 
200 mM 
Ca(OAc)2 
21% PEG4000 
100 mM NaOAc 
pH 4.4 
150 mM 
(NH4)2SO4 
21% PEG4000 
100 mM NaOAc 
pH 4.6 
100 mM 
(NH4)2SO4 
21% PEG4000 
100mM NaOAc 
pH 4.8 
150 mM 
(NH4)2SO4 
21% PEG4000 
100mM NaOAc 
pH 5.0 
200 mM 
(NH4)2SO4 
1.1 M (NH4)2SO4 
100 mM NaOAc 
pH 4.4 
1.1 M (NH4)2SO4 
100 mM NaOAc 
pH 4.6 
1.1 M (NH4)2SO4 
100 mM NaOAc 
pH 4.8 
1.1 M (NH4)2SO4 
100 mM NaOAc 
pH 5.0 
C 
14% PEG8000 
100mM MES pH 
5.8 
200 mM 
Ca(OAc)2 
14% PEG8000 
100mM MES pH 
6.0 
200 mM 
Ca(OAc)2 
14% PEG8000 
100mM MES pH 
6.2 
100 mM 
Ca(OAc)2 
14% PEG8000 
100mM MES pH 
6.4 
150 mM 
Ca(OAc)2 
23% PEG4000 
100mM NaOAc 
pH 4.4 
200 mM 
(NH4)2SO4 
23% PEG4000 
100mM NaOAc 
pH 4.6 
200 mM 
(NH4)2SO4 
23% PEG4000 
100mM NaOAc 
pH 4.8 
100 mM 
(NH4)2SO4 
23% PEG4000 
100mM NaOAc 
pH 5.0 
150 mM 
(NH4)2SO4 
1.3 M (NH4)2SO4 
100 mM NaOAc 
pH 4.4 
1.3 M (NH4)2SO4 
100 mM NaOAc 
pH 4.6 
1.3 M (NH4)2SO4 
100 mM NaOAc 
pH 4.8 
1.3 M (NH4)2SO4 
100 mM NaOAc 
pH 5.0 
D 
16% PEG8000 
100 mM MES 
pH 5.8 
150 mM 
Ca(OAc)2 
16% PEG8000 
100 mM MES 
pH 6.0 
200 mM 
Ca(OAc)2 
16% PEG8000 
100 mM MES 
pH 6.2 
100 mM 
Ca(OAc)2 
16% PEG8000 
100 mM MES 
pH 6.4 
100 mM 
Ca(OAc)2 
24% PEG4000 
100 mM NaOAc 
pH 4.4 
150 mM 
(NH4)2SO4 
24% PEG4000 
100 mM NaOAc 
pH 4.6 
200 mM 
(NH4)2SO4 
24% PEG4000 
100 mM NaOAc 
pH 4.8 
100 mM 
(NH4)2SO4 
24% PEG4000 
100 mM NaOAc 
pH 5.0 
100 mM 
(NH4)2SO4 
1.4 M (NH4)2SO4 
100 mM NaOAc 
pH 4.4 
1.4 M (NH4)2SO4 
100 mM NaOAc 
pH 4.6 
1.4 M (NH4)2SO4 
100 mM NaOAc 
pH 4.8 
1.4 M (NH4)2SO4 
100 mM NaOAc 
pH 5.0 
E 
18% PEG8000 
100 mM MES 
pH 5.8 
100 mM 
Ca(OAc)2 
18% PEG8000 
100 mM MES 
pH 6.0 
150 mM 
Ca(OAc)2 
18% PEG8000 
100 mM MES 
pH 6.2 
200 mM 
Ca(OAc)2 
18% PEG8000 
100 mM MES 
pH 6.4 
150 mM 
Ca(OAc)2 
26% PEG4000 
100 mM NaOAc 
pH 4.4 
100 mM 
(NH4)2SO4 
26% PEG4000 
100 mM NaOAc 
pH 4.6 
150 mM 
(NH4)2SO4 
26% PEG4000 
100 mM NaOAc 
pH 4.8 
200 mM 
(NH4)2SO4 
26% PEG4000 
100 mM NaOAc 
pH 5.0 
150 mM 
(NH4)2SO4 
1.6 M (NH4)2SO4 
100 mM NaOAc 
pH 4.4 
1.6 M (NH4)2SO4 
100 mM NaOAc 
pH 4.6 
1.6 M (NH4)2SO4 
100 mM NaOAc 
pH 4.8 
1.6 M (NH4)2SO4 
100 mM NaOAc 
pH 5.0 
F 
20% PEG8000 
100 mM MES 
pH 5.8 
200 mM 
Ca(OAc)2 
20% PEG8000 
100 mM MES 
pH 6.0 
100 mM 
Ca(OAc)2 
20% PEG8000 
100 mM MES 
pH 6.2 
150 mM 
Ca(OAc)2 
20% PEG8000 
100 mM MES 
pH 6.4 
200 mM 
Ca(OAc)2 
27% PEG4000 
100 mM NaOAc 
pH 4.4 
200 mM 
(NH4)2SO4 
27% PEG4000 
100 mM NaOAc 
pH 4.6 
100 mM 
(NH4)2SO4 
27% PEG4000 
100 mM NaOAc 
pH 4.8 
150 mM 
(NH4)2SO4 
27% PEG4000 
100 mM NaOAc 
pH 5.0 
200 mM 
(NH4)2SO4 
1.7 M (NH4)2SO4 
100 mM NaOAc 
pH 4.4 
1.7 M (NH4)2SO4 
100 mM NaOAc 
pH 4.6 
1.7 M (NH4)2SO4 
100 mM NaOAc 
pH 4.8 
1.7 M (NH4)2SO4 
100 mM NaOAc 
pH 5.0 
G 
22% PEG8000 
100 mM MES 
pH 5.8 
200 mM 
Ca(OAc)2 
22% PEG8000 
100 mM MES 
pH 6.0 
100 mM 
Ca(OAc)2 
22% PEG8000 
100 mM MES 
pH 6.2 
100 mM 
Ca(OAc)2 
22% PEG8000 
100 mM MES 
pH 6.4 
150 mM 
Ca(OAc)2 
29% PEG4000 
100 mM NaOAc 
pH 4.4 
200 mM 
(NH4)2SO4 
29% PEG4000 
100 mM NaOAc 
pH 4.6 
100 mM 
(NH4)2SO4 
29% PEG4000 
100 mM NaOAc 
pH 4.8 
100 mM 
(NH4)2SO4 
29% PEG4000 
100 mM NaOAc 
pH 5.0 
150 mM 
(NH4)2SO4 
1.9 M (NH4)2SO4 
100 mM NaOAc 
pH 4.4 
1.9 M (NH4)2SO4 
100 mM NaOAc 
pH 4.6 
1.9 M (NH4)2SO4 
100 mM NaOAc 
pH 4.8 
1.9 M (NH4)2SO4 
100 mM NaOAc 
pH 5.0 
H 
24% PEG8000 
100 mM MES 
pH 5.8 
150 mM 
Ca(OAc)2 
24% PEG8000 
100 mM MES 
pH 6.0 
200 mM 
Ca(OAc)2 
24% PEG8000 
100 mM MES 
pH 6.2 
150 mM 
Ca(OAc)2 
24% PEG8000 
100 mM MES 
pH 6.4 
100 mM 
Ca(OAc)2 
30% PEG4000 
100 mM NaOAc 
pH 4.4 
150 mM 
(NH4)2SO4 
30% PEG4000 
100 mM NaOAc 
pH 4.6 
200 mM 
(NH4)2SO4 
30% PEG4000 
100 mM NaOAc 
pH 4.8 
150 mM 
(NH4)2SO4 
30% PEG4000 
100 mM NaOAc 
pH 5.0 
100 mM 
(NH4)2SO4 
2.0 M (NH4)2SO4 
100 mM NaOAc 
pH 4.4 
2.0 M (NH4)2SO4 
100 mM NaOAc 
pH 4.6 
2.0 M (NH4)2SO4 
100 mM NaOAc 
pH 4.8 
2.0 M (NH4)2SO4 
100 mM NaOAc 
pH 5.0 
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5.11 Discussion 
The data presented in this chapter provide valuable insight into the alterations in activity 
identified in Chapter 4. Further experiments would be required to deduce the detailed 
mechanisms of binding and catalysis for each variant and each substrate as discussed in 
Chapter 6. However, based on the observation that the published structures of GO variants 
show minimal structural rearrangements, it is possible to model the variants identified in this 
study in silico using the program COOT (Emsley et al., 2010). The rotamer which resulted in the 
least disruption to the surrounding molecule was selected for each mutation. When 
considered with the biochemical data presented here, it is possible to use these structures to 
postulate how the new activities might be brought about. For each mutation, it is important to 
consider both the effect on activity with the alternative substrate (D-glucose, D-arabinose or D-
xylose) and with the native substrate D-galactose. 
There are four main points to be considered for the variants showing altered D-arabinose, D-
glucose or D-xylose activity: 
1. The C383E and C383S mutations result in significant enhancements in activity towards 
the alternative substrates D-glucose, D-arabinose and D-xylose compared to WT; 
however the effect on D-galactose activity at pH 7.0 is limited 
2. F194G/ I/ T and F227W mutations result in significant reductions in activity towards D-
galactose at pH 7.0, compared to WT; however the effect on activity towards 
alternative substrates is limited 
3. N245H/ R/ W mutations result in moderate reductions in activity towards D-galactose 
at pH 7.0, compared to WT; activity towards alternative substrates is enhanced in most 
cases 
4. In most cases, the double mutants combine the reduced D-galactose activity of the 
F194, F227 or N245 mutation with the increased activity of the C383 mutation. 
The C383 mutations 
Despite previous work on mutations at position 383 (Section 1.6.2), including solution of the 
crystal structure of C383S (Wilkinson et al., 2004), the effect on catalysis of the different 
mutations at this position is yet to be explained. C383S shows similar specific activity values 
with 1 M D-galactose as WT GO, while specific activity for C383E is reduced by around half. 
Chapter 5: Characterisation of Altered Enzyme Activities 
199 
 
Despite this, both enzymes show an improved efficiency (kcat/ KM) compared to WT due to 
significantly reduced KM values, implying more efficient substrate binding. Activity towards 
methyl D-galactopyranosides shows exactly the same trends as the WT enzyme: activity 
towards the α-anomer is reduced by half and activity towards the β-anomer is reduced by 
around a quarter compared to the isomeric, non-methylated mixture. Therefore it would seem 
that, whatever effect the C383E/ S mutation has on D-galactose binding and oxidation, the 
area around C-1 of the D-galactose molecule is not involved.  
The C383S mutation is thought to bring about the observed changes due to subtle changes in 
active site structure or flexibility caused by the introduction of the stronger hydrogen bonding 
group (–OH compared to –SH) which affects the hydrogen bonding network around the active 
site (Wilkinson et al., 2004). The C383E mutation (Figure 5.34) introduces a much more 
significant change as glutamate is much larger than cysteine and is a charged residue. A 
number of interactions around the active site may be affected. For example, Thr440 and 
Phe441 may move away from the Glu383 due to unfavourable interactions and the hydrogen 
bond between Cys383 and Tyr405 via a water molecule may be replaced by a direct hydrogen 
bond between the two residues. Tyr405 has been shown previously to play an important role 
within the active site (Deacon, 2008) which is supported by the high level of conservation of 
this residue in the 50 sequences showing highest identity to F. graminearum GO (Figure 5.1). 
Movement of Tyr405 or changes in the hydrogen bond interactions due to changes at positions 
383, 440 and 441 may affect copper ligation by Tyr495 and maybe Tyr272, resulting in major 
changes in substrate binding and catalysis. 
 
Figure 5.34. Comparison of WT and C383E structures 
The figure was created with PyMol using .pdb file 1GOF and shows all residues which 
may be affected by the C383E substitution. Hydrogen bonds are shown as dashed black 
lines: Cys383 and Tyr405 both form hydrogen bonds with a water molecule in the WT 
structure, Glu383 may form a direct hydrogen bond with Tyr405 in the mutant. 
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With D-arabinose, D-glucose and D-xylose, activity compared to WT was greatly increased with 
the C383E variant and, to a lesser extent, the C383S variant. In the case of D-glucose and D-
xylose, addition of the methyl group at position C-1 did not affect activity significantly, 
implying that the pyranose substrate binds in a similar conformation to WT, although the C-6 
hydroxyl is not present in D-xylose. With D-arabinose however, C383E and C383S show a strong 
preference for methyl α-D-arabinofuranoside over methyl β-D-arabinopyranoside and activity 
is much higher with the α-furanoside compared to the isomeric mixture. As this effect is not 
seen with the WT, D-arabinose may bind differently in the mutants than in the WT active site. 
Measurements with D-arabinose also displayed significantly greater changes in the oxidative 
half reaction than D-glucose or D-xylose, again implying major changes to substrate binding 
and/ or catalysis.  
Comparing the pH profiles of D-glucose activity of C383E and C383S with WT reveals an 
increase in the optimum pH of around 2.0 units in both cases. While this matches previous 
data for the D-galactose pH profile for C383E, C383S has been previously reported to show a 
decrease in the pH optimum with D-galactose (Deacon, 2008). The different results are likely 
due to variations in preparation of the protein or different experimental conditions. The 
changes in pH optimum for D-galactose and D-glucose activity cannot be directly explained by 
the data presented here but may be due to alterations in the environment of residues involved 
in binding or catalysis resulting in a change in pKa. It is, perhaps, surprising that introduction of 
the negatively charged glutamate results in an increased pH optimum as the opposite would 
normally be expected. As the C383E mutation has a similar effect on the pH profile of D-
glucose and D-galactose activities and the N245R/ C383E variant oxidises D-glucose at the C-6 
hydroxyl, the same as WT oxidation of D-galactose, it is likely that D-glucose binds the C383E 
active site in a similar way to D-galactose binding to WT. How the steric clash with the 
equatorial C-4 hydroxyl in D-glucose is accommodated (Section 1.6.2) cannot be explained 
without further knowledge of the structural changes induced by C383E, for which a crystal 
structure is absolutely required. The increased activity for the three alternative substrates is 
most likely due to changes in the shape of the active site and/ or increased flexibility, brought 
about by the C383X mutations, leading to more efficient binding of substrates which are less 
complementary to the shape of the active site. Molecular modelling or analysis of the crystal 
structure of an enzyme-substrate complex will provide more information on the basis of the 
increased activities. 
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The F194 and F227 mutations 
The three mutations at position 194 resulted in a significant disruption of activity towards D-
galactose, particularly F194G and F194I. The data imply that these two mutations have a 
negative effect on D-galactose binding in the active site as the KM(galactose), which gives an 
indication of binding affinity, is significantly increased. Relative activities with the α- and β-
anomers of methyl D-galactopyranoside reveal another difference which can be attributed to 
substrate binding, as WT GO shows a preference for the β-anomer while the F194G and F194I 
mutants show no preference. This may suggest that there is more space around the C-1 
position in the active site of the mutants and that the hydrogen bonding interaction with 
Tyr329 (Section 1.6.2) may not be present. In 42 of the 50 GO sequences showing highest 
identity with GO from F. graminearum a bulky aromatic residue is present at position 194. 
While it is thought that the hydrophobic nature of Phe194 may be important in substrate 
positioning through hydrophobic interactions with the B-face of D-galactose (Section 1.6.2) 
(Wachter and Branchaud, 1996), it is possible that the size of this residue is a more important 
feature. Glycine and isoleucine are both hydrophobic residues but are significantly smaller 
than phenylalanine. Perhaps substitution with these residues increases the space around 
position 194 resulting in less optimal positioning of D-galactose for hydrogen bonding 
interactions with other residues in the active site (Section 1.6.2) (Figure 5.35).  
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Figure 5.35. Surface view of WT GO and the F194G and F194I variants 
F194 mutations were modelled using COOT and the rotamer which led to the least 
potential structural disruption was selected. The figure was created with PyMOL using 
.pdb file 1GOF and shows the view looking down from bulk solvent into the active site. 
F464 is green, W290 is yellow and the residue at position 194 is magenta. It is clear that 
substitution with a Gly or Ile at position 194 results in much more space in this area of 
the active site compared to the Phe194 in the WT structure. 
 
The F194T mutation results in reduced activity towards D-galactose but to a lesser extent than 
the F194G or F194I mutations. The variant shows a preference for methyl β-D-
galactopyranoside over the α-anomer, similar to WT GO. KM(galactose) is also within a similar 
range to WT, implying that this mutation has not led to as significant a disruption of D-
galactose binding as the other two mutations. Introduction of the polar threonine at position 
194 (Figure 5.36) is likely to have a significant effect on substrate binding in this area. As well 
as reducing the hydrophobicity of the region, Thr194 may interact unfavourably with Phe227. 
Due to its packing against Trp290 and proximity to the copper and the thioether bond, Phe227 
seems unlikely to be able to move away from Thr194. It is more likely that the loop containing 
Thr194 (residues 192-196) would instead move away from the copper resulting in a greater 
increase in space in this area of the active site than was seen with the F194G and F194I 
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mutations (Figure 5.36). The polar Thr may also permit waters to occupy this portion of the 
active site and form hydrogen bonds with Thr194, as well as the substrate hydroxyl(s). 
However, the only moderate reduction in D-galactose activity that was observed is difficult to 
explain.  
 
Figure 5.36. Comparison of WT and F194T structures 
The F194T mutation was modelled using COOT and the rotamer which led to the least 
potential structural disruption was selected. The loop containing residue 194, which may 
move away from the copper upon mutation to Thr, is shown in magenta. Figure created 
with PyMOL using .pdb file 1GOF. 
 
The reductions in activity of the three F194 mutants towards D-glucose were not as significant 
as the reductions in D-galactose activity. The significant reductions in activity upon addition of 
a methyl group at position C-1 of D-glucose in the F194G and F194I mutants imply that binding 
of D-glucose occurs quite differently in these mutants than in WT. This is likely due to the 
increased space around the area of the active site normally involved in preventing D-glucose 
binding caused by the substitution of Phe194 for smaller residues (Figure 5.35). Perhaps the C-
1 end of the D-glucose molecule points into the active site rather than being relatively solvent 
exposed as predicted for D-galactose binding to the WT enzyme (Wachter and Branchaud, 
1996). The likelihood of a different binding conformation was further backed up by the 
significant change in the pH profile of D-glucose activity to a much more acidic pH optimum. 
The oxidative half of the reaction does not seem to be significantly affected in the F194G/ 
C383S and F194I/ C383S variants, although it would be interesting to see the effect of the F194 
single mutants. Unfortunately due to the extremely low activity towards the methyl D-
glucopyranosides, it was not possible to analyse the products of the oxidation by NMR to 
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determine the position of oxidation on the D-glucose molecule for these variants. However, 
given the differences observed with methyl D-glucopyranosides, it would not be surprising if 
oxidation by F194 mutants occurred at a different position on the D-glucose molecule 
compared to the N245R/ C383E variant which was shown to oxidise at C-6 (Section 5.8).  
F194I shows a moderate decrease in activity towards D-arabinose compared to WT. The 
mutant is barely active against the methyl α-D-furanoside, unlike WT, although activity towards 
the methyl β-D-pyranoside is the same as WT. This could imply that WT GO binds and oxidises 
the two methyl D-arabinosides by different mechanisms and that only one is disrupted by the 
F194I mutation. However, it could also be the case that binding of methyl β-D-
arabinopyranoside is quite different in WT and F194I. 
The F227W mutation leads to a significant reduction in activity towards D-galactose but the 
only slightly reduced KM, compared to WT, implies that D-galactose is still able to bind in the 
active site. Without QM/ MM calculations or a crystal structure, it is not possible to estimate 
the structure of the mutant active site as the bulky tryptophan residue exists in close proximity 
to key residues including Trp290, Tyr272, Cys228 and the active site copper and copper ligand 
His496. It is likely this proximity that explains the lack of activity with any substrate for the 
majority of variants in libraries containing mutations at position 227. F227W shows only small 
reductions in activity towards D-glucose and D-xylose, compared to WT, while D-arabinose 
activity is increased. The dramatically different pH profile implies significant differences in 
binding and/ or oxidation of D-glucose but this is unsurprising given the significant structural 
change required to accommodate the tryptophan residue. 
The N245 mutations 
The N245H, N245R and N245W mutations all result in reduction of D-galactose activity, but not 
to the same degree as for the F194 and F227 mutations. The KM values remain in a similar 
range to WT, implying that substrate binding is not majorly affected. The effect of adding a 
methyl group at position C-1 is also very similar to WT for the N245H and N245R mutants, 
while there is barely any effect for the N245W mutant compared to activity with the non-
methylated isomeric mixture. The N245H and N245R mutations result in increased activity 
towards D-xylose while N245W reduces D-xylose activity. No effect is observed when a methyl 
group is added to D-xylopyranose, as with WT. N245R also has minor effects on D-glucose and 
D-arabinose activities with the most significant change being a relatively high level of activity 
towards methyl α-D-arabinofuranoside while methyl β-D-arabinopyranoside activity is similar 
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to WT. These minor changes may be explained by changes in the surface charge in this area of 
the active site by addition of the arginine which may affect how different substrates access the 
active site (Figure 5.37).  
 
Figure 5.37. Surface view of the active site showing relative charge 
Positively charged regions are shown in blue while negatively charged regions are red. 
The image was generated with PyMOL using .pdb file 1GOF. It is clear that the N245R 
substitution increases the positive charge at a region of the protein surface (indicated by 
an arrow) which may affect substrate access to the active site. D-galactose is shown in 
black, modelled according to Wachter and Branchaud (1996). 
 
Changes to hydrogen bonding interactions with Asp225 or Ser197 brought about by the N245R 
or N245H mutations or changes in the environment close to Phe227 and Trp290 may also 
account for the differences (Figure 5.38). It is, however, surprising that substitution of Asn with 
the much larger, more hydrophobic Trp did not result in more dramatic changes to enzyme 
activity. 
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Figure 5.38. The predicted structures of the N245H and N245R variants compared to WT 
N245 mutations were modelled using COOT and the rotamer which led to the least 
potential structural disruption was selected. Introduction of a histidine or arginine may 
alter the environment of the surrounding residues (shown). Figure created with PyMOL 
using .pdb file 1GOF. 
 
Double mutants 
Phe194, Phe227 and Asn245 occur close to the active site copper and are more surface 
exposed than Cys383. This makes it more straightforward to postulate how mutations at these 
positions can change enzyme activity. As explaining the changes observed with the Cys383Glu 
and Cys383Ser mutations is much more difficult, it is not possible to fully rationalise the novel 
activities of the double mutants which contain a mutation at position 194, 227 or 245 
combined with C383E or C383S.  
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With the exception of the results for F194T which appear to be anomalous, when the F194 or 
F227 mutations are combined with C383E/ S, D-galactose activity shows similar trends to the 
F194X/ F227X single mutants, i.e. reduced kcat, increased KM and limited or no preference for 
the α- or β-anomer of the methyl D-galactopyranoside. This is likely due to the changes in the 
area of the active site around position 194 or 227 which reduce the efficiency of D-galactose 
binding to such an extent that the increased flexibility or changes induced by the C383 
mutations cannot counteract the effect.  
Addition of the C383S mutation to the F194I mutant led to an increase in D-arabinose activity 
with essentially no effect on the specific activity with 1 M D-galactose. The maintenance of the 
strong preference for methyl β-D-arabinopyranoside over methyl α-D-arabinofuranoside seen 
in F194I/ C383S implies that D-arabinose binds in the same way in the single and double 
mutants, but that the increased flexibility induced by the C383S mutation improves the 
efficiency of binding and therefore catalysis. NMR data reveals that oxidation occurs at the C-4 
position which implies the methyl β-D-arabinopyranoside binds in a different orientation to 
how D-galactose binds to WT GO, where the axial C-4 hydroxyl forms hydrogen bond 
interactions with R330 and Y495 (Section 1.6.2). It is surprising that improvement in D-
arabinose activity of the F194I/ C383S variant is so much greater than for the F194G/ C383S 
mutant (Table 4.11) and implies that the larger size of the Ile at this position is important in 
correct positioning of the D-arabinose molecule. When C383S was added to mutations of F194 
the strong inhibition of D-glucose activity upon addition of a methyl group at C-1 was 
maintained. However, the pH profile of the double mutant is much more similar to the C383 
mutant or WT. Taken together, these results suggest that if the binding conformation has 
significantly changed as suggested above, this does not explain the change in pH profile seen 
for the F194 single mutants. Perhaps the F194 mutation has changed the environment of one 
or more ionisable residues resulting in a shift in the pH profile of D-glucose activity, but the 
increased flexibility of the C383S mutation restored the environment of the residue(s) meaning 
pH is less important in the reaction. 
In order to accommodate the bulky Trp at position 227, significant changes in a number of 
surrounding residues would need to occur for each of the possible rotamers. It is not possible 
to estimate which is the most likely rotamer from visual analysis of the structure as with the 
other mutations. Addition of the C383E mutation to F227W led to small enhancements in the 
D-arabinose, D-glucose and D-xylose activities compared to F227W alone. Changes in the 
relative activities towards the different substrates and corresponding methyl glycosides 
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compared to both the F227W and C383E single mutants implies that the two mutations are 
having combined effects on binding of the different substrates. However, the pH profile for D-
glucose activity and the oxidative half reaction for D-xylose or D-arabinose activities both 
follow similar trends to C383E. Further analysis of this double mutant is required before the 
novel activities can be explained, most notably determination of the position of the tryptophan 
at position 227 within the structure by QM/ MM calculations and/ or solution of the crystal 
structure.  
When combined with the C383E mutation, N245H and N245R result in a significant loss of 
activity towards D-galactose, which is surprising as all three single mutants display only 
moderate reduction in activity. The relative activities with the methyl D-galactopyranosides 
show similar trends to WT and each of the single mutants, however substrate binding does 
appear to be improved as KM values for both single mutants are significantly reduced. Perhaps 
this reveals an increased affinity of the enzyme for D-galactose meaning catalysis is limited by 
slow release of the aldehyde product. Both double mutants show enhanced activity towards D-
xylose compared to WT or the N245 single mutants although relative activity towards the 
methyl D-xylopyranosides does not reveal any large differences. The N245H/ C383E variant 
displays an increased sensitivity to oxygen concentration, compared to C383E or WT, implying 
that the combined mutations have an effect on the oxidative half reaction. Although it is 
possible that this effect is as a result of the higher turnover rate of this variant towards D-
xylose compared to WT GO-N6M1. The two mutations appear to have effects on both D-xylose 
binding and catalysis making it difficult to deduce the precise structural reasons behind the 
change in activity. The 1H-NMR data reveals the possibility of oxidation of methyl β-D-
xylopyranoside at multiple positions. This seems more likely for D-xylose due to the presence 
of three equatorial hydroxyl groups than for D-arabinose which contains two equatorial and 
one axial hydroxyl group. The different shape of the two molecules may affect the relative 
accessibility of the different hydroxyls for oxidation (Figure 5.39).  
 
Figure 5.39. Structures of D-arabinose (left) and D-xylose (right) 
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The enhanced D-glucose activity of N245R/ C383E follows a similar trend to that seen with D-
xylose. However, with D-arabinose the variant shows much greater activity for methyl α-D-
arabinofuranoside than the β-pyranoside, as also seen with the C383E single mutant. This 
implies that the C383E mutation plays a significant role in binding of D-arabinose in the active 
site. It is interesting that N245R/ C383E shows a preference for the α-furanoside over the β-
pyranoside, unlike F194I/ C383S and F227W/ C383E, as all three variants oxidise methyl β-D-
arabinopyranoside at the C-4 position. It seems likely that binding of methyl α-D-
arabinofuranoside may be different in N245R/ C383E than the other two variants showing 
enhanced D-arabinose activity. 
Addition of the C383S mutation to N245R or N245W has essentially no effect on D-galactose 
activity compared to the N245X single mutants, apart from a small reduction in KM as seen for 
the C383S single mutant. However, D-xylose activity is enhanced more than either of the single 
mutants, compared to WT, implying a synergistic effect of the two mutations, i.e. one 
mutation enhances the effect of the other. N245R/ C383S shows the highest level of activity 
towards 1 M D-xylose of all variants identified, while N245W/ C383S is interesting because the 
N245W single mutant displays such low levels of D-xylose activity. All single and double 
mutants show a moderate preference for methyl β-D-xylopyranoside over the α-anomer and 
the double mutants both display increased sensitivity to oxygen concentration. While the 
enhancement in D-xylose activity in these two variants is probably due to different features, 
given the different characteristics of arginine and tryptophan, it is only possible to estimate 
how either mutation brings about the observed effects with additional structural data.  
Of all the variants identified, only the F194W/ W290F variant displays higher activity with an 
alternative substrate than with D-galactose. It is unfortunate that further analysis of this 
activity was not possible within the time frame of the project as this variant likely has the 
greatest potential for further biotechnological development. Of particular interest is 
identification of the product generated upon oxidation of glycerol. This would be a priority if 
the project were to be continued. It was not possible to estimate the positions of the residues 
upon mutation, however their relative positions in the WT structure are shown in Figure 5.40. 
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Figure 5.40. Positions of F194 and W290 in relation to key active site residues 
F194 and W290 are shown in magenta, other residues are shown in white, copper is 
shown as a cyan sphere. Figure created with PyMOL using .pdb file 1GOF. 
 
The non-hyperbolic plots of reaction velocity versus substrate concentration seen for most of 
the mutants with the alternative substrates (Section 5.4.2) could have a number of different 
meanings. The linear plots could simply indicate that the enzyme displays a KM for the 
substrate which is much higher than the substrate concentrations that activity was measured 
at. In these experiments however, very high substrate concentrations of up to 3 M were used 
so if the KM is above this value, the enzyme must have extremely low affinity for the substrate. 
Sigmoidal velocity curves can often be attributed to cooperativity between multiple binding 
sites on an enzyme, a relatively common occurrence with multimeric enzymes such as 
pyruvate dehydrogenase (Bisswanger, 1984). However, as GO is a monomeric protein, 
cooperativity seems unlikely. If cooperativity was occurring with the alternative substrates it 
could possibly involve binding at the postulated binding site in domain 1 (Section 1.6.1.1). 
Removal of this domain has been shown previously to have no effect on catalysis for WT GO 
with galactose, but that does not rule out a role in the oxidation of alternate substrates 
(Mahmoud et al., 2000). Another possibility for the non-hyperbolic dependence of reaction 
velocity on substrate concentration includes a change in the reaction mechanism from bi bi 
ping pong (Section 1.6.3.2) to a random bi bi reaction mechanism which can result in a variety 
of different velocity curves depending on a number of different factors (Segel, 1975). Various 
hybrid mechanisms, such as a ping pong-ordered mechanism can also lead to generation of 
non-hyperbolic plots (Segel, 1975). It has been previously shown that substitution of as little as 
one residue can alter an enzyme mechanism (Berry et al., 1989). However, the most likely 
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explanation for the non-hyperbolic relationship requires recognition that the reaction 
catalysed by GO is a two-substrate reaction (galactose and oxygen). In Section 5.7 it was 
identified that many of the mutations have altered the sensitivity of the enzyme to oxygen so 
atmospheric oxygen concentrations (used in activity measurements in Section 5.4.2) will not 
be saturating in many cases. It therefore seems likely that if the same measurements were 
carried out under saturating oxygen concentrations, hyperbolic plots of reaction velocity 
versus substrate concentration would be seen for most of the mutants. 
Unfortunately, in the time-scale of this project, it was not possible to fully characterise each 
new activity, even by the selection of methods shown in this chapter. The effect of varying 
oxygen concentration on enzyme activity and the determination of the oxidation position by 
NMR were only carried out for a subset of the variants. As the oxygen concentrations were not 
determined, it cannot be ruled out that the differences observed in sensitivity to oxygen are 
due to inaccuracies during the experimental procedure. Oxygen may also display different 
solubility in the different sugar solutions, which would complicate any comparisons between 
the different substrates. Determination of the position of oxidation is only valid for those 
variants studied. Even variants carrying similar mutations may oxidise the same substrate at a 
different position. Optimisation of the NMR procedure could, however, be useful in future 
studies to refine the selectivity of the enzyme as well as characterising and optimising the 
experiment over long time periods. 
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Conclusions 
The nine variants identified in Chapter 4 were characterised using a variety of methods and 
some significant changes were identified. C383E and, to a lesser extent C383S, greatly 
enhanced the activity of GO towards D-arabinose, D-glucose and D-xylose due to alterations of 
the active site which appear to generally improve binding; D-arabinose binding seemed most 
significantly altered. Combination of C383E/ S with mutations of either F194, F227 or N245 led 
to reductions in activity towards D-galactose, but maintained the enhanced activity towards 
the other substrates compared to WT. Variants containing F194X mutations appeared to make 
different interactions with D-glucose and/ or D-arabinose and may bind the substrates in a 
different orientation from WT. Oxidation of methyl β-D-arabinopyranoside was shown to occur 
at the C-4 hydroxyl. The F227W mutation had significant effects on several aspects of catalysis, 
most notably the pH profile, but the altered activity is difficult to rationalise without structural 
data. Mutations of N245 may have altered the enzyme specificity by altering the surface 
charge around the active site, or by changing the environment of key active site residues. The 
most significant results were seen with the N245R/ C383S and N245W/ C383S variants which 
showed high levels of D-xylose activity due to synergistic effects between the two mutations. 
Finally, the F194W/ W290F variant displays higher activity towards glycerol than D-galactose 
across a range of substrate concentrations. This variant is probably the most important 
identified in this study in terms of development of GO for industrial applications although 
further characterisation of the new activity is required. 
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6.1 Comparison with similar studies by other groups 
GO represents a promising target for enzyme engineering due to the existence of high 
throughput screening methods, which have already been used successfully; and a wealth of 
information on the roles of specific residues in substrate binding and catalysis. In this project, 
screening assays were further optimised (Chapter 3) and libraries were designed and 
generated incorporating mutations at all previously identified positions of interest in the first 
and second coordination sphere, excluding essential catalytic residues (Chapter 4). 
It is interesting to compare the residues selected for mutagenesis in the study presented here 
with that of two similar projects from the Arnold and Turner groups. The Arnold group 
demonstrated a small level of improved activity towards D-glucose by mutagenesis at positions 
290, 330 and 406 (194 and 464 were also targeted but did not improve activity) (Sun et al., 
2002); while the Turner group constructed a series of CAST libraries (Section 1.3.6) targeting 
residues surrounding the active site to improve activity towards D-glucose, D-mannose and D-
N-acetyl glucosamine (Rannes et al., 2011). The residues selected in the two studies are shown 
in Table 6.1. All of the residues which led to altered activity upon mutagenesis by the other 
groups were included in the project described here, although not all of the relevant libraries 
were screened to >95% completion. This may be why the same variants were not identified. 
The libraries designed in Chapter 4 also did not contain the same combinations of residues as 
some of the successful combinations identified by Turner and co-workers. This is something to 
consider if the randomised oligonucleotides generated here are to be used in future library 
generation.  
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Table 6.1. The amino acid positions targeted in studies aiming to alter the substrate 
specificity of GO 
Residue This project 
Sun et. al. 
(2002) 
Rannes et. al.  
(2011) 
F194    
G195   
F227    
N245    
W290    
S291   
Q326    
Y329    
R330    
N333    
C383    
Y405    
Q406    
E407    
P463    
F464    
V494    
L514    
C515    
C518    
Mutations shown in red and green were randomised in this project and alterations in 
substrate specificity identified. Those in red were further characterised while those in 
green were not. Mutations shown in yellow are those variants identified and 
characterised in other projects and shown to lead to altered substrate specificity. 
 
The W290F/ R330K/ Q406T variant was reported to show 100-fold increased activity towards 
250 mM D-glucose compared to the M1 variant (Sun et al., 2002) although, when reported by 
the Turner group, the increase in activity was only four-fold when 50 mM D-glucose was used 
(Rannes et al., 2011). This demonstrates the importance of the substrate concentration used in 
screening and characterisation of variants as discussed below. The specific activities in this 
project were measured using higher concentrations of substrate than the other studies, so 
only limited comparisons can be carried out. The increases in D-glucose activity compared to 
WT GO-N6M1 of two- to five-fold are within a similar range to those reported by the Turner 
group, who identified variants displaying increases of up to four-fold compared to the parent 
enzyme (Rannes et al., 2011). The mutations introduced by the Turner group only had a limited 
effect on activity towards D-galactose. However, as most libraries were constructed using the 
W290F/ R330K/ Q406T variant as the parent sequence, the D-galactose activity was already 
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reduced by around 70-fold compared to the M1 variant. This resulted in a much greater shift in 
specificity away from D-galactose and towards D-glucose than for the variants reported here. It 
would be interesting to introduce these three mutations into the variants identified in the 
study presented here. Arnold and co-workers reported a reduction in activity towards 250 mM 
D-galactose of 1000-fold compared to native WT GO for the W290F/ R330K/ Q406T variant 
(Sun et al., 2002). It is interesting to note that all previously reported variants showing 
significant shifts in specificity contain the W290F mutation. It would seem that this mutation 
leads to a loss in activity towards D-galactose but has neutral or positive effects on activity 
towards other substrates, as seen here with the glycerol oxidase F194W/ W290F. This is likely 
due to altered hydrogen bonding interactions with substrates but further study would be 
required to confirm this. 
The increase in activity towards D-xylose is much greater than the increases seen towards D-
glucose, perhaps because GO-N6M1 already shows a significant level of activity towards D-
xylose so less significant changes to the enzyme were required to improve activity. The 20-fold 
enhancement in D-xylose activity upon introduction of the N245R/ C383S mutations is greater 
than the enhancement in activity towards any substrate reported by Turner and co-workers 
(activity towards D-xylose and D-arabinose was not investigated by Turner and co-workers). 
The greatest increase in activity towards D-arabinose was for the C383E mutant which is six-
fold more active than GO-N6M1. Again, this is greater than any increase observed with D-
glucose, perhaps because of the already higher level of activity of the parent enzyme. 
While shifts in specificity away from D-galactose and towards the alternative substrate(s) have 
been achieved, it was unfortunately not possible to introduce mutations which reduced D-
galactose activity to such an extent that the variant displayed higher activity for D-arabinose, D-
glucose or D-xylose than for D-galactose. This has not been reported by any groups working on 
GO and is probably due to the fact that GO displays a very high level of activity for D-galactose 
(the kcat is around 1000 s
-1). The enzyme also displays a relatively low specificity for the D-
galactose substrate, implied by a high KM of 50-70 mM, as well as broad substrate specificity. 
As D-galactose is not tightly or very specifically bound within the active site, it is difficult to 
significantly disrupt this binding. The overall rigidity of the structure may mean that 
introduction of mutations only has a very limited effect on the shape of the binding site, as 
seen with the crystal structure of the C383S (Wilkinson et al., 2004) and W290F/ R330K/ 
Q406T/ P463I (Rannes et al., 2011) variants. Removal of the D-galactose activity is not an 
essential requirement for development of GO for industrial uses. This would only be required 
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where substrate is provided in a mixture including D-galactose and pure product is required 
(which is unlikely). In fact, enzymes displaying broad substrate specificity are often desirable in 
the chemical synthesis industry as they can be used in various different transformations, 
removing the need for development of multiple enzymes (Breuer et al., 2004). 
No characterisation has been previously reported for the oxidation of D-arabinose, D-xylose or 
glycerol by GO. However, 13C- and 1H-NMR on the products of GO catalysed reactions has 
shown that variants active towards D-glucose maintain the WT regioselectivity for the C-6 
hydroxyl (Sun et al., 2002, Rannes et al., 2011). This matches the observation in this project 
with variants showing enhanced activity towards D-glucose. 
6.2 Evaluation of the library generation method  
As discussed in Section 1.3.4, the use of trimer phosphoramidites in generation of randomised 
oligonucleotides has a number of advantages. However, the significant financial cost of this 
library generation method should be reflected in the generation of high quality libraries. In all 
variants sequenced, no stop codons were identified at the randomised positions and no 
sequence bias was detected. In order to fully evaluate the quality of the libraries, significantly 
more sequence analysis would be required, but the identification of 27 variants showing 
enhanced activity confirms that the method was successful. Unfortunately, the process of 
library generation using the high quality oligonucleotides was not optimal, as shown by a 
number of sequencing variants with frameshifts and random insertions and deletions (Section 
4.4.2). However, generation of correct clones in >70% of cases (and in some cases >90%) is still 
a good achievement. The library generation process consisted of a number of steps (Figure 
4.10), increasing the opportunity for errors to be introduced. Despite extremely high fidelity, it 
would appear that the Phusion and KOD polymerases used in the overlap extension and PCR 
stages of library generation may have introduced errors. This could be due to inclusion of 
contaminants in the reaction mix, such as those used in epPCR (Section 1.3.2), but could also 
be due to damage to the DNA during manipulations such as gel extraction and purification. It is 
likely that a reduction in the number of steps required for library generation would reduce the 
number of errors incorporated, although this would require further optimisation of the 
process. Alternative methods for introducing mutations at defined positions all involve use of 
oligonucleotides (Section 1.3.4). While it may reduce the overall cost of library generation, use 
of degenerate codons (NNK/ NDT/ ’22-codon trick’) or MAX codons would not prevent the 
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errors observed here and would likely lead to libraries with lower diversity. If further libraries 
are to be generated it would therefore make sense to further optimise the process to increase 
the chance of generating variants with the desired activities with minimal introduction of 
errors. 
Another disadvantage of the library generation process was that it was not possible to target 
certain residues individually due to the close proximity of another selected residue which was 
therefore randomised on the same oligonucleotide. This is unfortunately a drawback of 
oligonucleotide-based mutagenesis and could only be avoided by generation of more 
oligonucleotides. Libraries would need to be designed before the oligonucleotides were 
generated as, for example, it would not be economical to generate oligonucleotides for each of 
the 15 possible combinations of Q326, Y329, R330 and N333 found on oligonucleotide 
QYRN326-333. 
6.3 Selection of an appropriate substrate concentration 
As mentioned in Section 6.1, similar studies carried out by other groups have used substrate 
concentrations of 50 mM (Rannes et al., 2011) or 250 mM (Sun et al., 2002) in screening 
libraries and characterising GO variants. This makes comparison of results difficult as the effect 
of increasing substrate concentrations is different for the different variants (as shown by 
attempts to determine kinetic parameters in Section 5.4.2). In this project, much higher 
substrate concentrations, up to 2 M, were used for microtitre plate-based screening and 
characterisation of variants due to the potential future use of variants in synthesis of different 
chemicals or pharmaceutical intermediates (Section 1.6.5.2) where the substrate is generally 
provided at high concentrations (Section 1.3.8) (Woodley, 2013). However, use of such high 
concentrations also has disadvantages: 
 As the concentrations used are higher than the KM for most, if not all substrates 
screened, it is not possible to quickly identify improvements in KM as the concentration 
used is likely to be saturating in all cases. 
 High substrate concentrations may result in enzyme inhibition. While it is perhaps 
desirable to exclude variants showing inhibition at high substrate concentrations, it 
may prevent identification of variants showing significant improvements in activity at 
lower concentrations which could be selected for further development and 
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optimisation. Higher substrate concentrations may also result in product inhibition 
effects. 
 High concentrations of the sugar substrates used increases the viscosity of the assay 
mixtures which may affect diffusion and reduce the apparent rate. Variants may 
appear less active than they are. Viscosity effects could be reduced by altering the 
temperature or by continuous mixing. 
More variants may have been identified if multiple screening rounds were carried out using 
different substrate concentrations. For example, the first round could identify variants with 
increased activity compared to WT at lower substrate concentrations, while later rounds could 
determine whether any of the selected variants also displayed improved activity at the higher 
concentrations likely required for industrial development of the enzyme. However, this would 
greatly increase the amount of time required to identify variants of interest.  
As mentioned in Chapter 3, the substrate concentration used in screening was selected upon 
consideration of Arnold’s law: ‘you get what you screen for’ (You and Arnold, 1996). High 
substrate concentrations were used in order to find variants active under these conditions. 
However, upon screening the mutant libraries with the two assays, some of the enhanced 
activities were not reproduced with the purified protein, suggesting that the observed 
enhancements in activity may have actually been due to enhanced expression levels. The agar 
plate- and microtitre plate-based assays had therefore not only been developed to identify 
higher levels of enzyme activity but also, unintentionally, to identify higher expression levels, 
as long as activity still remained. Fortunately, this was not a significant problem as only a small 
number of the selected variants did not show the expected activity enhancement. 
Development of a high-throughput screen to detect enhanced activity regardless of expression 
levels would need to involve some level of purification of the enzyme from the E. coli culture 
and quantification of the enzyme before measurement of the relative activity. Such an assay is 
likely to be more time-consuming and expensive than the assays used here. 
In Chapter 4, substrate concentrations were selected based on concentrations which are 
saturating for the WT enzyme (Section 4.5.2). However, as seen with the data for the glycerol 
oxidase (F194W/ W290F, Section 5.9), activity is enhanced to different extents at different 
substrate concentrations. For example, the enhancements in D-glucose activity were much less 
significant with 1 M than with 2 M D-glucose due to different effects of substrate 
concentration on WT and on the variants (Sections 4.5.2 and 5.3). Ideally, an appropriate 
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substrate concentration for the potential downstream application(s) of the variants would 
have been determined at the beginning of the project and only this concentration used in 
screening, confirmation of screening data, and subsequent characterisation. If 1 M substrate 
had been used for the measurements presented in Chapter 4, it is possible that a different 
selection of variants may have been taken forward. The different behaviour of the variants 
towards different substrate concentrations may reflect substrate/ product inhibition in some 
cases. Future exploration of this would be essential if the variants were to be developed for 
use in the biotechnology industry. 
6.4 Future directions 
6.4.1 Continuation of the project 
This project and the results displayed in this thesis could be improved in various ways. Further 
repeats of some of the measurements taken would increase the confidence in the conclusions 
drawn. For example the different activity measurements with the F194T single mutant are 
hard to interpret; repeating the data with freshly purified protein would rule out the possibility 
of contamination, for example with WT GO-N6M1. Within the timescale of the project, it was 
only possible to carry out the more comprehensive characterisations detailed in Chapter 5 
with some of the variants. It would be very interesting to complete this characterisation for all 
nine of the variants selected. For example different variants may show different 
regioselectivity. This seems particularly likely with the variants showing enhanced D-glucose 
activity, as addition of the methyl group at position C-1 had a significant effect on activity for 
some variants and not for others (Table 5.6) implying differences in binding of D-glucose within 
the active site. Identification of the product(s) of glycerol oxidation would also be a priority as 
the potential products have numerous industrial applications (Section 1.6.5.2). In order to 
confirm the assignments of chemical shifts in the oxidation of methyl β-D-arabinopyranoside, 
the predicted product could be generated by a different route and the 1H-NMR spectra 
compared. For example, chromium trioxide or ruthenium tetroxide could be used to oxidise 
methyl β-D-arabinopyranoside with protecting groups at the C-2 and C-3 hydroxyls; this would 
result in oxidation exclusively at the C-4 hydroxyl. Similar methods could also be used to aid in 
the assignments of chemical shifts for the other reactions. 
The identification of changes in the oxidative half reaction in some variants by measuring the 
effect on activity of increased or decreased oxygen concentrations is relatively qualitative data 
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as the oxygen concentration was not measured and may have shown some variation between 
different measurements. More complete characterisation of the effect of mutations on the 
oxidative half reaction could be carried out by determining the full oxygen kinetics for each 
variant, where possible, by measuring activity over a range of defined oxygen concentrations 
while keeping the concentration of sugar substrate (D-galactose/ D-arabinose/ D-xylose/ D-
glucose/ glycerol) constant. 
Unfortunately diffraction quality crystals of E. coli-expressed GO were not obtained in this 
project. Frustratingly, the available structures of GO mutants (Wilkinson et al., 2004, Rannes et 
al., 2011) did not provide any clear explanations for the observed changes in activity in this 
study. If this work is continued however, crystal structures will prove very useful in explaining 
the changes in activity: 
 The position of the introduced tryptophan residues at position 227 or 245 could not be 
modelled using COOT alone, as significant structural changes would be required to 
accommodate the large side chain. Crystal structures of F227X mutations would be 
particularly interesting to observe the effect on the copper environment and thioether 
bond which are very close to this residue in the structure.  
 Where it has not been possible to determine the regioselectivity by 1H-NMR, solution 
of the structure of an enzyme-substrate complex could provide this information, 
although no such structure has ever been published for GO, perhaps due to crystal 
packing constraints, but more likely due to the relatively low affinity of WT for all 
substrates. Variants displaying increased affinity for substrate may overcome this 
problem. In addition, the different space group observed in crystals of the E. coli-
expressed GO (Rannes et al., 2011) compared to that previously reported for GO (Ito et 
al., 1991), may permit entry of substrate into the active site of GO within the crystal 
(the E. coli-expressed GO crystallised in space group P6522 compared to space group 
C2 for previous structures (Ito et al., 1991)). 
 While the C383S mutation did not result in any major structural changes in the crystal 
structure (Wilkinson et al., 2004), introduction of a glutamate at this position is a more 
significant change as the residue is larger than cysteine or serine and also carries a 
negative charge. Solution of the crystal structure of the C383E mutant may reveal 
structural differences which could help explain the activity and substrate specificity 
changes induced upon introduction of this mutation. 
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Modelling studies similar to (Wachter and Branchaud, 1996) could also be carried out instead 
of, or in addition to, crystallisation studies. These studies may prove very useful as there have 
been significant advances in computing resources for molecular modelling since 1996 - 
significant additional information, such as long range interactions, can now be predicted much 
more easily. Information on regioselectivity and changes in substrate specificity determined 
here could be used to guide such studies. Changes in the secondary structure of the enzyme, 
and in the active site environment, brought about by the mutations could be identified by 
circular dichroism and UV/ vis spectroscopy (Section 1.6.3.1). 
Determining the mechanism by which the GO variants catalyse oxidation of the alternative 
substrates will require a significant amount of work, especially given the possibility that some 
mutations may have altered the catalytic mechanism (Sections 5.4.2 and 5.7). Determination 
of the mechanism would require several techniques, including the use of substrate analogues, 
analysis of the kinetic isotope effects (as carried out by (Whittaker et al., 1998)) or even 
following the reaction crystallographically, although such methods are still in relatively early 
stages of development (Pearson and Owen, 2009). 
Purification and characterisation of GO family members, such as glyoxal oxidase (Section 
1.6.1.3) and GO from other species (Section 5.2) would likely aid in the explanation of changes 
observed with the different mutations. It is also likely that family members may show different 
substrate specificities due to the different niches inhabited by the host organisms - this 
information could prove invaluable in design of future mutagenesis projects. 
6.4.2 Other potential directions 
As discussed earlier, the randomised oligonucleotides generated for this project can be used to 
generate a wide variety of further libraries. Screening could be carried out towards the same 
potential substrates used here, or also a range of others including different monosaccharides 
such as D-fructose, D-ribose or L-isomers of sugars; polysaccharides such as guar, already 
targeted by (Delagrave et al., 2001); or even biomarkers which could be developed for use in 
diagnostic assays. One of the original targets considered for this project was glycated albumin, 
a biomarker for hyperglycaemia in the blood of people suffering from diabetes. Glycation of 
serum proteins occurs under hyperglycaemic conditions and can alter protein function causing 
health problems such as atherosclerosis and retinopathy (Nathan, 1993). Detection of the level 
of glycation by mass spectrometry- and HPLC-based techniques is used in diagnosis of diabetes 
and in management of the condition (Barnaby et al., 2010, Frolov et al., 2006, Frolov and 
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Hoffmann, 2010). Development of a biosensor using a GO variant could provide a more rapid 
and cost-effective alternative. 
Generation of variants by less random approaches such as addition of specific mutations (i.e. 
C383S or W290F) into existing variants or combination of advantageous mutations from 
different libraries by methods such as DNA shuffling, detailed in Section 1.3.5, may also 
improve the activity and specificity of GO towards different substrates. Many variants were 
identified upon initial screening of Libraries E, L, M and N (Section 4.4) which, following 
confirmation of the enhanced activities, could be combined with the variants which were 
characterised in Chapter 5. Design and screening of mutant libraries in silico followed by 
confirmation of results in the laboratory could also lead to increased efficiency in finding 
variants with the desired activities. 
6.4.3 Potential future development of variants 
Unfortunately, as also observed by the Turner group (Rannes et al., 2011), the broad specificity 
of the GO variants identified thus far precludes their use in specific labelling of cell surface 
glycans. However, following further development, all of the variants have the potential for use 
as biocatalysts in chemical synthetic processes, generation of complex molecules and process 
monitoring as detailed in Section 1.6.5.2. Further development of the variants would have to 
consider the process they would be used in and the conditions they would be exposed to. As 
detailed in Section 1.3.8 these may include high substrate and product concentrations, specific 
pH and temperatures, the use of organic solvents and heterogeneity in the reaction conditions 
(Woodley, 2013). Different areas of the molecule than the active site would likely be also 
targeted to improve the already high stability of GO at different temperatures and resistance 
to solvents (Kelly-Falcoz et al., 1965). Libraries may be designed following analysis of sequence 
alignments (Jochens et al., 2010) and/ or using the B-FIT method (Reetz et al., 2006a) as 
detailed in Section 1.3.6. Many of the potential problems associated with traditional reaction 
conditions, such as product inhibition, are likely easily overcome by use of appropriate 
reaction vessels, such as batch stirred tank reactors, continuous stirred tank reactors or 
continuous packed bed reactors (Woodley, 2013). 
The pH optima of the variants can be determined by the targeted residues close to the active 
site, as shown in Section 5.6.3. Unfortunately it was only possible to measure the pH profile for 
activity towards D-glucose. However, all of the variants showing enhanced activity towards D-
glucose (double mutants and C383S single mutants) showed an increase in pH optimum 
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compared to WT. GO has been shown to also catalyse oxidation of alcohols to form the 
carboxylic acid as well as the aldehyde (Kelleher and Bhavanandan, 1986, Parikka and 
Tenkanen, 2009) which may lead to acidification of the reaction medium within the reaction 
vessel. Therefore, ideally the engineered variants should show better resistance to acidic 
conditions, although the current activities at low pH may be acceptable. Parikka and Tenkanen 
(2009) demonstrated that oxidation of D-galactose by WT GO can lead to formation of multiple 
products (Figure 6.1) and demonstrated that reaction conditions can be optimised to reduce 
formation of unwanted by-products. This will be important in developing an efficient process 
for use on larger scales. 
 
Figure 6.1. The different products which can be generated upon oxidation of D-galactose by 
GO 
Copied from Parikka and Tenkanen (2009). 
 
Another consideration in development of variants for industrial uses is the processivity, or 
residual rate of activity, of the enzyme, i.e. the number of times it will turnover before 
inactivation due to a number of possible factors. In the case of GO this is largely determined by 
the reaction conditions. For example, catalase is included here in the reaction mix to remove 
the hydrogen peroxide generated which has been shown to damage the enzyme, while the 
presence of an oxidising agent such as ferricyanide or HRP is essential to maintain GO in the 
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oxidised, active form. The relative quantities of these components may vary with different 
variants and substrates. 
 
Conclusions 
This work has contributed to the already significant area of research into the enzyme GO and 
further expanded and displayed its potential for biotechnological development. High 
throughput assays, already successfully used by other groups, have been improved by 
optimisation of a number of aspects. Mutant libraries were designed based on the wealth of 
information on the role of different residues within the GO structure and generated using high 
quality oligonucleotides to prevent the introduction of any sequence bias. The libraries were 
screened using the optimised assays and a number of variants identified with enhanced 
activity towards different substrates with potentially important applications in biotechnology. 
The most significant achievement is the identification of a variant displaying higher activity 
towards glycerol than towards D-galactose. Other noteworthy observations include the 
significant effect on glucose binding of mutations at position 194 and the regioselectivity for 
the C-4 hydroxyl of methyl β-D-arabinopyranoside displayed by some of the GO variants. The 
activities of the variants were characterised by a variety of methods to provide some 
understanding of the reaction catalysed as well as the optimal conditions under which the 
enzyme variants function. The variants, particularly the glycerol oxidase, show great promise 
for future development as valuable biocatalysts for the chemical synthesis and pharmaceutical 
industries and as tools in process monitoring. 
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